DiCE Clinical Trials Database

Patients undergoing treatment often ask about the possibility of enrolling in a clinical trial. A clinical trial is a scientific study. It tests new molecules in the hope that they are safe and more effective than current treatments.

This database is based on clinicaltrials.gov – a global clinical trials database of all diseases and all molecules in development worldwide. It is a shortened version of this, focusing on current clinical trials related to digestive cancers in Europe. The information is updated daily.

Important to remember: please always discuss with your treating physicians first your considerations of partaking in a clinical trial. They are the best judges of its benefits to your particular case.

NCT IDNameStudy typePhaseStatusCountryDisease typeMore infos
NCT00002692Intravenous Compared With Intrahepatic Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the LiverInterventionalPhase 3Unknown statusUnited KingdomColorectal CancerInfos
NCT00002692Intravenous Compared With Intrahepatic Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the LiverInterventionalPhase 3Unknown statusUnited KingdomMetastatic CancerInfos
NCT00002793Chemotherapy Via an Implantable Pump Compared With a Subcutaneous Port for Unresectable Liver Metastases in Patients With Resected Colorectal CancerInterventionalPhase 3Unknown statusGermanyColorectal CancerInfos
NCT00002793Chemotherapy Via an Implantable Pump Compared With a Subcutaneous Port for Unresectable Liver Metastases in Patients With Resected Colorectal CancerInterventionalPhase 3Unknown statusGermanyMetastatic CancerInfos
NCT00002884Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the EsophagusInterventionalPhase 3Unknown statusFranceEsophageal CancerInfos
NCT00002893Palliative Chemotherapy in Treating Patients With Advanced Colorectal CancerInterventionalPhase 3Unknown statusUnited KingdomColorectal CancerInfos
NCT00002896Radiation Therapy Plus Chemotherapy Before Surgery With or Without Chemotherapy After Surgery in Treating Patients With Rectal CancerInterventionalPhase 3Unknown statusItalyColorectal CancerInfos
NCT00003063Biological Therapy With Combination Chemotherapy in Patients With Colorectal CancerInterventionalPhase 3Unknown statusGreeceColorectal CancerInfos
NCT00003063Biological Therapy With Combination Chemotherapy in Patients With Colorectal CancerInterventionalPhase 3Unknown statusItalyColorectal CancerInfos
NCT00003260Combination Chemotherapy in Treating Patients With Recurrent Metastatic Colorectal CancerInterventionalPhase 3Unknown statusFranceColorectal CancerInfos
NCT00003617Chlorambucil Compared With No Further Therapy Following Anti-Helicobacter Therapy in Treating Patients With Low-Grade Lymphoma of the StomachInterventionalPhase 3Unknown statusPolandGastric CancerInfos
NCT00003617Chlorambucil Compared With No Further Therapy Following Anti-Helicobacter Therapy in Treating Patients With Low-Grade Lymphoma of the StomachInterventionalPhase 3Unknown statusSwitzerlandGastric CancerInfos
NCT00003617Chlorambucil Compared With No Further Therapy Following Anti-Helicobacter Therapy in Treating Patients With Low-Grade Lymphoma of the StomachInterventionalPhase 3Unknown statusUnited KingdomGastric CancerInfos
NCT00004115Monoclonal Antibody Therapy in Treating Patients With Ovarian Cancer or Primary Peritoneal Cancer in Remission Following Surgery and ChemotherapyInterventionalPhase 3Unknown statusUnited KingdomOvarian CancerInfos
NCT00004115Monoclonal Antibody Therapy in Treating Patients With Ovarian Cancer or Primary Peritoneal Cancer in Remission Following Surgery and ChemotherapyInterventionalPhase 3Unknown statusUnited KingdomPrimary Peritoneal Cavity CancerInfos
NCT00004236Liposomal Doxorubicin in Treating Patients With Advanced Stomach CancerInterventionalPhase 2Unknown statusUnited KingdomEsophageal CancerInfos
NCT00004236Liposomal Doxorubicin in Treating Patients With Advanced Stomach CancerInterventionalPhase 2Unknown statusUnited KingdomGastric CancerInfos
NCT00006112Fluorouracil With or Without Mitomycin in Treating Patients With Peritoneal CancerInterventionalPhase 2Unknown statusFranceCarcinoma of the AppendixInfos
NCT00006112Fluorouracil With or Without Mitomycin in Treating Patients With Peritoneal CancerInterventionalPhase 2Unknown statusFranceColorectal CancerInfos
NCT00006112Fluorouracil With or Without Mitomycin in Treating Patients With Peritoneal CancerInterventionalPhase 2Unknown statusFrancePrimary Peritoneal Cavity CancerInfos
NCT00006115Combination Chemotherapy in Treating Patients With Metastatic Colorectal CancerInterventionalPhase 2Unknown statusFranceColorectal CancerInfos
NCT00006117Gemcitabine and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerInterventionalPhase 2Unknown statusBelgiumPancreatic CancerInfos
NCT00006117Gemcitabine and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerInterventionalPhase 2Unknown statusFrancePancreatic CancerInfos
NCT00006468Comparing Two Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal CancerInterventionalPhase 3Unknown statusFranceColorectal CancerInfos
NCT00006479Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal CancerInterventionalPhase 3Unknown statusAustriaColorectal CancerInfos
NCT00006479Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal CancerInterventionalPhase 3Unknown statusAustriaMetastatic CancerInfos
NCT00006479Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal CancerInterventionalPhase 3Unknown statusBelgiumColorectal CancerInfos
NCT00006479Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal CancerInterventionalPhase 3Unknown statusBelgiumMetastatic CancerInfos
NCT00006479Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal CancerInterventionalPhase 3Unknown statusFranceColorectal CancerInfos
NCT00006479Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal CancerInterventionalPhase 3Unknown statusFranceMetastatic CancerInfos
NCT00006479Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal CancerInterventionalPhase 3Unknown statusGermanyColorectal CancerInfos
NCT00006479Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal CancerInterventionalPhase 3Unknown statusGermanyMetastatic CancerInfos
NCT00006479Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal CancerInterventionalPhase 3Unknown statusItalyColorectal CancerInfos
NCT00006479Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal CancerInterventionalPhase 3Unknown statusItalyMetastatic CancerInfos
NCT00006479Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal CancerInterventionalPhase 3Unknown statusNetherlandsColorectal CancerInfos
NCT00006479Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal CancerInterventionalPhase 3Unknown statusNetherlandsMetastatic CancerInfos
NCT00006479Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal CancerInterventionalPhase 3Unknown statusNorwayColorectal CancerInfos
NCT00006479Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal CancerInterventionalPhase 3Unknown statusNorwayMetastatic CancerInfos
NCT00006479Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal CancerInterventionalPhase 3Unknown statusPortugalColorectal CancerInfos
NCT00006479Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal CancerInterventionalPhase 3Unknown statusPortugalMetastatic CancerInfos
NCT00006479Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal CancerInterventionalPhase 3Unknown statusSwedenColorectal CancerInfos
NCT00006479Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal CancerInterventionalPhase 3Unknown statusSwedenMetastatic CancerInfos
NCT00006479Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal CancerInterventionalPhase 3Unknown statusUnited KingdomColorectal CancerInfos
NCT00006479Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal CancerInterventionalPhase 3Unknown statusUnited KingdomMetastatic CancerInfos
NCT00007826Monoclonal Antibody Therapy and/or Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Colorectal CancerInterventionalPhase 1/Phase 2Unknown statusUnited KingdomColorectal CancerInfos
NCT00008047Combination Chemotherapy Combined With Radiation Therapy in Treating Patients Who Have Stage II or Stage III Cancer of the EsophagusInterventionalPhase 1/Phase 2Unknown statusFranceEsophageal CancerInfos
NCT00010062Fluorouracil Plus Radiation Therapy Following Surgery in Treating Patients With Pancreatic CancerInterventionalPhase 2Unknown statusFrancePancreatic CancerInfos
NCT00010062Fluorouracil Plus Radiation Therapy Following Surgery in Treating Patients With Pancreatic CancerInterventionalPhase 2Unknown statusLuxembourgPancreatic CancerInfos
NCT00010088Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas or Bile DuctInterventionalPhase 2Unknown statusFrancePancreatic CancerInfos
NCT00010088Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas or Bile DuctInterventionalPhase 2Unknown statusLuxembourgPancreatic CancerInfos
NCT00010270LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal CancerInterventionalPhase 1Unknown statusGermanyColorectal CancerInfos
NCT00010270LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal CancerInterventionalPhase 1Unknown statusGermanyEsophageal CancerInfos
NCT00010270LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal CancerInterventionalPhase 1Unknown statusGermanyGastric CancerInfos
NCT00010270LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal CancerInterventionalPhase 1Unknown statusGermanyPancreatic CancerInfos
NCT00024375DHA-Paclitaxel in Treating Patients With Metastatic Pancreatic CancerInterventionalPhase 2Unknown statusGermanyPancreatic CancerInfos
NCT00024375DHA-Paclitaxel in Treating Patients With Metastatic Pancreatic CancerInterventionalPhase 2Unknown statusNetherlandsPancreatic CancerInfos
NCT00024375DHA-Paclitaxel in Treating Patients With Metastatic Pancreatic CancerInterventionalPhase 2Unknown statusUnited KingdomPancreatic CancerInfos
NCT00033319Aspirin and/or Folic Acid in Preventing Recurrent Colorectal PolypsInterventionalNot ApplicableUnknown statusUnited KingdomColorectal CancerInfos
NCT00041262Combination Chemotherapy in Treating Patients With Esophageal CancerInterventionalPhase 3Unknown statusUnited KingdomEsophageal CancerInfos
NCT00045461Combination Chemotherapy With or Without Whole-Body Hyperthermia in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal CancerInterventionalPhase 2/Phase 3Unknown statusGermanyFallopian Tube CancerInfos
NCT00045461Combination Chemotherapy With or Without Whole-Body Hyperthermia in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal CancerInterventionalPhase 2/Phase 3Unknown statusGermanyOvarian CancerInfos
NCT00045461Combination Chemotherapy With or Without Whole-Body Hyperthermia in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal CancerInterventionalPhase 2/Phase 3Unknown statusGermanyPrimary Peritoneal Cavity CancerInfos
NCT00045461Combination Chemotherapy With or Without Whole-Body Hyperthermia in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal CancerInterventionalPhase 2/Phase 3Unknown statusHungaryFallopian Tube CancerInfos
NCT00045461Combination Chemotherapy With or Without Whole-Body Hyperthermia in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal CancerInterventionalPhase 2/Phase 3Unknown statusHungaryOvarian CancerInfos
NCT00045461Combination Chemotherapy With or Without Whole-Body Hyperthermia in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal CancerInterventionalPhase 2/Phase 3Unknown statusHungaryPrimary Peritoneal Cavity CancerInfos
NCT00045461Combination Chemotherapy With or Without Whole-Body Hyperthermia in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal CancerInterventionalPhase 2/Phase 3Unknown statusNetherlandsFallopian Tube CancerInfos
NCT00045461Combination Chemotherapy With or Without Whole-Body Hyperthermia in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal CancerInterventionalPhase 2/Phase 3Unknown statusNetherlandsOvarian CancerInfos
NCT00045461Combination Chemotherapy With or Without Whole-Body Hyperthermia in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal CancerInterventionalPhase 2/Phase 3Unknown statusNetherlandsPrimary Peritoneal Cavity CancerInfos
NCT00046995Combination Chemotherapy in Treating Patients With Colon CancerInterventionalPhase 3Unknown statusBelgiumColorectal CancerInfos
NCT00070005J-Pouch Coloanal Anastomosis Compared With Side-to-End Coloanal Anastomosis After Radiation Therapy and Surgery to Remove the Rectum in Treating Patients With Rectal AdenocarcinomaInterventionalPhase 3Unknown statusNetherlandsColorectal CancerInfos
NCT00072553Celecoxib, Leucovorin, Fluorouracil, and Oxaliplatin in Treating Patients With Metastatic Colorectal CancerInterventionalPhase 2Unknown statusFranceColorectal CancerInfos
NCT00075452Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Unresectable Pancreatic AdenocarcinomaInterventionalPhase 3Unknown statusFrancePancreatic CancerInfos
NCT00075465Docetaxel and Epirubicin as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Adenocarcinoma of the StomachInterventionalPhase 2Unknown statusFranceGastric CancerInfos
NCT00075556Neoadjuvant Radiation Therapy and Capecitabine in Treating Patients With Stage III or Stage IV Colorectal AdenocarcinomaInterventionalPhase 2Unknown statusFranceColorectal CancerInfos
NCT00075595Fluorouracil, Leucovorin, and Irinotecan in Treating Patients With Recurrent or Refractory Metastatic Unresectable Colorectal CancerInterventionalPhase 2Unknown statusFranceColorectal CancerInfos
NCT00075738Fluorouracil, Irinotecan, Leucovorin, and Cisplatin as First-Line Therapy in Treating Patients With Metastatic Esophageal CancerInterventionalPhase 2Unknown statusFranceEsophageal CancerInfos
NCT00077389Intensive Neoadjuvant Chemotherapy in Treating Young Patients Undergoing Surgical Resection for High-Risk HepatoblastomaInterventionalPhase 2Unknown statusFranceLiver CancerInfos
NCT00077389Intensive Neoadjuvant Chemotherapy in Treating Young Patients Undergoing Surgical Resection for High-Risk HepatoblastomaInterventionalPhase 2Unknown statusIrelandLiver CancerInfos
NCT00077389Intensive Neoadjuvant Chemotherapy in Treating Young Patients Undergoing Surgical Resection for High-Risk HepatoblastomaInterventionalPhase 2Unknown statusNetherlandsLiver CancerInfos
NCT00077389Intensive Neoadjuvant Chemotherapy in Treating Young Patients Undergoing Surgical Resection for High-Risk HepatoblastomaInterventionalPhase 2Unknown statusUnited KingdomLiver CancerInfos
NCT00079027Doxorubicin By Infusion or Chemoembolization in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer)InterventionalPhase 3Unknown statusUnited KingdomLiver CancerInfos
NCT00091312Fluorouracil and Irinotecan With or Without Leucovorin Compared With Observation in Treating Patients Who Have Undergone Surgery for Stage II Colon CancerInterventionalPhase 3Unknown statusFranceColorectal CancerInfos
NCT00091312Fluorouracil and Irinotecan With or Without Leucovorin Compared With Observation in Treating Patients Who Have Undergone Surgery for Stage II Colon CancerInterventionalPhase 3Unknown statusGermanyColorectal CancerInfos
NCT00091312Fluorouracil and Irinotecan With or Without Leucovorin Compared With Observation in Treating Patients Who Have Undergone Surgery for Stage II Colon CancerInterventionalPhase 3Unknown statusItalyColorectal CancerInfos
NCT00091312Fluorouracil and Irinotecan With or Without Leucovorin Compared With Observation in Treating Patients Who Have Undergone Surgery for Stage II Colon CancerInterventionalPhase 3Unknown statusPortugalColorectal CancerInfos
NCT00091312Fluorouracil and Irinotecan With or Without Leucovorin Compared With Observation in Treating Patients Who Have Undergone Surgery for Stage II Colon CancerInterventionalPhase 3Unknown statusSpainColorectal CancerInfos
NCT00108875Survivin Peptide Vaccination for Patients With Advanced Melanoma, Pancreatic, Colon and Cervical CancerInterventionalPhase 1/Phase 2Unknown statusGermanyColon CancerInfos
NCT00108875Survivin Peptide Vaccination for Patients With Advanced Melanoma, Pancreatic, Colon and Cervical CancerInterventionalPhase 1/Phase 2Unknown statusGermanyPancreatic CancerInfos
NCT00114829Preoperative Assessment of Colon TumorInterventionalPhase 4Unknown statusDenmarkColorectal CancerInfos
NCT00119912NORCCAP: Norwegian Colorectal Cancer Prevention TrialInterventionalNot ApplicableActive but recruitment closedNorwayAdenomaInfos
NCT00119912NORCCAP: Norwegian Colorectal Cancer Prevention TrialInterventionalNot ApplicableActive but recruitment closedNorwayColorectal CancerInfos
NCT00121914Treatment of Hepatocellular Carcinoma: Long-Acting Somatostatin Plus Percutaneous Ethanol Instillation (PEI) Versus Long-Acting Somatostatin AloneInterventionalPhase 3Unknown statusAustriaCarcinoma, HepatocellularInfos
NCT00134758Ursodeoxycholic Acid in the Treatment of Duodenal Adenomas in Familial Adenomatous Polyposis (FAP) PatientsInterventionalPhase 2/Phase 3Unknown statusFranceAdenomatous Polyposis Coli, FamilialInfos
NCT00141466Implementation of a New Strategy to Identify HNPCC PatientsInterventionalNot ApplicableUnknown statusNetherlandsHereditary Nonpolyposis Colorectal CancerInfos
NCT00162669Bevacizumab in Advanced Hepatocellular CarcinomaInterventionalPhase 2Unknown statusFranceHepatocellular CarcinomaInfos
NCT00182715Combination Chemotherapy With or Without Cetuximab as First-Line Therapy in Treating Patients With Metastatic Colorectal CancerInterventionalPhase 3Unknown statusIrelandColorectal CancerInfos
NCT00182715Combination Chemotherapy With or Without Cetuximab as First-Line Therapy in Treating Patients With Metastatic Colorectal CancerInterventionalPhase 3Unknown statusUnited KingdomColorectal CancerInfos
NCT00188110Performance of the Water-Enema Computed Tomography (WE-CT)InterventionalNot ApplicableUnknown statusFranceColon CancerInfos
NCT00189683Xeloda Vs Monitoring in Advanced Colorectal Cancer Responsive to ChemotherapyInterventionalPhase 3Unknown statusFranceColorectal CancerInfos
NCT00215722XELOX Plus Cetuximab as First-Line Therapy in Patients With Metastatic Colorectal CancerInterventionalPhase 2Unknown statusPortugalColorectal CarcinomaInfos
NCT00220077Determination of the Role of Microarray for Prognosis and Prediction to Chemotherapy Sensitivity in Patients With Operable, Locally Advanced and Metastatic Oesophageal CancerInterventionalNot ApplicableUnknown statusUnited KingdomOesophageal CancerInfos
NCT00220246Clinical and Molecular Characterization of Familial Microsatellite Stable Colorectal CancerObservationalN/AUnknown statusNetherlandsColorectal NeoplasmsInfos
NCT00225641Assessment of Frequency of Surveillance After Curative Resection in Patients With Stage II and III Colorectal CancerInterventionalNot ApplicableUnknown statusDenmarkColorectal CancerInfos
NCT00250328Evaluation of NiTi Laparoscopic Compression Anastomosis Clip (LapCAC) Device for Intra-Corporeal Lap-ColectomyInterventionalPhase 1Unknown statusIsraelColon CancerInfos
NCT00253812Adenoma Detection Rate:NBI, AFI, Chromoscopic or Standard EndoscopyInterventionalNot ApplicableUnknown statusUnited KingdomFamilial Adenomatous PolyposisInfos
NCT00259532Three New Methods for Diagnosing Pancreas CancerInterventionalNot ApplicableUnknown statusDenmarkPancreas CancerInfos
NCT00268411Gemcitabine and Oxaliplatin in Treating Patients With Metastatic Pancreatic CancerInterventionalPhase 3Unknown statusFrancePancreatic CancerInfos
NCT00274872Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By SurgeryInterventionalPhase 2/Phase 3Unknown statusFranceColorectal CancerInfos
NCT00274885Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal CancerInterventionalPhase 4Unknown statusFranceCancerInfos
NCT00275119Gemcitabine and Oxaliplatin Followed By Radiation Therapy, Fluorouracil, and Oxaliplatin in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By SurgeryInterventionalPhase 2Unknown statusFrancePancreatic CancerInfos
NCT00276705Combination Chemotherapy and Thalidomide in Treating Younger Patients Undergoing Surgery For Newly Diagnosed Liver CancerInterventionalPhase 2Unknown statusIrelandLiver CancerInfos
NCT00276705Combination Chemotherapy and Thalidomide in Treating Younger Patients Undergoing Surgery For Newly Diagnosed Liver CancerInterventionalPhase 2Unknown statusUnited KingdomLiver CancerInfos
NCT00287976Irinotecan in Treating Young Patients With Refractory or Recurrent HepatoblastomaInterventionalPhase 2Unknown statusIrelandLiver CancerInfos
NCT00287976Irinotecan in Treating Young Patients With Refractory or Recurrent HepatoblastomaInterventionalPhase 2Unknown statusNetherlandsLiver CancerInfos
NCT00287976Irinotecan in Treating Young Patients With Refractory or Recurrent HepatoblastomaInterventionalPhase 2Unknown statusUnited KingdomLiver CancerInfos
NCT00299299Modelling Internal Hepatic Movement With an External Abdominal MarkerObservationalN/AUnknown statusUnited KingdomPatients With Liver Metastases From Colorectal CancerInfos
NCT00303745Irinotecan With or Without Capecitabine as Second-Line Therapy in Treating Older Patients With Progressive, Metastatic Colorectal Cancer That Cannot Be Removed By SurgeryInterventionalPhase 2Unknown statusFranceColorectal CancerInfos
NCT00305838CA 125 Levels in Treating Patients With Relapsed Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Who Are Receiving TamoxifenInterventionalPhase 2Unknown statusUnited KingdomFallopian Tube CancerInfos
NCT00305838CA 125 Levels in Treating Patients With Relapsed Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Who Are Receiving TamoxifenInterventionalPhase 2Unknown statusUnited KingdomOvarian CancerInfos
NCT00305838CA 125 Levels in Treating Patients With Relapsed Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Who Are Receiving TamoxifenInterventionalPhase 2Unknown statusUnited KingdomPrimary Peritoneal Cavity CancerInfos
NCT00319007Influence of Sulindac and Probiotics on the Development of Pouch Adenomas in Patients With Familial Adenomatous PolyposisInterventionalPhase 2Unknown statusNetherlandsAdenomatous Polyposis ColiInfos
NCT0034628132P BioSiliconTM in Addition to Gemcitabine in Pancreatic CancerInterventionalPhase 2Unknown statusUnited KingdomPancreatic CancerInfos
NCT00356161HAI Via Interventionally Implanted Port Catheter SystemsInterventionalPhase 2Unknown statusGermanyColorectal CancerInfos
NCT00356161HAI Via Interventionally Implanted Port Catheter SystemsInterventionalPhase 2Unknown statusGermanyHepatocellular CarcinomaInfos
NCT00357682A Phase III, Randomized, Study of Aspirin and Esomeprazole Chemoprevention in Barrett's MetaplasiaInterventionalPhase 3Unknown statusUnited KingdomEsophageal CancerInfos
NCT00383695Oxaliplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients Undergoing Surgery for High-Risk Rectal CancerInterventionalPhase 2Unknown statusSpainColorectal CancerInfos
NCT00383695Oxaliplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients Undergoing Surgery for High-Risk Rectal CancerInterventionalPhase 2Unknown statusSwedenColorectal CancerInfos
NCT00383695Oxaliplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients Undergoing Surgery for High-Risk Rectal CancerInterventionalPhase 2Unknown statusUnited KingdomColorectal CancerInfos
NCT00392470Radiation Therapy, Irinotecan, and Cetuximab in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Rectal CancerInterventionalPhase 1Unknown statusSwitzerlandColorectal CancerInfos
NCT00407186Randomized Phase III Trial of Adjuvant Chemotherapy or Chemoradiotherapy in Resectable Gastric Cancer (CRITICS)InterventionalPhase 3Active but recruitment closedNetherlandsGastric CancerInfos
NCT00411112Sentinel Node in Colon CancerInterventionalNot ApplicableUnknown statusFranceColon CancerInfos
NCT00420394Perioperative Chemoradiotherapy for Potentially Resectable Gastric CancerInterventionalPhase 2Unknown statusIsraelStomach NeoplasmsInfos
NCT00425425Cetuximab, Oxaliplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Esophageal CancerInterventionalPhase 1/Phase 2Unknown statusGermanyEsophageal CancerInfos
NCT004339275-FU, Folinic Acid and Irinotecan (FOLFIRI) Plus Cetuximab Versus FOLFIRI Plus Bevacizumab in First Line Treatment Colorectal Cancer (CRC)InterventionalPhase 3Unknown statusGermanyColorectal CancerInfos
NCT004339275-FU, Folinic Acid and Irinotecan (FOLFIRI) Plus Cetuximab Versus FOLFIRI Plus Bevacizumab in First Line Treatment Colorectal Cancer (CRC)InterventionalPhase 3Unknown statusGermanyNeoplasm MetastasisInfos
NCT00435097Computer Assisted Early Detection of Liver Metastases From fMRI MapsObservationalN/AUnknown statusIsraelMetastatic Colorectal CancerInfos
NCT00438737Cetuximab, Leucovorin, Oxaliplatin, and Fluorouracil With or Without Bevacizumab in Treating Patients With Resectable Liver Metastases From Colorectal CancerInterventionalPhase 2Unknown statusFranceColorectal CancerInfos
NCT00438737Cetuximab, Leucovorin, Oxaliplatin, and Fluorouracil With or Without Bevacizumab in Treating Patients With Resectable Liver Metastases From Colorectal CancerInterventionalPhase 2Unknown statusFranceMetastatic CancerInfos
NCT00440167Capecitabine/Erlotinib Followed of Gemcitabine Versus Gemcitabine/Erlotinib Followed of CapecitabineInterventionalPhase 3Unknown statusGermanyPancreatic CancerInfos
NCT00442637Maintenance Treatment Versus Observation After Induction in Advanced Colorectal CarcinomaInterventionalPhase 3Unknown statusNetherlandsColorectal Cancer MetastaticInfos
NCT00450203Chemotherapy With or Without Bevacizumab or Lapatinib to Treat Operable Oesophagogastric CancerInterventionalPhase 2/Phase 3Unknown statusUnited KingdomOesophagogastric CancerInfos
NCT00450788Esophageal Cancer in Northeastern IranObservationalN/AActive but recruitment closedFranceEsophageal CancerInfos
NCT00450788Esophageal Cancer in Northeastern IranObservationalN/AActive but recruitment closedFranceGI DiseaseInfos
NCT00468416Evaluation of NiTi Shape Memory End-to-End Compression Anastomosis Ring (CAR) for Compression Anastomosis in Anterior ResectionInterventionalPhase 2Unknown statusIsraelColorectal CancerInfos
NCT00474734Intravascular Ultrasound for Hepatocellular Carcinoma StagingObservationalN/AUnknown statusSwitzerlandHepatocellular CarcinomaInfos
NCT00478946A Study of Picoplatin in Colorectal CancerInterventionalPhase 1/Phase 2Unknown statusRussian FederationColorectal CancerInfos
NCT00482222Combination Chemotherapy With or Without Cetuximab Before and After Surgery in Treating Patients With Resectable Liver Metastases Caused By Colorectal CancerInterventionalPhase 3Unknown statusUnited KingdomColorectal CancerInfos
NCT00482222Combination Chemotherapy With or Without Cetuximab Before and After Surgery in Treating Patients With Resectable Liver Metastases Caused By Colorectal CancerInterventionalPhase 3Unknown statusUnited KingdomMetastatic CancerInfos
NCT00486460Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Advance or Inoperable Pancreatic CancerInterventionalPhase 3Unknown statusIsraelPancreatic CancerInfos
NCT00509561Cisplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients With Esophageal CancerInterventionalPhase 2/Phase 3Unknown statusUnited KingdomEsophageal CancerInfos
NCT00513266Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by SurgeryInterventionalPhase 2Unknown statusSwitzerlandColorectal CancerInfos
NCT00513266Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by SurgeryInterventionalPhase 2Unknown statusSwitzerlandMetastatic CancerInfos
NCT00514930Multicentre Prospective Clinical Trial for RFA Tumour Aspirator Treatment of Primary and Secondary Malignancies of the LiverInterventionalPhase 1/Phase 2Unknown statusGreeceLiver CancerInfos
NCT00516347Studying Genes for Barrett's Esophagus in Brothers and SistersObservationalN/AUnknown statusUnited KingdomEsophageal CancerInfos
NCT00541021Gemcitabine With or Without Sorafenib in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerInterventionalPhase 3Unknown statusFrancePancreatic CancerInfos
NCT00544011Bevacizumab and Combination Chemotherapy in Treating Patients With Metastatic Colorectal CancerInterventionalPhase 2Unknown statusFranceColorectal CancerInfos
NCT00551057Expression of Inflammatory Proteins in Pancreatic CancerObservationalN/AUnknown statusSwitzerlandPancreatic NeoplasmsInfos
NCT00559858Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine for Advanced Colorectal Cancer or Breast CancerInterventionalPhase 3Unknown statusUnited KingdomBreast CancerInfos
NCT00559858Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine for Advanced Colorectal Cancer or Breast CancerInterventionalPhase 3Unknown statusUnited KingdomColorectal CancerInfos
NCT00559858Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine for Advanced Colorectal Cancer or Breast CancerInterventionalPhase 3Unknown statusUnited KingdomPalmar-plantar ErythrodysesthesiaInfos
NCT00560365Follow-Up Study of Patients Who Have Undergone Surgery for Stage I, Stage II, or Stage III Colorectal CancerObservationalN/AUnknown statusUnited KingdomColorectal CancerInfos
NCT00582257Early Onset and Familial Gastric Cancer RegistryObservationalN/AActive but recruitment closedIsraelGastric CancerInfos
NCT00628368Biological Factors in Predicting Response to Treatment in Patients With Esophageal Cancer or Rectal CancerInterventionalNot ApplicableUnknown statusFranceColorectal CancerInfos
NCT00628368Biological Factors in Predicting Response to Treatment in Patients With Esophageal Cancer or Rectal CancerInterventionalNot ApplicableUnknown statusFranceEsophageal CancerInfos
NCT00647530Fluorouracil and Oxaliplatin With or Without Panitumumab In Treating Patients With High-Risk Colon Cancer That Can Be Removed by SurgeryInterventionalPhase 2/Phase 3Unknown statusUnited KingdomColorectal CancerInfos
NCT00669370Biweekly Docetaxel in Combination With Capecitabine as First-Line Treatment in Patients With Advanced Gastric CancerInterventionalPhase 2Unknown statusFinlandStomach NeoplasmsInfos
NCT00680901LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus LapatinibInterventionalPhase 3Active but recruitment closedEstoniaNeoplasms, Gastrointestinal TractInfos
NCT00680901LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus LapatinibInterventionalPhase 3Active but recruitment closedHungaryNeoplasms, Gastrointestinal TractInfos
NCT00680901LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus LapatinibInterventionalPhase 3Active but recruitment closedIsraelNeoplasms, Gastrointestinal TractInfos
NCT00680901LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus LapatinibInterventionalPhase 3Active but recruitment closedItalyNeoplasms, Gastrointestinal TractInfos
NCT00680901LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus LapatinibInterventionalPhase 3Active but recruitment closedNetherlandsNeoplasms, Gastrointestinal TractInfos
NCT00680901LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus LapatinibInterventionalPhase 3Active but recruitment closedPolandNeoplasms, Gastrointestinal TractInfos
NCT00680901LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus LapatinibInterventionalPhase 3Active but recruitment closedRussian FederationNeoplasms, Gastrointestinal TractInfos
NCT00680901LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus LapatinibInterventionalPhase 3Active but recruitment closedTurkeyNeoplasms, Gastrointestinal TractInfos
NCT00680901LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus LapatinibInterventionalPhase 3Active but recruitment closedUkraineNeoplasms, Gastrointestinal TractInfos
NCT00690300Docetaxel Plus Oxaliplatin as Therapy in Patients With Pancreatic CancerInterventionalPhase 2Unknown statusGermanyPancreas NeoplasmsInfos
NCT00693290Improving Outcomes for Patients Requiring Oral Bowel Preparation for ColonoscopyInterventionalNot ApplicableUnknown statusUnited KingdomColorectal CancerInfos
NCT00710632Screening to Predict Weight Loss in Patients With CancerInterventionalNot ApplicableUnknown statusUnited KingdomGastrointestinal CancerInfos
NCT00722228Autologous and Allogeneic Whole Cell Cancer Vaccine for Metastatic TumorsInterventionalPhase 1/Phase 2Unknown statusIsraelColorectal CancerInfos
NCT00722228Autologous and Allogeneic Whole Cell Cancer Vaccine for Metastatic TumorsInterventionalPhase 1/Phase 2Unknown statusIsraelGastric CancerInfos
NCT00756509Treatment of Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumors in First Line With NilotinibInterventionalPhase 4Active but recruitment closedFinlandGastrointestinal Stromal TumorsInfos
NCT00756509Treatment of Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumors in First Line With NilotinibInterventionalPhase 4Active but recruitment closedFranceGastrointestinal Stromal TumorsInfos
NCT00756509Treatment of Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumors in First Line With NilotinibInterventionalPhase 4Active but recruitment closedGermanyGastrointestinal Stromal TumorsInfos
NCT00756509Treatment of Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumors in First Line With NilotinibInterventionalPhase 4Active but recruitment closedItalyGastrointestinal Stromal TumorsInfos
NCT00756509Treatment of Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumors in First Line With NilotinibInterventionalPhase 4Active but recruitment closedSpainGastrointestinal Stromal TumorsInfos
NCT00757614Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United KingdomObservationalN/AUnknown statusUnited KingdomEsophageal CancerInfos
NCT00757614Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United KingdomObservationalN/AUnknown statusUnited KingdomPancreatic CancerInfos
NCT00757965Study of Genes and the Environment in Patients With Colorectal Cancer in the East Anglia Region of the United KingdomObservationalN/AUnknown statusUnited KingdomColorectal CancerInfos
NCT00758381Metastatic Advanced Pancreas SorafenibInterventionalPhase 2Unknown statusItalyLocally Advanced Pancreatic CancerInfos
NCT00777478Capiri-sutent Phase-1 in Advanced Colo-rectal CancerInterventionalPhase 1Unknown statusNetherlandsColorectal CancerInfos
NCT00777504Study to the Optimal Duration of Therapy With Oral Angiogenesis InhibitorsInterventionalPhase 4Unknown statusNetherlandsGastrointestinal Stromal TumorInfos
NCT00790140Trial of Enteral Nutrition Enriched With Eicosapentaenoic Acid (EPA) in Upper Gastrointestinal Cancer SurgeryInterventionalPhase 4Unknown statusIrelandEsophageal CancerInfos
NCT00797251Anatomical Right Posterior Sectionectomy of the Liver by IOUS-Guided Finger CompressionObservationalN/AUnknown statusItalyHepatocellular CarcinomaInfos
NCT00797485Bevacizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Metastatic Colorectal Cancer That Cannot Be Removed By SurgeryInterventionalPhase 3Unknown statusItalyColorectal CancerInfos
NCT00813696Gemcitabine or Gemcitabine and Cisplatin in the Treatment of Advanced Pancreatic CancerInterventionalPhase 3Unknown statusItalyPancreatic CancerInfos
NCT00819208Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon CancerInterventionalNot ApplicableRecruitment openFranceAnxiety DisorderInfos
NCT00819208Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon CancerInterventionalNot ApplicableRecruitment openFranceCognitive/Functional EffectsInfos
NCT00819208Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon CancerInterventionalNot ApplicableRecruitment openFranceColorectal CancerInfos
NCT00819208Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon CancerInterventionalNot ApplicableRecruitment openFranceDepressionInfos
NCT00819208Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon CancerInterventionalNot ApplicableRecruitment openFranceExcerciseInfos
NCT00819208Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon CancerInterventionalNot ApplicableRecruitment openFranceFatigueInfos
NCT00819208Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon CancerInterventionalNot ApplicableRecruitment openFrancePsychosocial Effects of Cancer and Its TreatmentInfos
NCT00819208Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon CancerInterventionalNot ApplicableRecruitment openFranceSleep DisordersInfos
NCT00819208Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon CancerInterventionalNot ApplicableRecruitment openUnited KingdomAnxiety DisorderInfos
NCT00819208Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon CancerInterventionalNot ApplicableRecruitment openUnited KingdomCognitive/Functional EffectsInfos
NCT00819208Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon CancerInterventionalNot ApplicableRecruitment openUnited KingdomColorectal CancerInfos
NCT00819208Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon CancerInterventionalNot ApplicableRecruitment openUnited KingdomDepressionInfos
NCT00819208Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon CancerInterventionalNot ApplicableRecruitment openUnited KingdomExcerciseInfos
NCT00819208Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon CancerInterventionalNot ApplicableRecruitment openUnited KingdomFatigueInfos
NCT00819208Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon CancerInterventionalNot ApplicableRecruitment openUnited KingdomPsychosocial Effects of Cancer and Its TreatmentInfos
NCT00819208Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon CancerInterventionalNot ApplicableRecruitment openUnited KingdomSleep DisordersInfos
NCT00821912TaxXel: Taxotere and Xeloda in Esophageal CancerInterventionalPhase 1/Phase 2Unknown statusNorwayCancer of the EsophagusInfos
NCT00821912TaxXel: Taxotere and Xeloda in Esophageal CancerInterventionalPhase 1/Phase 2Unknown statusNorwayGastric Cardia CarcinomaInfos
NCT00821912TaxXel: Taxotere and Xeloda in Esophageal CancerInterventionalPhase 1/Phase 2Unknown statusSwedenCancer of the EsophagusInfos
NCT00821912TaxXel: Taxotere and Xeloda in Esophageal CancerInterventionalPhase 1/Phase 2Unknown statusSwedenGastric Cardia CarcinomaInfos
NCT00825110SS-GCC1- Screening Study of Genetic Changes in Colorectal CancerObservationalN/AUnknown statusUnited KingdomColorectal CancerInfos
NCT00838656Two Different Schedules of Carboplatin, Paclitaxel, Gemcitabine, and Surgery in Treating Patients With Newly Diagnosed Stage IIIC or Stage IV Primary Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerInterventionalPhase 2Unknown statusUnited KingdomFallopian Tube CancerInfos
NCT00838656Two Different Schedules of Carboplatin, Paclitaxel, Gemcitabine, and Surgery in Treating Patients With Newly Diagnosed Stage IIIC or Stage IV Primary Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerInterventionalPhase 2Unknown statusUnited KingdomOvarian CancerInfos
NCT00838656Two Different Schedules of Carboplatin, Paclitaxel, Gemcitabine, and Surgery in Treating Patients With Newly Diagnosed Stage IIIC or Stage IV Primary Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerInterventionalPhase 2Unknown statusUnited KingdomPrimary Peritoneal Cavity CancerInfos
NCT00845884Phase I/II Study of Weekly Docetaxel and Cisplatin Together With Capecitabine and Bevacizumab in Advanced Gastric CancerInterventionalPhase 1/Phase 2Unknown statusIsraelAdvanced Gastric CancerInfos
NCT00848952Performance of Imaging for the Diagnosis of Small Hepatocellular Carcinoma (< 3 cm)on CirrhosisInterventionalNot ApplicableUnknown statusFranceHepatocellular CarcinomaInfos
NCT00852228Optimal Control of Liver Metastases From Colorectal Cancer With Cetuximab and Hepatic Artery Infusion of ChemotherapyInterventionalPhase 2Unknown statusBelgiumHepatic LesionsInfos
NCT00852228Optimal Control of Liver Metastases From Colorectal Cancer With Cetuximab and Hepatic Artery Infusion of ChemotherapyInterventionalPhase 2Unknown statusBelgiumLiver MetastasesInfos
NCT00852228Optimal Control of Liver Metastases From Colorectal Cancer With Cetuximab and Hepatic Artery Infusion of ChemotherapyInterventionalPhase 2Unknown statusBelgiumMetastatic Colorectal CancerInfos
NCT00852228Optimal Control of Liver Metastases From Colorectal Cancer With Cetuximab and Hepatic Artery Infusion of ChemotherapyInterventionalPhase 2Unknown statusFranceHepatic LesionsInfos
NCT00852228Optimal Control of Liver Metastases From Colorectal Cancer With Cetuximab and Hepatic Artery Infusion of ChemotherapyInterventionalPhase 2Unknown statusFranceLiver MetastasesInfos
NCT00852228Optimal Control of Liver Metastases From Colorectal Cancer With Cetuximab and Hepatic Artery Infusion of ChemotherapyInterventionalPhase 2Unknown statusFranceMetastatic Colorectal CancerInfos
NCT00852228Optimal Control of Liver Metastases From Colorectal Cancer With Cetuximab and Hepatic Artery Infusion of ChemotherapyInterventionalPhase 2Unknown statusItalyHepatic LesionsInfos
NCT00852228Optimal Control of Liver Metastases From Colorectal Cancer With Cetuximab and Hepatic Artery Infusion of ChemotherapyInterventionalPhase 2Unknown statusItalyLiver MetastasesInfos
NCT00852228Optimal Control of Liver Metastases From Colorectal Cancer With Cetuximab and Hepatic Artery Infusion of ChemotherapyInterventionalPhase 2Unknown statusItalyMetastatic Colorectal CancerInfos
NCT00852228Optimal Control of Liver Metastases From Colorectal Cancer With Cetuximab and Hepatic Artery Infusion of ChemotherapyInterventionalPhase 2Unknown statusPortugalHepatic LesionsInfos
NCT00852228Optimal Control of Liver Metastases From Colorectal Cancer With Cetuximab and Hepatic Artery Infusion of ChemotherapyInterventionalPhase 2Unknown statusPortugalLiver MetastasesInfos
NCT00852228Optimal Control of Liver Metastases From Colorectal Cancer With Cetuximab and Hepatic Artery Infusion of ChemotherapyInterventionalPhase 2Unknown statusPortugalMetastatic Colorectal CancerInfos
NCT00860691Double Blinded Randomized Clinical Trial of the Effect of Open Versus Laparoscopic Colectomy on Neutrophils in Patients With Colon CancerInterventionalNot ApplicableUnknown statusCroatiaColonic NeoplasmsInfos
NCT00865982Study to Evaluate Safety and Efficacy of Perioperative Chemotherapy With Docetaxel, Cisplatin and Capecitabine (DCX) in Patients With Gastro-esophageal CancerInterventionalPhase 2Unknown statusGermanyEsophageal CancerInfos
NCT00865982Study to Evaluate Safety and Efficacy of Perioperative Chemotherapy With Docetaxel, Cisplatin and Capecitabine (DCX) in Patients With Gastro-esophageal CancerInterventionalPhase 2Unknown statusGermanyGastric CancerInfos
NCT00883792The Northern-European Initiative on Colorectal CancerInterventionalPhase 3Active but recruitment closedIcelandColorectal CancerInfos
NCT00883792The Northern-European Initiative on Colorectal CancerInterventionalPhase 3Active but recruitment closedLatviaColorectal CancerInfos
NCT00883792The Northern-European Initiative on Colorectal CancerInterventionalPhase 3Active but recruitment closedNetherlandsColorectal CancerInfos
NCT00883792The Northern-European Initiative on Colorectal CancerInterventionalPhase 3Active but recruitment closedNorwayColorectal CancerInfos
NCT00883792The Northern-European Initiative on Colorectal CancerInterventionalPhase 3Active but recruitment closedPolandColorectal CancerInfos
NCT00883792The Northern-European Initiative on Colorectal CancerInterventionalPhase 3Active but recruitment closedSwedenColorectal CancerInfos
NCT00884767Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving OxaliplatinInterventionalPhase 2Unknown statusFranceChemotherapeutic Agent ToxicityInfos
NCT00884767Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving OxaliplatinInterventionalPhase 2Unknown statusFranceColorectal CancerInfos
NCT00884767Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving OxaliplatinInterventionalPhase 2Unknown statusFranceNeurotoxicityInfos
NCT00888797β-adrenergic Blocker and a COX2 Inhibitor for Prevention of Colorectal Cancer RecurrenceInterventionalPhase 3Unknown statusIsraelColorectal NeoplasmsInfos
NCT00903565A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrintObservationalN/AUnknown statusAustriaColon CancerInfos
NCT00903565A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrintObservationalN/AUnknown statusDenmarkColon CancerInfos
NCT00903565A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrintObservationalN/AUnknown statusFranceColon CancerInfos
NCT00903565A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrintObservationalN/AUnknown statusGermanyColon CancerInfos
NCT00903565A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrintObservationalN/AUnknown statusNetherlandsColon CancerInfos
NCT00903565A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrintObservationalN/AUnknown statusSpainColon CancerInfos
NCT00903565A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrintObservationalN/AUnknown statusSwedenColon CancerInfos
NCT00903565A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrintObservationalN/AUnknown statusSwitzerlandColon CancerInfos
NCT00903565A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrintObservationalN/AUnknown statusUnited KingdomColon CancerInfos
NCT00906997Colorectal Cancer Screening in Average-risk Population: Immunochemical Fecal Occult Blood Testing Versus ColonoscopyInterventionalPhase 3Unknown statusSpainColorectal CancerInfos
NCT00906997Colorectal Cancer Screening in Average-risk Population: Immunochemical Fecal Occult Blood Testing Versus ColonoscopyInterventionalPhase 3Unknown statusSpainColorectal NeoplasmInfos
NCT00931840A Study of EZN-2208 Administered With or Without Cetuximab in Patients With Metastatic Colorectal CarcinomaInterventionalPhase 2Unknown statusIsraelMetastatic Colorectal CancerInfos
NCT00931840A Study of EZN-2208 Administered With or Without Cetuximab in Patients With Metastatic Colorectal CarcinomaInterventionalPhase 2Unknown statusNetherlandsMetastatic Colorectal CancerInfos
NCT00931840A Study of EZN-2208 Administered With or Without Cetuximab in Patients With Metastatic Colorectal CarcinomaInterventionalPhase 2Unknown statusUnited KingdomMetastatic Colorectal CancerInfos
NCT00934505Predictive Value of Pet Scan With Fdg Performed During Irradiation in Patients Treated for Oesaphagus CarcinomaObservationalN/AUnknown statusFranceOesophageal CancerInfos
NCT00947102Influence of Gemcitabine Treatment on Immunological and Serological Profile in Patients With Pancreatic CancerObservationalN/AUnknown statusSloveniaPancreatic Tubular AdenocarcinomaInfos
NCT00958737Combination Chemotherapy for 3 Months or 6 Months in Treating Patients With Stage III Colon CancerInterventionalPhase 3Active but recruitment closedFranceColorectal CancerInfos
NCT00963092Study of Blood and Tissue Samples From Patients With Stomach Cancer, Esophageal Cancer, or Gastroesophageal Junction CancerObservationalN/AUnknown statusUnited KingdomAdenocarcinoma of the Gastroesophageal JunctionInfos
NCT00963092Study of Blood and Tissue Samples From Patients With Stomach Cancer, Esophageal Cancer, or Gastroesophageal Junction CancerObservationalN/AUnknown statusUnited KingdomEsophageal CancerInfos
NCT00963092Study of Blood and Tissue Samples From Patients With Stomach Cancer, Esophageal Cancer, or Gastroesophageal Junction CancerObservationalN/AUnknown statusUnited KingdomGastric CancerInfos
NCT00963352Colon Cancer Prognosis After Radical SurgeryObservationalN/AUnknown statusNorwayColon CancerInfos
NCT00964171Efavirenz as Second-Line Therapy in Treating Patients With Metastatic Pancreatic CancerInterventionalPhase 2Unknown statusFrancePancreatic CancerInfos
NCT00964457Treatment of Patients With Advanced Rectum Cancer With Capecitabine and Oxaliplatin Before, Under and After Radiation and With Adding Cetuximab to K-RAS Wild-type PatientsInterventionalPhase 2Unknown statusDenmarkRectum CancerInfos
NCT00973869Curcumin in Preventing Colorectal Cancer in Patients Undergoing Colorectal Endoscopy or Colorectal SurgeryInterventionalPhase 1Unknown statusUnited KingdomColorectal CancerInfos
NCT00987857Endoscopy Every 2 Years or Only as Needed in Monitoring Patients With Barrett EsophagusInterventionalNot ApplicableUnknown statusUnited KingdomEsophageal CancerInfos
NCT01013649Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by SurgeryInterventionalPhase 2/Phase 3Active but recruitment closedBelgiumPancreatic AdenocarcinomaInfos
NCT01013649Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by SurgeryInterventionalPhase 2/Phase 3Active but recruitment closedBelgiumPancreatic Ductal AdenocarcinomaInfos
NCT01013649Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by SurgeryInterventionalPhase 2/Phase 3Active but recruitment closedBelgiumPancreatic Intraductal Papillary-Mucinous NeoplasmInfos
NCT01013649Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by SurgeryInterventionalPhase 2/Phase 3Active but recruitment closedBelgiumStage II Pancreatic Cancer AJCC v6 and v7Infos
NCT01013649Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by SurgeryInterventionalPhase 2/Phase 3Active but recruitment closedBelgiumStage I Pancreatic Cancer AJCC v6 and v7Infos
NCT01013649Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by SurgeryInterventionalPhase 2/Phase 3Active but recruitment closedIsraelPancreatic AdenocarcinomaInfos
NCT01013649Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by SurgeryInterventionalPhase 2/Phase 3Active but recruitment closedIsraelPancreatic Ductal AdenocarcinomaInfos
NCT01013649Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by SurgeryInterventionalPhase 2/Phase 3Active but recruitment closedIsraelPancreatic Intraductal Papillary-Mucinous NeoplasmInfos
NCT01013649Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by SurgeryInterventionalPhase 2/Phase 3Active but recruitment closedIsraelStage II Pancreatic Cancer AJCC v6 and v7Infos
NCT01013649Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by SurgeryInterventionalPhase 2/Phase 3Active but recruitment closedIsraelStage I Pancreatic Cancer AJCC v6 and v7Infos
NCT01037049Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 WeeksInterventionalPhase 2Unknown statusCyprusDigestive System NeoplasmsInfos
NCT01037049Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 WeeksInterventionalPhase 2Unknown statusUnited KingdomDigestive System NeoplasmsInfos
NCT01038154Study to Evaluate the Efficacy of Pravastatin on Survival and Recurrence of Advanced Gastroesophageal CancerInterventionalPhase 4Unknown statusSpainEsophageal CancerInfos
NCT01038154Study to Evaluate the Efficacy of Pravastatin on Survival and Recurrence of Advanced Gastroesophageal CancerInterventionalPhase 4Unknown statusSpainStomach CancerInfos
NCT01044511Quality of Life With Esophageal Stent TrialInterventionalNot ApplicableUnknown statusDenmarkEsophageal CancerInfos
NCT01048216Partial Liver Radiotherapy for Unresectable Liver MetastasesInterventionalNot ApplicableUnknown statusUnited KingdomMetastatic Colorectal Liver CancerInfos
NCT01056796Compression Anastomosis For Low Anterior Resection in Previously Radiated Patients Using the CARā„¢ 27InterventionalPhase 2Unknown statusBelgiumColorectal CancerInfos
NCT01062334Peritoneal Microdialysis in Patients Undergoing Low Anterior Resection for Rectum CancerInterventionalNot ApplicableUnknown statusDenmarkCancerInfos
NCT01067053Efficacy/Safety Study of Bevacizumab,Capecitabine,Oxaliplatin to Metastatic Colorectal Adenocarcinoma Elderly Patients.InterventionalPhase 2Unknown statusSpainMetastatic Colorectal CancerInfos
NCT01071824Comparison of Limb Size of Transverse Coloplasty PouchInterventionalNot ApplicableRecruitment openSwitzerlandColon CancerInfos
NCT01073358Resection of Colorectal Liver Metastases With or Without Routine Hilar LymphadenectomyInterventionalNot ApplicableUnknown statusGermanyColorectal CancerInfos
NCT01087268Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic CancerInterventionalPhase 3Unknown statusUnited KingdomColorectal CancerInfos
NCT01097265Study of Micrometastases in Patients With Stage I or Stage II Localized Colon Cancer That Can Be Removed by SurgeryInterventionalPhase 2/Phase 3Unknown statusNetherlandsColorectal CancerInfos
NCT01110785Simvastatin and Panitumumab in Treating Patients With Advanced or Metastatic Colorectal CancerInterventionalPhase 2Unknown statusNetherlandsColorectal CancerInfos
NCT01110798J-Pouch Colorectal Anastomosis or Straight Colorectal Anastomosis in Treating Patients With Rectal Cancer Who Have Undergone Surgery to Remove the TumorInterventionalNot ApplicableUnknown statusItalyColorectal CancerInfos
NCT01144195A Clinical Trial of Panitumumab in Combination With FOLFIRI Chemotherapy as Second Line Treatment in Subjects With Metastatic Colorectal Cancer Expressing Wild-type KRAS and Who Had Progressed ≄ 6 Months After the Last Dose of the First Line ChemotherapyInterventionalPhase 2Unknown statusSpainMetastatic Colorectal CancerInfos
NCT01160419Multicenter Study to Perioperative Chemotherapy for Resectable Adenocarcinoma in Gastric CancerInterventionalPhase 2Unknown statusGermanyGastric CancerInfos
NCT01182246AXP107-11 in Combination With Standard Gemcitabine (GemzarĀ® ) Therapy for Treatment in Patients With Pancreatic CancerInterventionalPhase 1/Phase 2Unknown statusSwedenAdenocarcinomaInfos
NCT01182272Sorafenib Tosylate in Treating Patients With Liver Cancer That Can Be Removed by SurgeryInterventionalPhase 2Unknown statusFranceLiver CancerInfos
NCT01183156Re-invitation to Screening Colonoscopy: a Randomized StudyInterventionalNot ApplicableUnknown statusPolandColorectal CancerInfos
NCT01190462Cetuximab and Simvastatin in Treating Patients With Advanced or Metastatic Colorectal CancerInterventionalPhase 2Unknown statusNetherlandsColorectal CancerInfos
NCT01214681Chemoprevention of Colorectal Cancer: the Role of Non-digestible CarbohydratesInterventionalNot ApplicableUnknown statusUnited KingdomColorectal CancerInfos
NCT01226394Trial Comparing Simple Follow-up to Exploratory Laparotomy Plus "in Principle" (Hyperthermic Intraperitoneal Chemotherapy) HIPEC in Colorectal PatientsInterventionalPhase 3Unknown statusFranceColorectal Cancer With a Resected Minimal Synchronous PCInfos
NCT01230697Perspective Evaluation of Hormones Involved in Serum Phosphate Homeostasis in Patients With Metastatic Renal Cells Carcinoma or Hepatocellular Carcinoma Treated With Sorafenib (SORHORM)ObservationalN/AUnknown statusItalyKidney CancerInfos
NCT01230697Perspective Evaluation of Hormones Involved in Serum Phosphate Homeostasis in Patients With Metastatic Renal Cells Carcinoma or Hepatocellular Carcinoma Treated With Sorafenib (SORHORM)ObservationalN/AUnknown statusItalyLiver CancerInfos
NCT01234246Sexual Dysfunction and the Quality of Sexual Life in Patients With Colorectal Cancer and Their Partners.ObservationalN/AUnknown statusNetherlandsColorectal Cancer Patients and Their PartnersInfos
NCT01236989Prognostic Impact of Anatomical Resection Vs. Non-anatomical Resection for HCCInterventionalNot ApplicableUnknown statusItalyPatients Affected by Hepatocellular CarcinomaInfos
NCT01249638Cap+Bev vs Cap+Iri+Bev 1st-line Therapy in mCRCInterventionalPhase 3Unknown statusGermanyColorectal Cancer MetastaticInfos
NCT01254591Positron Emission Tomography/Computed Tomography Scanning Before Surgery in Patients With Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer, Esophageal Cancer, or Head and Neck CancerInterventionalNot ApplicableUnknown statusUnited KingdomBreast CancerInfos
NCT01254591Positron Emission Tomography/Computed Tomography Scanning Before Surgery in Patients With Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer, Esophageal Cancer, or Head and Neck CancerInterventionalNot ApplicableUnknown statusUnited KingdomColorectal CancerInfos
NCT01254591Positron Emission Tomography/Computed Tomography Scanning Before Surgery in Patients With Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer, Esophageal Cancer, or Head and Neck CancerInterventionalNot ApplicableUnknown statusUnited KingdomEsophageal CancerInfos
NCT01254591Positron Emission Tomography/Computed Tomography Scanning Before Surgery in Patients With Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer, Esophageal Cancer, or Head and Neck CancerInterventionalNot ApplicableUnknown statusUnited KingdomHead and Neck CancerInfos
NCT01254591Positron Emission Tomography/Computed Tomography Scanning Before Surgery in Patients With Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer, Esophageal Cancer, or Head and Neck CancerInterventionalNot ApplicableUnknown statusUnited KingdomLung CancerInfos
NCT01272557Sorafenib Plus Doxorubicin Versus Sorafenib Alone for the Treatment of Advanced Hepatocellular Carcinoma: a Randomized Phase II TrialInterventionalPhase 2Unknown statusGermanyLiver CarcinomaInfos
NCT01276574Epithelial Ovarian Cancer- Staging and Response to Chemotherapy Evaluated by PET/CTObservationalN/AActive but recruitment closedFinlandPeritoneal CancerInfos
NCT01279278Does the Invitation by the General Practitioner Improve Patients' Participation in Colorectal Cancer Screening?InterventionalNot ApplicableUnknown statusFranceColorectal CancerInfos
NCT01279330Does the Recall by the General Practitioner Improve Patients' Participation in Colorectal Cancer Screening?InterventionalNot ApplicableUnknown statusFranceColorectal CancerInfos
NCT01286064Colorectal Cancer Detection by Means of Optical FluoroscopyInterventionalNot ApplicableUnknown statusItalyColorectal CancerInfos
NCT01292369Breath Testing for Breast and Colon Cancer Diagnosis- NaNose StudyObservationalN/AUnknown statusIsraelBreast CancerInfos
NCT01292369Breath Testing for Breast and Colon Cancer Diagnosis- NaNose StudyObservationalN/AUnknown statusIsraelColon CancerInfos
NCT01292681Multi-modality Imaging in the Prediction of Response to Systemic Treatment in Colorectal CancerInterventionalNot ApplicableUnknown statusNetherlandsColorectal CancerInfos
NCT01308086Adjuvant Therapy(3 vs. 6 Months) With the FOLFOX 4 or XELOX for Stage II or Stage III Colon CancerInterventionalPhase 3Unknown statusGreeceCRCInfos
NCT01315990FOLFIRI in Combination With Cetuximab in the First-line Treatment of Metastatic Colorectal Cancer Including a Regular Dermal Prophylaxis to Prevent Acneiforme Follicular ExanthemaInterventionalPhase 4Unknown statusGermanyColorectal Cancer MetastaticInfos
NCT01320319Effect of EPA on Aerobic Performance, Muscle, and Quality of Life in Colorectal Cancer Surgery PatientsInterventionalPhase 2/Phase 3Unknown statusUnited KingdomColorectal CancerInfos
NCT01322477Contribution of F-18 Fluoro-Deoxy-Glucose PET/CT (Positron Emission Tomography) to the Assessment of HCC (Hepato-cellular Carcinoma) Treatment EfficiencyObservationalN/AUnknown statusIsraelHepatocellular CarcinomaInfos
NCT01324076Transarterial Chemoembolization Using Doxorubicin Beads With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By SurgeryInterventionalPhase 3Unknown statusUnited KingdomLiver CancerInfos
NCT01324856Pancreaticogastrostomy Versus Pancreaticojejunostomy in Reconstruction After Cephalic DuodenopancreatectomyInterventionalPhase 1Unknown statusSerbiaPancreatic CancerInfos
NCT01330186Predictive Value of FMISO-PET, FDG-PET-CT, DWI-MRI and DCE-MRI Scans for Patients With Anal Cancer Receiving Radiotherapy +/- ChemotherapyObservationalN/AUnknown statusDenmarkAnal CancerInfos
NCT01351103A Study of LGK974 in Patients With Malignancies Dependent on Wnt LigandsInterventionalPhase 1Active but recruitment closedFranceBRAF Mutant Colorectal CancerInfos
NCT01351103A Study of LGK974 in Patients With Malignancies Dependent on Wnt LigandsInterventionalPhase 1Active but recruitment closedFrancePancreatic CancerInfos
NCT01351103A Study of LGK974 in Patients With Malignancies Dependent on Wnt LigandsInterventionalPhase 1Active but recruitment closedGermanyBRAF Mutant Colorectal CancerInfos
NCT01351103A Study of LGK974 in Patients With Malignancies Dependent on Wnt LigandsInterventionalPhase 1Active but recruitment closedGermanyPancreatic CancerInfos
NCT01351103A Study of LGK974 in Patients With Malignancies Dependent on Wnt LigandsInterventionalPhase 1Active but recruitment closedItalyBRAF Mutant Colorectal CancerInfos
NCT01351103A Study of LGK974 in Patients With Malignancies Dependent on Wnt LigandsInterventionalPhase 1Active but recruitment closedItalyPancreatic CancerInfos
NCT01351103A Study of LGK974 in Patients With Malignancies Dependent on Wnt LigandsInterventionalPhase 1Active but recruitment closedNetherlandsBRAF Mutant Colorectal CancerInfos
NCT01351103A Study of LGK974 in Patients With Malignancies Dependent on Wnt LigandsInterventionalPhase 1Active but recruitment closedNetherlandsPancreatic CancerInfos
NCT01351103A Study of LGK974 in Patients With Malignancies Dependent on Wnt LigandsInterventionalPhase 1Active but recruitment closedSpainBRAF Mutant Colorectal CancerInfos
NCT01351103A Study of LGK974 in Patients With Malignancies Dependent on Wnt LigandsInterventionalPhase 1Active but recruitment closedSpainPancreatic CancerInfos
NCT01351714Safe D3 Right Hemicolectomy for Cancer Through Multidetector Computed Tomography (MDCT) AngioInterventionalNot ApplicableUnknown statusNorwayColon CancerInfos
NCT01359397Docetaxel, Oxaliplatin, Capecitabine, Bevacizumab and Trastuzumab in Patients With Locally Advanced or Metastatic Gastric CancerInterventionalPhase 2Unknown statusNetherlandsAdenocarcinoma of the Gastro-oesophageal JunctionInfos
NCT01359397Docetaxel, Oxaliplatin, Capecitabine, Bevacizumab and Trastuzumab in Patients With Locally Advanced or Metastatic Gastric CancerInterventionalPhase 2Unknown statusNetherlandsMetastatic Gastric CancerInfos
NCT01363739Evaluation of VEGF Polymorphism as Predictive Factor in Metastatic Colorectal Cancer Treated With Folfiri Plus BevacizumabObservationalN/AUnknown statusItalyMetastatic Colorectal CancerInfos
NCT01372735Trial of Neoadjuvant Short Course IMRT Followed by Surgery and IORT for Resectable Pancreatic CancerInterventionalPhase 1/Phase 2Unknown statusGermanyPancreatic NeoplasmsInfos
NCT01377220Evaluation of 11 C-Choline PET-CT for Detection of Hepatocellular CarcinomaInterventionalPhase 2Unknown statusFranceHepatocellular CarcinomaInfos
NCT01380262Pre-emptive Low-dose Doxycycline During Anti-EGFR TreatmentObservationalN/AUnknown statusPolandColorectal CancerInfos
NCT01384994Panitumumab After Resection of Liver Metastases From Colorectal Cancer in KRAS Wild-type PatientsInterventionalPhase 2Unknown statusGermanyAfter Resection of Liver MetastasesInfos
NCT01384994Panitumumab After Resection of Liver Metastases From Colorectal Cancer in KRAS Wild-type PatientsInterventionalPhase 2Unknown statusGermanyColorectal CancerInfos
NCT01384994Panitumumab After Resection of Liver Metastases From Colorectal Cancer in KRAS Wild-type PatientsInterventionalPhase 2Unknown statusGermanyKRAS WildtypeInfos
NCT01394120Chemotherapy Selection Based on Therapeutic Targets for Advanced Pancreatic CancerInterventionalPhase 2Unknown statusSpainCarcinoma, Pancreatic DuctalInfos
NCT01410760PERfusion CT in the FOXFIRE Trial to Study Blood Flow to Liver MetastasesInterventionalEarly Phase 1Unknown statusUnited KingdomMetastatic Colorectal CancerInfos
NCT01441453Transient Elastography in Hepatectomy for Hepatocellular CarcinomaInterventionalNot ApplicableUnknown statusItalyHepatocellular CarcinomaInfos
NCT01441453Transient Elastography in Hepatectomy for Hepatocellular CarcinomaInterventionalNot ApplicableUnknown statusItalySurgeryInfos
NCT01442324Pilot Study of Irreversible Electroporation (IRE) to Treat Metastatic Liver Cancer & CholangiocarcinomaInterventionalNot ApplicableUnknown statusItalyCholangiocarcinomaInfos
NCT01442324Pilot Study of Irreversible Electroporation (IRE) to Treat Metastatic Liver Cancer & CholangiocarcinomaInterventionalNot ApplicableUnknown statusItalyMetastatic Liver CancerInfos
NCT01442324Pilot Study of Irreversible Electroporation (IRE) to Treat Metastatic Liver Cancer & CholangiocarcinomaInterventionalNot ApplicableUnknown statusItalyNeoplasm MetastasisInfos
NCT01444755The Effect of Neoadjuvant Chemotherapy on Locally Advanced Gastric CancerObservationalN/AUnknown statusTurkeyGastric CancerInfos
NCT01448655Iscador Qu as Supportive Treatment in Colorectal Cancer (Union International Cancer Control, UICC Stages II-IV)ObservationalN/AUnknown statusAustriaColorectal CancerInfos
NCT01448655Iscador Qu as Supportive Treatment in Colorectal Cancer (Union International Cancer Control, UICC Stages II-IV)ObservationalN/AUnknown statusGermanyColorectal CancerInfos
NCT01448668Iscador Qu as Supportive Treatment in Pancreatic Cancer (Union for International Cancer Control, UICC Stages II-IV)ObservationalN/AUnknown statusAustriaPancreas CancerInfos
NCT01448668Iscador Qu as Supportive Treatment in Pancreatic Cancer (Union for International Cancer Control, UICC Stages II-IV)ObservationalN/AUnknown statusGermanyPancreas CancerInfos
NCT01456455Gastric Cancer Metastasized to the Central Nervous System (CNS)ObservationalN/AUnknown statusSwitzerlandGastric CancerInfos
NCT01458353Microbiological Spectrum of the Intraperitoneal Surface After Elective Right-sided Colon CancerInterventionalPhase 3Unknown statusSpainIntra-abdominal AbscessInfos
NCT01458353Microbiological Spectrum of the Intraperitoneal Surface After Elective Right-sided Colon CancerInterventionalPhase 3Unknown statusSpainPeritoneal Contamination After Ileocolonic AnastomosisInfos
NCT01458353Microbiological Spectrum of the Intraperitoneal Surface After Elective Right-sided Colon CancerInterventionalPhase 3Unknown statusSpainWound InfectionInfos
NCT01470235Hypodontia and Ovarian CancerObservationalN/AUnknown statusDenmarkColon CancerInfos
NCT01479608Liver Transplantation and Colorectal CancerInterventionalPhase 2Recruitment openNorwayColorectal CancerInfos
NCT01479608Liver Transplantation and Colorectal CancerInterventionalPhase 2Recruitment openNorwayLiver MetastasisInfos
NCT01492127Evaluation of Proteasome as a Marker of Hepatocellular Carcinoma in Cirrhotic Patients Following Curative TreatmentInterventionalNot ApplicableUnknown statusFranceCirrhosisInfos
NCT01492127Evaluation of Proteasome as a Marker of Hepatocellular Carcinoma in Cirrhotic Patients Following Curative TreatmentInterventionalNot ApplicableUnknown statusFranceHepatocellular CarcinomaInfos
NCT01509911A Clinical Trial of Anti-Angiogenic Drug Combination Tl-118 for Pancreatic Cancer Patients Who Are Starting Gemcitabine TreatmentInterventionalPhase 2Unknown statusIsraelMetastatic Pancreatic CancerInfos
NCT01515787PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing SurgeryInterventionalPhase 2/Phase 3Active but recruitment closedIsraelColorectal CancerInfos
NCT01515787PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing SurgeryInterventionalPhase 2/Phase 3Active but recruitment closedSwitzerlandColorectal CancerInfos
NCT01531595Study of Bevacizumab in Combination With Alternating Xeliri and Xelox in Metastatic Colorectal CancerInterventionalPhase 2Recruitment openFinlandMetastatic Colorectal CancerInfos
NCT01531621A Population-based Prospective Study of Metastatic Colorectal Cancer (CRC) Patients in FinlandObservationalN/ARecruitment openFinlandMetastatic Colorectal CancerInfos
NCT01538550Pilot Study of a National Screening Programme for Bowel Cancer in NorwayInterventionalNot ApplicableActive but recruitment closedNorwayColorectal CancerInfos
NCT01563133Clinical Evaluation Of Needle-based Confocal Laser Endomicroscopy in The Lymph Nodes Along With Masses and Cystic Tumors of the PancreasInterventionalNot ApplicableUnknown statusFrancePancreatic CancerInfos
NCT01570010Effect of Norwegian Food Based Dietary Guidelines on Chronic Diseases in CRC SurvivorsInterventionalNot ApplicableActive but recruitment closedNorwayColorectal CancerInfos
NCT01573468Capecitabine/Tesetaxel Versus Capecitabine/Placebo as Second-line Therapy for Gastric CancerInterventionalPhase 2Unknown statusGermanyGastric CarcinomaInfos
NCT01585805Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerInterventionalPhase 2Active but recruitment closedIsraelLocally Advanced Pancreatic AdenocarcinomaInfos
NCT01585805Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerInterventionalPhase 2Active but recruitment closedIsraelMetastatic Pancreatic AdenocarcinomaInfos
NCT01585805Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerInterventionalPhase 2Active but recruitment closedIsraelStage III Pancreatic Cancer AJCC v8Infos
NCT01585805Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerInterventionalPhase 2Active but recruitment closedIsraelStage IV Pancreatic Cancer AJCC v8Infos
NCT01589146ONE WEEK VERSUS FOUR WEEK HEPARIN PROPHYLAXIS AFTER LAPAROSCOPIC SURGERY FOR COLORECTAL CANCER.InterventionalPhase 3Unknown statusItalyFrom Surgery in the Two Study Groups.Infos
NCT01589146ONE WEEK VERSUS FOUR WEEK HEPARIN PROPHYLAXIS AFTER LAPAROSCOPIC SURGERY FOR COLORECTAL CANCER.InterventionalPhase 3Unknown statusItalyProphylaxis Given for 8±2 Days After Planned LaparoscopicInfos
NCT01589146ONE WEEK VERSUS FOUR WEEK HEPARIN PROPHYLAXIS AFTER LAPAROSCOPIC SURGERY FOR COLORECTAL CANCER.InterventionalPhase 3Unknown statusItalySafety of Extended 4-week Heparin Prophylaxis Compared toInfos
NCT01589146ONE WEEK VERSUS FOUR WEEK HEPARIN PROPHYLAXIS AFTER LAPAROSCOPIC SURGERY FOR COLORECTAL CANCER.InterventionalPhase 3Unknown statusItalySurgery for Colorectal Cancer.Infos
NCT01589146ONE WEEK VERSUS FOUR WEEK HEPARIN PROPHYLAXIS AFTER LAPAROSCOPIC SURGERY FOR COLORECTAL CANCER.InterventionalPhase 3Unknown statusItalyThe Clinical Benefit Will be Evaluated as the Difference inInfos
NCT01589146ONE WEEK VERSUS FOUR WEEK HEPARIN PROPHYLAXIS AFTER LAPAROSCOPIC SURGERY FOR COLORECTAL CANCER.InterventionalPhase 3Unknown statusItalythe Incidence of VTE or VTE-related Death Occurring Within 30 DaysInfos
NCT01589146ONE WEEK VERSUS FOUR WEEK HEPARIN PROPHYLAXIS AFTER LAPAROSCOPIC SURGERY FOR COLORECTAL CANCER.InterventionalPhase 3Unknown statusItalyThe Primary Study Objective is to Assess the Efficacy andInfos
NCT01601808Clinical Trial Comparing Gemcitabine and Vandetanib Therapy With Gemcitabine Alone in Pancreatic CarcinomaInterventionalPhase 2Unknown statusUnited KingdomPancreatic CancerInfos
NCT01626963Single-port Versus Conventional Laparoscopic Colorectal SurgeryInterventionalPhase 1/Phase 2Unknown statusUnited KingdomColorectal CancerInfos
NCT01628211Second Look Laparoscopy in Colorectal CancerInterventionalPhase 2Recruitment openItalyColorectal CancerInfos
NCT01639326Study to Evaluate the Efficacy and Safety of FOLFIRI-AD in Patients With Metastatic Colorectal Cancer UGT1A Genotype 1InterventionalPhase 2Unknown statusSpainMetastatic Colorectal CancerInfos
NCT01641003Isolation and Characterization of Cancer Stem Cells Using iFP TechniqueObservationalN/AUnknown statusIsraelPancreatic CancerInfos
NCT01642875Early Oral Versus Enteral Nutrition After PancreatoduodenectomyInterventionalPhase 4Unknown statusPolandPancreatic CancerInfos
NCT01651013Observational Study on Treatment of Metastatic Colorectal Cancer and the Role of K-RasObservationalN/AActive but recruitment closedItalyMetastatic Colorectal CancerInfos
NCT01651026Multicenter Cohort Prospective Study on Multidisciplinary Treatment of Rectal CancerObservationalN/ARecruitment openItalyMetastatic Colorectal CancerInfos
NCT01658878An Immuno-therapy Study to Evaluate the Effectiveness, Safety and Tolerability of Nivolumab or Nivolumab in Combination With Other Agents in Patients With Advanced Liver CancerInterventionalPhase 1/Phase 2Active but recruitment closedFranceHepatocellular CarcinomaInfos
NCT01658878An Immuno-therapy Study to Evaluate the Effectiveness, Safety and Tolerability of Nivolumab or Nivolumab in Combination With Other Agents in Patients With Advanced Liver CancerInterventionalPhase 1/Phase 2Active but recruitment closedGermanyHepatocellular CarcinomaInfos
NCT01658878An Immuno-therapy Study to Evaluate the Effectiveness, Safety and Tolerability of Nivolumab or Nivolumab in Combination With Other Agents in Patients With Advanced Liver CancerInterventionalPhase 1/Phase 2Active but recruitment closedItalyHepatocellular CarcinomaInfos
NCT01658878An Immuno-therapy Study to Evaluate the Effectiveness, Safety and Tolerability of Nivolumab or Nivolumab in Combination With Other Agents in Patients With Advanced Liver CancerInterventionalPhase 1/Phase 2Active but recruitment closedSpainHepatocellular CarcinomaInfos
NCT01658878An Immuno-therapy Study to Evaluate the Effectiveness, Safety and Tolerability of Nivolumab or Nivolumab in Combination With Other Agents in Patients With Advanced Liver CancerInterventionalPhase 1/Phase 2Active but recruitment closedUnited KingdomHepatocellular CarcinomaInfos
NCT01659502Investigator's Initiated Phase II Study for Pancreatic Cancer PatientsInterventionalPhase 2Unknown statusIsraelPancreatic CancerInfos
NCT01662739Cremona Population-Based Gastric Tumors RegistryObservationalN/AUnknown statusItalyGastric CancerInfos
NCT01673607Study of Immune Response and Liver Damage Induced by Chemotherapy for Liver Metastases of Colorectal CancerInterventionalPhase 2Unknown statusFranceResectable Hepatic Metastases of Colorectal CancerInfos
NCT01675258Identifying Saliva Markers of Patients With Stomach, Colorectal (Including Pre-cancer Polyp) and Pancreatic CancersObservationalN/AUnknown statusIsraelColorectal Cancer and Pre-cancer PolypsInfos
NCT01675258Identifying Saliva Markers of Patients With Stomach, Colorectal (Including Pre-cancer Polyp) and Pancreatic CancersObservationalN/AUnknown statusIsraelGastric CancerInfos
NCT01675258Identifying Saliva Markers of Patients With Stomach, Colorectal (Including Pre-cancer Polyp) and Pancreatic CancersObservationalN/AUnknown statusIsraelPancreatic CancerInfos
NCT01675505Psychological Well-being Outcomes in Disease-free Survivors of Colorectal Cancer Following Curative SurgeryObservationalN/AUnknown statusGreeceAdaptation, PsychologicalInfos
NCT01675505Psychological Well-being Outcomes in Disease-free Survivors of Colorectal Cancer Following Curative SurgeryObservationalN/AUnknown statusGreeceFunctional InsufficiencyInfos
NCT01675999Trial of Neoadjuvant Chemotherapy in Locally Advanced Colon CancerInterventionalPhase 2Unknown statusFranceColon CancerInfos
NCT01675999Trial of Neoadjuvant Chemotherapy in Locally Advanced Colon CancerInterventionalPhase 2Unknown statusFranceLocally Advanced Malignant NeoplasmInfos
NCT01676259A Phase 2 Study of siG12D LODER in Combination With Chemotherapy in Patients With Locally Advanced Pancreatic CancerInterventionalPhase 2Unknown statusIsraelPancreatic CancerInfos
NCT01676259A Phase 2 Study of siG12D LODER in Combination With Chemotherapy in Patients With Locally Advanced Pancreatic CancerInterventionalPhase 2Unknown statusIsraelPancreatic Ductal AdenocarcinomaInfos
NCT01679756INtracorporeal Versus EXTracorpoREal anastoMOsis After Laparoscopic Right Colectomy for CancerInterventionalNot ApplicableUnknown statusItalyColorectal CancerInfos
NCT01686971The Needs of Cancer SurvivorsObservationalN/AUnknown statusIsraelColon Cancer Patients.Infos
NCT01688232The Immunoscore as a Prognostic Marker for Patients With a Colorectal CancerObservationalN/AActive but recruitment closedFranceColorectal CancerInfos
NCT01688232The Immunoscore as a Prognostic Marker for Patients With a Colorectal CancerObservationalN/AActive but recruitment closedFranceSurgical Resection of the Colorectal TumorInfos
NCT01704664Perioperative Immunonutrition, Phagocytic and Bactericidal Activity of Blood Platelets in Gastric Cancer PatientsInterventionalNot ApplicableUnknown statusPolandGastric CancerInfos
NCT01706809Comparing of Different Biomarkers From Vena Rectalis Superior and Vena Cubiti in Patients Undergoing Low Anterior Resection for Rectum CancerObservationalN/AUnknown statusDenmarkRectal CancerInfos
NCT01707511The Investigation of the EtCOā‚‚- PaCOā‚‚ Relation During Laparoscopic Colon SurgeryObservationalN/AUnknown statusTurkeyColorectal CancerInfos
NCT01713218Effect on Tumor Perfusion of a Chemotherapy Combining Gemcitabine and Vismodegib Before Surgery in Pancreatic CancerInterventionalEarly Phase 1Unknown statusBelgiumPancreatic Adenocarcinoma ResectableInfos
NCT01715402Optimization of Health Expenditure in Liver SurgeryObservationalN/AUnknown statusFranceHepatocellular CarcinomaInfos
NCT01717196Diagnostic Accuracy of FNA: is Aspiration- Related?InterventionalNot ApplicableUnknown statusItalyPANCREATIC CANCERInfos
NCT01717807C11-Erlotinib PET/CT as a Tool for Identification and Characterization of Tumor With High Expression of Epidermal Growth Factor Receptor(EGFR).ObservationalN/AUnknown statusIsraelPancreatic CancerInfos
NCT0172601022-G-Procore Needle for the Diagnosis of SETs of the Upper GI TractInterventionalNot ApplicableUnknown statusGermanySubepithelial Tumors of the Upper Gastrointestinal TractInfos
NCT01729481Gemcitabine Plus Erlotinib in RASH-positive Patients With Metastatic Pancreatic CancerInterventionalPhase 2Unknown statusGermanyMetastatic Pancreatic AdenocarcinomaInfos
NCT01731366The Effect of Whole Grain on Gut Microbiome and Metabolic HealthInterventionalNot ApplicableUnknown statusDenmarkInjury of Gastrointestinal TractInfos
NCT01744509PillCam Colon Capsule 2Ā® (PCC2) in the Setting of Colorectal Cancer Screening ProgramInterventionalNot ApplicableUnknown statusItalyColon CancerInfos
NCT01754272A Non-Interventional Follow-Up to the VELOUR Study - Translational ResearchObservationalN/AUnknown statusAustriaMetastatic Colorectal CancerInfos
NCT01754272A Non-Interventional Follow-Up to the VELOUR Study - Translational ResearchObservationalN/AUnknown statusBelgiumMetastatic Colorectal CancerInfos
NCT01754272A Non-Interventional Follow-Up to the VELOUR Study - Translational ResearchObservationalN/AUnknown statusDenmarkMetastatic Colorectal CancerInfos
NCT01754272A Non-Interventional Follow-Up to the VELOUR Study - Translational ResearchObservationalN/AUnknown statusEstoniaMetastatic Colorectal CancerInfos
NCT01754272A Non-Interventional Follow-Up to the VELOUR Study - Translational ResearchObservationalN/AUnknown statusGermanyMetastatic Colorectal CancerInfos
NCT01754272A Non-Interventional Follow-Up to the VELOUR Study - Translational ResearchObservationalN/AUnknown statusGreeceMetastatic Colorectal CancerInfos
NCT01754272A Non-Interventional Follow-Up to the VELOUR Study - Translational ResearchObservationalN/AUnknown statusItalyMetastatic Colorectal CancerInfos
NCT01754272A Non-Interventional Follow-Up to the VELOUR Study - Translational ResearchObservationalN/AUnknown statusNetherlandsMetastatic Colorectal CancerInfos
NCT01754272A Non-Interventional Follow-Up to the VELOUR Study - Translational ResearchObservationalN/AUnknown statusNorwayMetastatic Colorectal CancerInfos
NCT01754272A Non-Interventional Follow-Up to the VELOUR Study - Translational ResearchObservationalN/AUnknown statusRomaniaMetastatic Colorectal CancerInfos
NCT01754272A Non-Interventional Follow-Up to the VELOUR Study - Translational ResearchObservationalN/AUnknown statusRussian FederationMetastatic Colorectal CancerInfos
NCT01754272A Non-Interventional Follow-Up to the VELOUR Study - Translational ResearchObservationalN/AUnknown statusSpainMetastatic Colorectal CancerInfos
NCT01754272A Non-Interventional Follow-Up to the VELOUR Study - Translational ResearchObservationalN/AUnknown statusSwedenMetastatic Colorectal CancerInfos
NCT01754272A Non-Interventional Follow-Up to the VELOUR Study - Translational ResearchObservationalN/AUnknown statusUnited KingdomMetastatic Colorectal CancerInfos
NCT01761097Endocuff Adenoma Detection Rate Pilot StudyInterventionalNot ApplicableUnknown statusUnited KingdomColorectal CancerInfos
NCT01762813Assessment of Clinically Related Outcomes and Biomarker Analysis for Translational Integration in Colorectal CancerObservationalN/ARecruitment openNorwayColorectal CancerInfos
NCT01779583Circulating Exosomes As Potential Prognostic And Predictive Biomarkers In Advanced Gastric Cancer Patients ("EXO-PPP Study")ObservationalN/AUnknown statusSpainGastric CancerInfos
NCT01786122Clinical Trial: Effectiveness and Efficiency of Physical Exercise in Cancer PatientsInterventionalNot ApplicableUnknown statusSpainDigestive System NeoplasmsInfos
NCT01786200Physiological Effects of Altering Cancer-related InflammationInterventionalNot ApplicableUnknown statusUnited KingdomColon CancerInfos
NCT01787539The Role of Postoperative Cycles in the Perioperative Chemotherapy for Gastric CancerInterventionalPhase 2/Phase 3Unknown statusPolandGastric CancerInfos
NCT01792934Chemotherapy and Maximal Tumor Debulking of Multi-organ Colorectal Cancer MetastasesInterventionalNot ApplicableRecruitment openNetherlandsMulti-organ Metastatic Colorectal CancerInfos
NCT01792934Chemotherapy and Maximal Tumor Debulking of Multi-organ Colorectal Cancer MetastasesInterventionalNot ApplicableRecruitment openUnited KingdomMulti-organ Metastatic Colorectal CancerInfos
NCT01795768Proof-of-Concept Study of AZD4547 in Patients With FGFR1 or FGFR2 Amplified TumoursInterventionalPhase 2Unknown statusUnited KingdomGastric CancerInfos
NCT01795768Proof-of-Concept Study of AZD4547 in Patients With FGFR1 or FGFR2 Amplified TumoursInterventionalPhase 2Unknown statusUnited KingdomOesophageal CancerInfos
NCT01801904A Phase 2 Study of Panitumumab in Patients With Cetuximab-refractory Metastatic Colorectal CancerInterventionalPhase 2Active but recruitment closedItalyMetastatic Colorectal CancerInfos
NCT01802645Cetuximab/FOLFIRI With or Without Oxaliplatin and FOLFOXIRI With or Without Bevacizumab in Neoadjuvant Treatment of Non-resectable Colorectal Liver MetastasesInterventionalPhase 2Unknown statusGermanyColorectal CancerInfos
NCT01814150The Association Between Alpha 1 Acid Glycoprotein Level and Outcome Metastatic Cancer Treated With DocetaxelObservationalN/AUnknown statusIsraelMetastatic Gastric CancerInfos
NCT01827553Pancreatic Carcinoma: Chemoradiation Compared With Chemotherapy Alone After Induction ChemotherapyInterventionalPhase 3Active but recruitment closedGermanyPancreatic CancerInfos
NCT01843829A Feasibility Study of Chemo-radiotherapy to Treat Operable Oesophageal CancerInterventionalPhase 2Unknown statusUnited KingdomOesophageal CancerInfos
NCT01853059Functional Outcomes Following Anal Cancer TreatmentObservationalN/AUnknown statusUnited KingdomAnal CancerInfos
NCT01879878Pilot Study Evaluating Broccoli Sprouts in Advanced Pancreatic Cancer [POUDER Trial]InterventionalNot ApplicableUnknown statusGermanyPancreatic Ductal AdenocarcinomaInfos
NCT01885702Dendritic Cell Vaccination in Patients With Lynch Syndrome or Colorectal Cancer With MSIInterventionalPhase 1/Phase 2Active but recruitment closedNetherlandsColorectal CancerInfos
NCT01891539Observational Prospective Study on Chemoembolization With Doxorubicin for Unresectable Hepatocellular CarcinomaObservationalN/AUnknown statusItalyLiver Cell Carcinoma Non-resectableInfos
NCT01895257Comparing HAI-90Y (SIR-spheres)+Chemotx LV5FU2 Versus Chemotx LV5FU2 Alone to Treat Colorectal CancerInterventionalPhase 3Unknown statusBelgiumColorectal CancerInfos
NCT01898104Preoperative Valproic Acid and Radiation Therapy for Rectal CancerInterventionalPhase 1/Phase 2Recruitment openItalyColorectal CancerInfos
NCT01898741Cone-beam CT Guided Stereotactic Radiation Therapy for Locally Advanced Pancreatic CancerInterventionalPhase 2Unknown statusNetherlandsPancreatic CancerInfos
NCT01910610Multi-Line Therapy Trial in Unresectable Metastatic Colorectal CancerInterventionalPhase 3Unknown statusFranceColorectal Cancer MetastaticInfos
NCT01910610Multi-Line Therapy Trial in Unresectable Metastatic Colorectal CancerInterventionalPhase 3Unknown statusIrelandColorectal Cancer MetastaticInfos
NCT01910610Multi-Line Therapy Trial in Unresectable Metastatic Colorectal CancerInterventionalPhase 3Unknown statusIsraelColorectal Cancer MetastaticInfos
NCT01918527Neoadjuvant Chemotherapy Versus Standard Treatment in Patients With Locally Advanced Colon CancerInterventionalPhase 3Active but recruitment closedDenmarkColon CancerInfos
NCT01918527Neoadjuvant Chemotherapy Versus Standard Treatment in Patients With Locally Advanced Colon CancerInterventionalPhase 3Active but recruitment closedNorwayColon CancerInfos
NCT01918527Neoadjuvant Chemotherapy Versus Standard Treatment in Patients With Locally Advanced Colon CancerInterventionalPhase 3Active but recruitment closedSwedenColon CancerInfos
NCT01919151Micrometastasis in Gastrointestinal CancerObservationalN/AUnknown statusNorwayColorectal CancerInfos
NCT01919151Micrometastasis in Gastrointestinal CancerObservationalN/AUnknown statusNorwayPancreatic AdenocarcinomaInfos
NCT01927328Iron Replacement in Oesophagogastric NeoplasiaInterventionalPhase 4Unknown statusUnited KingdomEsophageal CancerInfos
NCT01927328Iron Replacement in Oesophagogastric NeoplasiaInterventionalPhase 4Unknown statusUnited KingdomGastric CancerInfos
NCT01937429Effectiveness of Instillation of Blue Water (Indigo CarminĀ®) for ColonoscopyInterventionalPhase 3Unknown statusFranceAdenoma Detection to Prevent Colorectal CancerInfos
NCT01937780Anal Cancer Radiotherapy StudyObservationalN/AActive but recruitment closedNorwayAnal CancerInfos
NCT01943786RAS Switch in Patients With Metastatic RAS Native Colorectal Tumors Treated With 1st Line FOLFIRI-CetuximabObservationalN/AUnknown statusSpainColorectal Cancer MetastaticInfos
NCT01945723Tissue Characterization From Various Parts of the Gastrointestinal Tract in Healthy VolunteersObservationalN/AUnknown statusIsraelHealthyInfos
NCT01958697Age and Gender Corrected Body Mass IndexObservationalN/AUnknown statusBelgiumEsophageal CancerInfos
NCT01959906Circumferential Section Pane Less Than 1 mm in Esophagectomy for Esophageal Cancer.ObservationalN/AUnknown statusBelgiumEsophageal CancerInfos
NCT01964534Efficacy of ABI-007 Plus Gemcitabine or sLV5FU2 as First-line Therapy in Patients With Metastatic Pancreatic CancerInterventionalPhase 2Unknown statusFranceMetastatic Pancreatic CancerInfos
NCT01966081AGARIC Case Control StudyInterventionalNot ApplicableUnknown statusFranceFirst Recently-diagnosed Colorectal CancerInfos
NCT01983098Analysis of Circulating Tumor DNA to Monitor Metastatic Colorectal Cancer TreatmentObservationalN/AUnknown statusFranceTo Compare the Monitoring of Circulating Tumor DNA With the Efficacy of Chemotherapy Evaluated by Computer Tomography Scan.Infos
NCT01991080The Relationship Between Relaxation or Wheat Germ Juice to the Immune Indices and Quality of Life (QoL) in Colorectal Cancer Patients on Adjuvant ChemotherapyInterventionalNot ApplicableUnknown statusIsraelColon CancerInfos
NCT01995942Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer (MARVEL) TrialObservationalN/AUnknown statusUnited KingdomDigestive System NeoplasmsInfos
NCT02002195Modified Folinic Acid-Fluorouracil-Oxaliplatin Regimen + Capecitabine for Elderly With Metastatic Gastric CancerObservationalN/AUnknown statusItalyMetastatic Gastric CancerInfos
NCT02002299Does Surface Tell us About the Invasive Front in Colorectal CancerObservationalN/AUnknown statusDenmarkColorectal CancerInfos
NCT02005965Low Rectal Cancer Study (MERCURY II)ObservationalN/AUnknown statusGermanyDigestive System NeoplasmsInfos
NCT02005965Low Rectal Cancer Study (MERCURY II)ObservationalN/AUnknown statusSerbiaDigestive System NeoplasmsInfos
NCT02005965Low Rectal Cancer Study (MERCURY II)ObservationalN/AUnknown statusUnited KingdomDigestive System NeoplasmsInfos
NCT02007148MetronomIc CApecitabine and DOcetaxel as Second-line Chemotherapy for Advanced Gastric CancerInterventionalPhase 2Unknown statusItalyGastric AdenocarcinomaInfos
NCT02007148MetronomIc CApecitabine and DOcetaxel as Second-line Chemotherapy for Advanced Gastric CancerInterventionalPhase 2Unknown statusItalyGastroesophageal Junction AdenocarcinomaInfos
NCT02012699Integrated Cancer Repository for Cancer ResearchObservationalN/ARecruitment openItalyAnal CancerInfos
NCT02012699Integrated Cancer Repository for Cancer ResearchObservationalN/ARecruitment openItalyColon CancerInfos
NCT02012699Integrated Cancer Repository for Cancer ResearchObservationalN/ARecruitment openItalyEsophageal CancerInfos
NCT02012699Integrated Cancer Repository for Cancer ResearchObservationalN/ARecruitment openItalyFamilial Adenomatous PolyposisInfos
NCT02012699Integrated Cancer Repository for Cancer ResearchObservationalN/ARecruitment openItalyGastric CancerInfos
NCT02012699Integrated Cancer Repository for Cancer ResearchObservationalN/ARecruitment openItalyLiver CancerInfos
NCT02012699Integrated Cancer Repository for Cancer ResearchObservationalN/ARecruitment openItalyLynch SyndromeInfos
NCT02012699Integrated Cancer Repository for Cancer ResearchObservationalN/ARecruitment openItalyPancreatic CancerInfos
NCT02017366Design of the EFECTS TrialInterventionalNot ApplicableUnknown statusBelgiumEsophageal CancerInfos
NCT02024009Systemic Therapy and Chemoradiation in Advanced Localised Pancreatic Cancer - 2InterventionalPhase 1/Phase 2Unknown statusUnited KingdomPancreatic Neoplasms (Locally Advanced Non-metastatic)Infos
NCT02039336Dacomitinib Plus PD-0325901 in Advanced KRAS Mutant NSCLCInterventionalPhase 1/Phase 2Unknown statusNetherlandsColorectal CancerInfos
NCT02045680RADOX' Reduced Abdominal Distension and Oxygen DeliveryObservationalN/AUnknown statusUnited KingdomColorectal CancerInfos
NCT02047994Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer MortalityInterventionalPhase 4Recruitment openLatviaAtrophic GastritisInfos
NCT02047994Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer MortalityInterventionalPhase 4Recruitment openLatviaGastric CancerInfos
NCT02047994Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer MortalityInterventionalPhase 4Recruitment openLatviaHelicobacter Pylori InfectionsInfos
NCT02051283Pretreatment MRI Predicting Outcome After Radio-frequency Ablation of HCCObservationalN/AUnknown statusBelgiumHepatocellular CarcinomaInfos
NCT02051868International Multicentre Study in Advanced Anal Cancer Comparing Cisplatin Plus 5 FU vs Carboplatin Plus Weekly PaclitaxelInterventionalPhase 2Unknown statusUnited KingdomSquamous Cell Carcinoma of the AnusInfos
NCT02052778A Study of TAS-120 in Patients With Advanced Solid TumorsInterventionalPhase 1/Phase 2Active but recruitment closedFranceGastric CancerInfos
NCT02052778A Study of TAS-120 in Patients With Advanced Solid TumorsInterventionalPhase 1/Phase 2Active but recruitment closedGermanyGastric CancerInfos
NCT02052778A Study of TAS-120 in Patients With Advanced Solid TumorsInterventionalPhase 1/Phase 2Active but recruitment closedItalyGastric CancerInfos
NCT02052778A Study of TAS-120 in Patients With Advanced Solid TumorsInterventionalPhase 1/Phase 2Active but recruitment closedNetherlandsGastric CancerInfos
NCT02052778A Study of TAS-120 in Patients With Advanced Solid TumorsInterventionalPhase 1/Phase 2Active but recruitment closedPortugalGastric CancerInfos
NCT02052778A Study of TAS-120 in Patients With Advanced Solid TumorsInterventionalPhase 1/Phase 2Active but recruitment closedSpainGastric CancerInfos
NCT02052778A Study of TAS-120 in Patients With Advanced Solid TumorsInterventionalPhase 1/Phase 2Active but recruitment closedUnited KingdomGastric CancerInfos
NCT02053805Prostate Cancer Screening Among Men With High Risk Genetic PredispositionInterventionalNot ApplicableUnknown statusIsraelLynch SyndromeInfos
NCT02060188A Study of Nivolumab Alone or Nivolumab Combination Therapy in Colon Cancer That Has Come Back or Has SpreadInterventionalPhase 2Active but recruitment closedBelgiumMicrosatellite Stable Colorectal CancerInfos
NCT02060188A Study of Nivolumab Alone or Nivolumab Combination Therapy in Colon Cancer That Has Come Back or Has SpreadInterventionalPhase 2Active but recruitment closedBelgiumMicrosatellite Unstable Colorectal CancerInfos
NCT02060188A Study of Nivolumab Alone or Nivolumab Combination Therapy in Colon Cancer That Has Come Back or Has SpreadInterventionalPhase 2Active but recruitment closedBelgiumMismatch Repair Deficient Colorectal CancerInfos
NCT02060188A Study of Nivolumab Alone or Nivolumab Combination Therapy in Colon Cancer That Has Come Back or Has SpreadInterventionalPhase 2Active but recruitment closedBelgiumMismatch Repair Proficient Colorectal CancerInfos
NCT02060188A Study of Nivolumab Alone or Nivolumab Combination Therapy in Colon Cancer That Has Come Back or Has SpreadInterventionalPhase 2Active but recruitment closedFranceMicrosatellite Stable Colorectal CancerInfos
NCT02060188A Study of Nivolumab Alone or Nivolumab Combination Therapy in Colon Cancer That Has Come Back or Has SpreadInterventionalPhase 2Active but recruitment closedFranceMicrosatellite Unstable Colorectal CancerInfos
NCT02060188A Study of Nivolumab Alone or Nivolumab Combination Therapy in Colon Cancer That Has Come Back or Has SpreadInterventionalPhase 2Active but recruitment closedFranceMismatch Repair Deficient Colorectal CancerInfos
NCT02060188A Study of Nivolumab Alone or Nivolumab Combination Therapy in Colon Cancer That Has Come Back or Has SpreadInterventionalPhase 2Active but recruitment closedFranceMismatch Repair Proficient Colorectal CancerInfos
NCT02060188A Study of Nivolumab Alone or Nivolumab Combination Therapy in Colon Cancer That Has Come Back or Has SpreadInterventionalPhase 2Active but recruitment closedIrelandMicrosatellite Stable Colorectal CancerInfos
NCT02060188A Study of Nivolumab Alone or Nivolumab Combination Therapy in Colon Cancer That Has Come Back or Has SpreadInterventionalPhase 2Active but recruitment closedIrelandMicrosatellite Unstable Colorectal CancerInfos
NCT02060188A Study of Nivolumab Alone or Nivolumab Combination Therapy in Colon Cancer That Has Come Back or Has SpreadInterventionalPhase 2Active but recruitment closedIrelandMismatch Repair Deficient Colorectal CancerInfos
NCT02060188A Study of Nivolumab Alone or Nivolumab Combination Therapy in Colon Cancer That Has Come Back or Has SpreadInterventionalPhase 2Active but recruitment closedIrelandMismatch Repair Proficient Colorectal CancerInfos
NCT02060188A Study of Nivolumab Alone or Nivolumab Combination Therapy in Colon Cancer That Has Come Back or Has SpreadInterventionalPhase 2Active but recruitment closedItalyMicrosatellite Stable Colorectal CancerInfos
NCT02060188A Study of Nivolumab Alone or Nivolumab Combination Therapy in Colon Cancer That Has Come Back or Has SpreadInterventionalPhase 2Active but recruitment closedItalyMicrosatellite Unstable Colorectal CancerInfos
NCT02060188A Study of Nivolumab Alone or Nivolumab Combination Therapy in Colon Cancer That Has Come Back or Has SpreadInterventionalPhase 2Active but recruitment closedItalyMismatch Repair Deficient Colorectal CancerInfos
NCT02060188A Study of Nivolumab Alone or Nivolumab Combination Therapy in Colon Cancer That Has Come Back or Has SpreadInterventionalPhase 2Active but recruitment closedItalyMismatch Repair Proficient Colorectal CancerInfos
NCT02060188A Study of Nivolumab Alone or Nivolumab Combination Therapy in Colon Cancer That Has Come Back or Has SpreadInterventionalPhase 2Active but recruitment closedSpainMicrosatellite Stable Colorectal CancerInfos
NCT02060188A Study of Nivolumab Alone or Nivolumab Combination Therapy in Colon Cancer That Has Come Back or Has SpreadInterventionalPhase 2Active but recruitment closedSpainMicrosatellite Unstable Colorectal CancerInfos
NCT02060188A Study of Nivolumab Alone or Nivolumab Combination Therapy in Colon Cancer That Has Come Back or Has SpreadInterventionalPhase 2Active but recruitment closedSpainMismatch Repair Deficient Colorectal CancerInfos
NCT02060188A Study of Nivolumab Alone or Nivolumab Combination Therapy in Colon Cancer That Has Come Back or Has SpreadInterventionalPhase 2Active but recruitment closedSpainMismatch Repair Proficient Colorectal CancerInfos
NCT02066259OctavaColon Cancer Blood Tests OctavaGold and OctavaSilver - Blood Tests for the Help in Diagnosis of Colon Cancer Clinical Study ProtocolObservationalN/AUnknown statusIsraelColon CancerInfos
NCT02070146Prospective Data Collection Initiative on Colorectal CancerObservationalN/ARecruitment openNetherlandsColorectal CancerInfos
NCT02075086Angiogenic Switch in Patients With Colorectal CancerInterventionalPhase 2Unknown statusSpainColorectal CancerInfos
NCT02077868Evaluation of MGN1703 Maintenance Treatment in Patients With mCRC With Tumor Reduction During Induction TreatmentInterventionalPhase 3Unknown statusAustriaMetastatic Colorectal CancerInfos
NCT02077868Evaluation of MGN1703 Maintenance Treatment in Patients With mCRC With Tumor Reduction During Induction TreatmentInterventionalPhase 3Unknown statusBelgiumMetastatic Colorectal CancerInfos
NCT02077868Evaluation of MGN1703 Maintenance Treatment in Patients With mCRC With Tumor Reduction During Induction TreatmentInterventionalPhase 3Unknown statusEstoniaMetastatic Colorectal CancerInfos
NCT02077868Evaluation of MGN1703 Maintenance Treatment in Patients With mCRC With Tumor Reduction During Induction TreatmentInterventionalPhase 3Unknown statusFranceMetastatic Colorectal CancerInfos
NCT02077868Evaluation of MGN1703 Maintenance Treatment in Patients With mCRC With Tumor Reduction During Induction TreatmentInterventionalPhase 3Unknown statusGermanyMetastatic Colorectal CancerInfos
NCT02077868Evaluation of MGN1703 Maintenance Treatment in Patients With mCRC With Tumor Reduction During Induction TreatmentInterventionalPhase 3Unknown statusItalyMetastatic Colorectal CancerInfos
NCT02077868Evaluation of MGN1703 Maintenance Treatment in Patients With mCRC With Tumor Reduction During Induction TreatmentInterventionalPhase 3Unknown statusSpainMetastatic Colorectal CancerInfos
NCT02077868Evaluation of MGN1703 Maintenance Treatment in Patients With mCRC With Tumor Reduction During Induction TreatmentInterventionalPhase 3Unknown statusUnited KingdomMetastatic Colorectal CancerInfos
NCT02078245Quality Control Study of MR Based Screening of Individual With Increased Risk for Pancreas Cancer.ObservationalN/ARecruitment openSwedenHereditary Pancreatic CancerInfos
NCT02078245Quality Control Study of MR Based Screening of Individual With Increased Risk for Pancreas Cancer.ObservationalN/ARecruitment openSwedenHereditary PancreatitisInfos
NCT02079363DNA Promoter Hypermethylation as a Blood Based Maker for Pancreatic CancerObservationalN/AUnknown statusDenmarkPancreatic DiseasesInfos
NCT02079363DNA Promoter Hypermethylation as a Blood Based Maker for Pancreatic CancerObservationalN/AUnknown statusDenmarkPancreatic NeoplasmsInfos
NCT02079363DNA Promoter Hypermethylation as a Blood Based Maker for Pancreatic CancerObservationalN/AUnknown statusDenmarkPancreatitisInfos
NCT02089269Tumor Registry Pancreatic CancerObservationalN/AActive but recruitment closedGermanyPancreas CancerInfos
NCT02112357Feasibility of a Molecular Characterisation Approach to TreatmentObservationalN/AUnknown statusUnited KingdomAdvanced Gastrointestinal CancersInfos
NCT02125409Acetylsalicylic Acid and Colorectal Cancer Prevention: Exploring the Platelet Function of Its Mechanism of ActionInterventionalPhase 3Unknown statusSpainColorectal CancerInfos
NCT02138370Comprehensive Immune-landscape in Localized Colorectal CancerObservationalN/AUnknown statusSwitzerlandColorectal CancerInfos
NCT02138370Comprehensive Immune-landscape in Localized Colorectal CancerObservationalN/AUnknown statusSwitzerlandImmune LandscapeInfos
NCT02145013Portal Hypertension and Liver Resection in Patients With Hepatocellular CarcinomaObservationalN/AUnknown statusFrancePrimary Liver CancersInfos
NCT02162563Treatment Strategies in Colorectal Cancer Patients With Initially Unresectable Liver-only MetastasesInterventionalPhase 3Recruitment openBelgiumColorectal CancerInfos
NCT02162563Treatment Strategies in Colorectal Cancer Patients With Initially Unresectable Liver-only MetastasesInterventionalPhase 3Recruitment openBelgiumLiver MetastasesInfos
NCT02162563Treatment Strategies in Colorectal Cancer Patients With Initially Unresectable Liver-only MetastasesInterventionalPhase 3Recruitment openNetherlandsColorectal CancerInfos
NCT02162563Treatment Strategies in Colorectal Cancer Patients With Initially Unresectable Liver-only MetastasesInterventionalPhase 3Recruitment openNetherlandsLiver MetastasesInfos
NCT02164149Length of Tumour Feeding Artery After Colon Cancer SurgeryObservationalN/AUnknown statusDenmarkColon CancerInfos
NCT02175914Erythromycin Treatment for Readthrough of APC Gene Stop Codon Mutations in Familial Adenomatous PolyposisInterventionalPhase 4Unknown statusIsraelFAP-Familial Adenomatous PolyposisInfos
NCT02184663Evaluation of an Adapted Physical Activity Program in Patients With Unresectable Pancreatic CancerInterventionalNot ApplicableActive but recruitment closedFranceMetastatic Pancreatic CancerInfos
NCT02184663Evaluation of an Adapted Physical Activity Program in Patients With Unresectable Pancreatic CancerInterventionalNot ApplicableActive but recruitment closedFranceUnresectable Locally Advanced CancerInfos
NCT02188927Effect of an Advanced Notification Letter on Screening Colonoscopy ParticipationInterventionalNot ApplicableUnknown statusPolandColorectal CancerInfos
NCT02197351Narrow Band Imaging for Gastric NeoplasiaInterventionalNot ApplicableRecruitment openPortugalGastric CancerInfos
NCT02208804Surefire Infusion System vs. Standard Microcatheter Use During Holmium-166 RadioembolizationInterventionalPhase 2/Phase 3Unknown statusNetherlandsDigestive System NeoplasmsInfos
NCT02209415EUFURO - EUS-based Follow-Up on R0-resected Patients for Esophageal, Gastric and Pancreatic CancerInterventionalNot ApplicableUnknown statusDenmarkEsophageal CancerInfos
NCT02209415EUFURO - EUS-based Follow-Up on R0-resected Patients for Esophageal, Gastric and Pancreatic CancerInterventionalNot ApplicableUnknown statusDenmarkPancreatic CancerInfos
NCT02209415EUFURO - EUS-based Follow-Up on R0-resected Patients for Esophageal, Gastric and Pancreatic CancerInterventionalNot ApplicableUnknown statusDenmarkStomach CancerInfos
NCT02215577ALPPS Versus PVE/PLInterventionalNot ApplicableUnknown statusDenmarkColorectal CancerInfos
NCT02215577ALPPS Versus PVE/PLInterventionalNot ApplicableUnknown statusNorwayColorectal CancerInfos
NCT02215577ALPPS Versus PVE/PLInterventionalNot ApplicableUnknown statusSwedenColorectal CancerInfos
NCT02215889Partial Liver Segment 2/3 Transplantation StudyInterventionalPhase 1/Phase 2Recruitment openNorwayColorectal CancerInfos
NCT02230553Lapatinib Plus Trametinib in KRAS Mutant NSCLCInterventionalPhase 1/Phase 2Unknown statusNetherlandsColorectal CancerInfos
NCT02231385Acetic Acid Colonoscopy Enhancement StudyInterventionalNot ApplicableUnknown statusItalyColorectal CancerInfos
NCT02246322A Clinical Trial With a New Needle Device Comparing Two Needles for EUS_FNA of Solid Lesions.InterventionalNot ApplicableUnknown statusItalyPancreatic CancerInfos
NCT02246634Screening for Synchronous Metastases in Colorectal Cancer With DW-MRI (SERENADE)InterventionalNot ApplicableRecruitment openUnited KingdomColorectal NeoplasmsInfos
NCT02246634Screening for Synchronous Metastases in Colorectal Cancer With DW-MRI (SERENADE)InterventionalNot ApplicableRecruitment openUnited KingdomHepatic NeoplasmsInfos
NCT02246634Screening for Synchronous Metastases in Colorectal Cancer With DW-MRI (SERENADE)InterventionalNot ApplicableRecruitment openUnited KingdomNeoplasm MetastasesInfos
NCT02246725Observational Study of Early Contact With Palliative Care Unit for Patients Receiving First Line Palliative Chemotherapy With Cancer in Upper Gastrointestinal Canal, or Second Line Palliative Chemotherapy in Patients With Colorectal Cancer - an Open, Randomised Investigator Initiated Trial.ObservationalN/AUnknown statusSwedenTumor in Upper Gastrointestinal Canal or Patients With Colorectal CancerInfos
NCT02248519Laparoscopic Versus Open Gastrectomy for Gastric CancerInterventionalNot ApplicableActive but recruitment closedNetherlandsGastric CancerInfos
NCT02254941Observational Study to Evaluate the Use of Targeted Therapies in Metastatic Colorectal CancerObservationalN/AActive but recruitment closedSpainMetastatic Colon CancerInfos
NCT02260128Effect of Chewing Gum on Postoperative Bowel Function Following Upper GI Tract Cancer SurgeryInterventionalNot ApplicableUnknown statusDenmarkPancreatic CancerInfos
NCT02260505Efficiency of Imatinib Treatment Maintenance or Interruption After 3 Years of Adjuvant Treatment in Patients With Gastrointestinal Stromal Tumours (GIST)InterventionalPhase 3Recruitment openFranceGastrointestinal Stromal TumorsInfos
NCT02260505Efficiency of Imatinib Treatment Maintenance or Interruption After 3 Years of Adjuvant Treatment in Patients With Gastrointestinal Stromal Tumours (GIST)InterventionalPhase 3Recruitment openFranceResected Gastrointestinal Stromal TumorsInfos
NCT02274753Personalizing Colorectal Cancer Medicine (ImmuCol2)ObservationalN/AActive but recruitment closedFranceColon CancerInfos
NCT02296203Cetuximab Rechallenge in Irinotecan-pretreated mCRC, KRAS, NRAS and BRAF Wild-type Treated in 1st Line With Anti-EGFR Therapy (CRICKET).InterventionalPhase 2Unknown statusItalyMetastatic Colorectal CancerInfos
NCT02299596Physical Activity in Relation to Surgical ProceduresInterventionalNot ApplicableActive but recruitment closedSwedenColorectal CancerInfos
NCT02301286A Trial of Aspirin on Recurrence and Survival in Colon Cancer PatientsInterventionalPhase 3Active but recruitment closedNetherlandsAdjuvant TherapyInfos
NCT02301286A Trial of Aspirin on Recurrence and Survival in Colon Cancer PatientsInterventionalPhase 3Active but recruitment closedNetherlandsColon CancerInfos
NCT02304978Prognostic Value of Tissue Factor (TF) in Blood t in Colorectal Cancer in AdultsInterventionalEarly Phase 1Unknown statusFranceColorectal CancerInfos
NCT02325323Prognosis and Risk Factors of Gastric Cancer in Patients With Intestinal MetaplasiaObservationalN/AUnknown statusFranceStomach CancerInfos
NCT02325453Robotic, Laparoscopic and Open Surgery for Gastric Cancer Compared on Surgical, Clinical and Oncological OutcomesObservationalN/AUnknown statusItalyGastric CancerInfos
NCT02327494Study to Evaluate Oxygen Monitoring at Different Stages of Neuromuscular Blockade in Colorectal SurgeryObservationalN/AUnknown statusSpainColorectal CancerInfos
NCT02327819The Effect of Branched-chain Amino Acid (BCAA) on the Progression of Primary Liver CancerInterventionalNot ApplicableUnknown statusIsraelPrimary Liver CancerInfos
NCT02328677ColoCare Study - Colorectal Cancer CohortObservationalN/ARecruitment openGermanyColorectal CancerInfos
NCT02331927PERMAD: Personalized Marker-driven Early Switch to Aflibercept in Patients With Metastatic Colorectal CancerInterventionalPhase 2Unknown statusGermanyMetastatic Colorectal CancerInfos
NCT02339116Folfoxiri Plus Bev Followed by Reintroduction of Folfoxiri Plus Bev at Progression Versus Folfox Plus Bev Followed by Folfiri Plus Bev in mCRCInterventionalPhase 3Unknown statusItalyMetastatic Colorectal CancerInfos
NCT02355119Italian Multicenter Study Comparing FOLFOXIRI Versus Gemcitabine as Adjuvant Treatment for Resected Pancreatic CancerInterventionalPhase 3Unknown statusItalyPancreatic CancerInfos
NCT02356406Celiac Plexus Radiosurgery for Pain ManagementInterventionalPhase 2Unknown statusIsraelDigestive System NeoplasmsInfos
NCT02363049Colectomy in Patients With Asymptomatic and Unresectable Stage IV Colon CancerInterventionalPhase 3Unknown statusFranceColon Cancer Liver MetastasisInfos
NCT02363049Colectomy in Patients With Asymptomatic and Unresectable Stage IV Colon CancerInterventionalPhase 3Unknown statusFranceMalignant Neoplasm of Large IntestineInfos
NCT02372500Trial of Chewing Gum to Reduce Post Operative Ileus in Elective Colorectal SurgeryInterventionalNot ApplicableUnknown statusUnited KingdomColorectal CancerInfos
NCT02379039Multimodal Monitoring of Radiotherapy Response in Squamous Cell CancerObservationalN/AUnknown statusSwedenAnal CancerInfos
NCT02379039Multimodal Monitoring of Radiotherapy Response in Squamous Cell CancerObservationalN/AUnknown statusSwedenEsophageal CancerInfos
NCT02395224A Longitudinal Study of Colorectal Cancer Patients With Metastatic Disease in Middle-NorwayObservationalN/AActive but recruitment closedNorwayNeoplasm MetastasisInfos
NCT02395224A Longitudinal Study of Colorectal Cancer Patients With Metastatic Disease in Middle-NorwayObservationalN/AActive but recruitment closedNorwayNeoplasms, ColorectalInfos
NCT02403050Feasibility Study of Fiducial Markers in Oesophageal CancerObservationalN/AUnknown statusUnited KingdomEsophageal NeoplasmsInfos
NCT02415101Timing of Resective Surgery After Neoadjuvant Chemoradiotherapy in Esophageal CancerInterventionalNot ApplicableActive but recruitment closedSwedenCancer of the EsophagusInfos
NCT02416609Low-dose Radiotherapy Plus Chemotherapy With Gem-based Doublets and Stereotactic Radiotherapy for Advanced Pancreatic CancerInterventionalNot ApplicableRecruitment openItalyPancreatic CancerInfos
NCT02423239A Study of Dexanabinol in Combination With Chemotherapy in Patients With Advanced TumoursInterventionalPhase 1Unknown statusGermanyHepatocellular CarcinomaInfos
NCT02423239A Study of Dexanabinol in Combination With Chemotherapy in Patients With Advanced TumoursInterventionalPhase 1Unknown statusGermanyPancreatic CancerInfos
NCT02423239A Study of Dexanabinol in Combination With Chemotherapy in Patients With Advanced TumoursInterventionalPhase 1Unknown statusPolandHepatocellular CarcinomaInfos
NCT02423239A Study of Dexanabinol in Combination With Chemotherapy in Patients With Advanced TumoursInterventionalPhase 1Unknown statusPolandPancreatic CancerInfos
NCT02423239A Study of Dexanabinol in Combination With Chemotherapy in Patients With Advanced TumoursInterventionalPhase 1Unknown statusSpainHepatocellular CarcinomaInfos
NCT02423239A Study of Dexanabinol in Combination With Chemotherapy in Patients With Advanced TumoursInterventionalPhase 1Unknown statusSpainPancreatic CancerInfos
NCT02423239A Study of Dexanabinol in Combination With Chemotherapy in Patients With Advanced TumoursInterventionalPhase 1Unknown statusUnited KingdomHepatocellular CarcinomaInfos
NCT02423239A Study of Dexanabinol in Combination With Chemotherapy in Patients With Advanced TumoursInterventionalPhase 1Unknown statusUnited KingdomPancreatic CancerInfos
NCT02424279Invasive Treatment of Pain Associated With Pancreatic Cancer on Different Levels of WHO Analgesic LadderInterventionalNot ApplicableUnknown statusPolandPainInfos
NCT02424279Invasive Treatment of Pain Associated With Pancreatic Cancer on Different Levels of WHO Analgesic LadderInterventionalNot ApplicableUnknown statusPolandPancreatic CancerInfos
NCT02425657Fast Track Module Based Colonoscopy Training Programme for Surgical Trainees at North Jutland Surgical DepartmentsObservationalN/AUnknown statusDenmarkColorectal CancerInfos
NCT02436564In Vitro Models of Liver and Pancreatic CancerObservationalN/AUnknown statusUnited KingdomCholangiocarcinomaInfos
NCT02436564In Vitro Models of Liver and Pancreatic CancerObservationalN/AUnknown statusUnited KingdomHepatocellular CarcinomaInfos
NCT02436564In Vitro Models of Liver and Pancreatic CancerObservationalN/AUnknown statusUnited KingdomPancreatic NeoplasmInfos
NCT02443948Circulating Cell-free Tumor DNA in the Plasma of Patients With Gastrointestinal Stromal Tumors (GIST)ObservationalN/AUnknown statusItalyGastrointestinal Stromal Tumor (GIST)Infos
NCT02454790Standard Follow-Up Program (SFP) for Patients With Esophageal CancerObservationalN/ARecruitment openNetherlandsEsophageal CancerInfos
NCT02457156Cattell-Warren Versus Blumgart Techniques of Pancreatico-jejunostomy Following Pancreato-duodenectomyInterventionalPhase 3Active but recruitment closedUnited KingdomPancreatic CancerInfos
NCT02458664BASE HSP110 : A New Therapeutic Target and a New Marker for Prognosis of Type MSI Colorectal CancerObservationalN/AUnknown statusFranceCancer of ColonInfos
NCT02458664BASE HSP110 : A New Therapeutic Target and a New Marker for Prognosis of Type MSI Colorectal CancerObservationalN/AUnknown statusFranceRectum CancerInfos
NCT02467582Adjuvant Aspirin Treatment for Colon Cancer PatientsInterventionalPhase 3Active but recruitment closedBelgiumColon CancerInfos
NCT02467582Adjuvant Aspirin Treatment for Colon Cancer PatientsInterventionalPhase 3Active but recruitment closedGermanyColon CancerInfos
NCT02467582Adjuvant Aspirin Treatment for Colon Cancer PatientsInterventionalPhase 3Active but recruitment closedHungaryColon CancerInfos
NCT02467582Adjuvant Aspirin Treatment for Colon Cancer PatientsInterventionalPhase 3Active but recruitment closedSwitzerlandColon CancerInfos
NCT02470585Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Adults With Newly Diagnosed Stage III or IV, High-grade Serous, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerInterventionalPhase 3Active but recruitment closedDenmarkOvarian CancerInfos
NCT02470585Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Adults With Newly Diagnosed Stage III or IV, High-grade Serous, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerInterventionalPhase 3Active but recruitment closedDenmarkOvarian NeoplasmInfos
NCT02470585Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Adults With Newly Diagnosed Stage III or IV, High-grade Serous, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerInterventionalPhase 3Active but recruitment closedIsraelOvarian CancerInfos
NCT02470585Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Adults With Newly Diagnosed Stage III or IV, High-grade Serous, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerInterventionalPhase 3Active but recruitment closedIsraelOvarian NeoplasmInfos
NCT02470585Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Adults With Newly Diagnosed Stage III or IV, High-grade Serous, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerInterventionalPhase 3Active but recruitment closedPolandOvarian CancerInfos
NCT02470585Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Adults With Newly Diagnosed Stage III or IV, High-grade Serous, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerInterventionalPhase 3Active but recruitment closedPolandOvarian NeoplasmInfos
NCT02470585Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Adults With Newly Diagnosed Stage III or IV, High-grade Serous, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerInterventionalPhase 3Active but recruitment closedSpainOvarian CancerInfos
NCT02470585Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Adults With Newly Diagnosed Stage III or IV, High-grade Serous, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerInterventionalPhase 3Active but recruitment closedSpainOvarian NeoplasmInfos
NCT02470585Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Adults With Newly Diagnosed Stage III or IV, High-grade Serous, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerInterventionalPhase 3Active but recruitment closedUnited KingdomOvarian CancerInfos
NCT02470585Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Adults With Newly Diagnosed Stage III or IV, High-grade Serous, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerInterventionalPhase 3Active but recruitment closedUnited KingdomOvarian NeoplasmInfos
NCT02476045Panitumumab-based Maintenance in Patients With RAS Wild-type, Metastatic Colorectal Cancer (Valentino)InterventionalPhase 2Unknown statusItalyMetastatic Colorectal CancerInfos
NCT02497820Finding the Best Dose of Aspirin to Prevent Lynch Syndrome CancersInterventionalPhase 3Not yet recruitingIsraelLynch Syndrome I (Site-specific Colonic Cancer)Infos
NCT02502656RAS Mutation Testing in the Circulating Blood of Patients With Metastatic Colorectal CancerObservationalN/AUnknown statusFranceColorectal CancerInfos
NCT02508467A Phase 1 Study of Fisogatinib (BLU-554) in Patients With Hepatocellular CarcinomaInterventionalPhase 1Active but recruitment closedFranceHepatocellular Carcinoma (HCC)Infos
NCT02508467A Phase 1 Study of Fisogatinib (BLU-554) in Patients With Hepatocellular CarcinomaInterventionalPhase 1Active but recruitment closedGermanyHepatocellular Carcinoma (HCC)Infos
NCT02508467A Phase 1 Study of Fisogatinib (BLU-554) in Patients With Hepatocellular CarcinomaInterventionalPhase 1Active but recruitment closedItalyHepatocellular Carcinoma (HCC)Infos
NCT02508467A Phase 1 Study of Fisogatinib (BLU-554) in Patients With Hepatocellular CarcinomaInterventionalPhase 1Active but recruitment closedSpainHepatocellular Carcinoma (HCC)Infos
NCT02508467A Phase 1 Study of Fisogatinib (BLU-554) in Patients With Hepatocellular CarcinomaInterventionalPhase 1Active but recruitment closedSwitzerlandHepatocellular Carcinoma (HCC)Infos
NCT02508467A Phase 1 Study of Fisogatinib (BLU-554) in Patients With Hepatocellular CarcinomaInterventionalPhase 1Active but recruitment closedUnited KingdomHepatocellular Carcinoma (HCC)Infos
NCT02512263Assessment of Adherence and Efficiency of a Home-based Training Program on Muscular Strength, Endurance and Qol for Colon Cancer PatientsInterventionalNot ApplicableUnknown statusBelgiumColon CancerInfos
NCT02513849Tamoxifen in Patients With Oesophageal CancerInterventionalPhase 1Unknown statusUnited KingdomCancerInfos
NCT02513849Tamoxifen in Patients With Oesophageal CancerInterventionalPhase 1Unknown statusUnited KingdomGastrointestinal NeoplasmsInfos
NCT02519348A Study of Durvalumab or Tremelimumab Monotherapy, or Durvalumab in Combination With Tremelimumab or Bevacizumab in Advanced Hepatocellular CarcinomaInterventionalPhase 2Active but recruitment closedItalyHepatocellular CarcinomaInfos
NCT02519348A Study of Durvalumab or Tremelimumab Monotherapy, or Durvalumab in Combination With Tremelimumab or Bevacizumab in Advanced Hepatocellular CarcinomaInterventionalPhase 2Active but recruitment closedSpainHepatocellular CarcinomaInfos
NCT02519582Drug Trial to Investigate the Safety and Efficacy of Niclosamide Tablets in Patients With Metastases of a Colorectal Cancer Progressing After TherapyInterventionalPhase 2Unknown statusGermanyColorectal CancerInfos
NCT02526264Evaluation of Quality of Life and Period of Hospitalization by EducationInterventionalNot ApplicableRecruitment openGermanyColorectal CancerInfos
NCT02526836Complete Mesocolic Excision With Central Vessel Ligation Compared With Conventional Surgery for Colon CancerInterventionalPhase 2/Phase 3Unknown statusItalyColon CancerInfos
NCT02530593QoLiCOL - Quality of Life in Colon CancerObservationalN/AActive but recruitment closedSwedenColonic NeoplasmInfos
NCT02539537A Randomized Phase III Trial Comparing Folfirinox to Gemcitabine in Locally Advanced Pancreatic CarcinomaInterventionalPhase 3Active but recruitment closedFrancePancreatic CancerInfos
NCT02545699Prospective Trial to Compare ADR of G-EYEā„¢ Colonoscopy With Standard ColonoscopyInterventionalNot ApplicableUnknown statusIsraelColorectal CancerInfos
NCT02546973Quality of Life in Patients With Anal CancerObservationalN/AActive but recruitment closedSwedenAnal CancerInfos
NCT02551458Comparison of Systematic Surgery Versus Surveillance and Rescue Surgery in Operable Oesophageal Cancer With a Complete Clinical Response to RadiochemotherapyInterventionalPhase 2/Phase 3Unknown statusFranceAdenocarcinoma of the Oesogastric Junction (Siewert Type I or II)Infos
NCT02551458Comparison of Systematic Surgery Versus Surveillance and Rescue Surgery in Operable Oesophageal Cancer With a Complete Clinical Response to RadiochemotherapyInterventionalPhase 2/Phase 3Unknown statusFranceAdenocarcinoma of the Thoracic Oesophagus orInfos
NCT02551458Comparison of Systematic Surgery Versus Surveillance and Rescue Surgery in Operable Oesophageal Cancer With a Complete Clinical Response to RadiochemotherapyInterventionalPhase 2/Phase 3Unknown statusFranceEpidermoid Carcinoma orInfos
NCT02551458Comparison of Systematic Surgery Versus Surveillance and Rescue Surgery in Operable Oesophageal Cancer With a Complete Clinical Response to RadiochemotherapyInterventionalPhase 2/Phase 3Unknown statusFranceStage cT2 N1-3 M0 or cT3-T4a N0 or N1-3 M0Infos
NCT02556281Prognostic Value of Circulating Tumoral Free DNA Versus Circulating Tumoral Cells in Patients With Colorectal Cancer Stage II-IIIInterventionalNot ApplicableUnknown statusFranceColorectal NeoplasmsInfos
NCT02568267Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)InterventionalPhase 2Active but recruitment closedBelgiumColorectal CancerInfos
NCT02568267Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)InterventionalPhase 2Active but recruitment closedBelgiumPancreatic CancerInfos
NCT02568267Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)InterventionalPhase 2Active but recruitment closedFranceColorectal CancerInfos
NCT02568267Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)InterventionalPhase 2Active but recruitment closedFrancePancreatic CancerInfos
NCT02568267Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)InterventionalPhase 2Active but recruitment closedGermanyColorectal CancerInfos
NCT02568267Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)InterventionalPhase 2Active but recruitment closedGermanyPancreatic CancerInfos
NCT02568267Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)InterventionalPhase 2Active but recruitment closedItalyColorectal CancerInfos
NCT02568267Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)InterventionalPhase 2Active but recruitment closedItalyPancreatic CancerInfos
NCT02568267Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)InterventionalPhase 2Active but recruitment closedNetherlandsColorectal CancerInfos
NCT02568267Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)InterventionalPhase 2Active but recruitment closedNetherlandsPancreatic CancerInfos
NCT02568267Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)InterventionalPhase 2Active but recruitment closedPolandColorectal CancerInfos
NCT02568267Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)InterventionalPhase 2Active but recruitment closedPolandPancreatic CancerInfos
NCT02568267Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)InterventionalPhase 2Active but recruitment closedSpainColorectal CancerInfos
NCT02568267Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)InterventionalPhase 2Active but recruitment closedSpainPancreatic CancerInfos
NCT02568267Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)InterventionalPhase 2Active but recruitment closedUnited KingdomColorectal CancerInfos
NCT02568267Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)InterventionalPhase 2Active but recruitment closedUnited KingdomPancreatic CancerInfos
NCT02574013Randomized Controlled Trial for Retractor SPONGE Evaluation in Laparoscopic Colorectal SurgeryInterventionalNot ApplicableUnknown statusNetherlandsColorectal CancerInfos
NCT02576431A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid TumorsInterventionalPhase 2Recruitment openBelgiumSolid Tumors Harboring NTRK FusionInfos
NCT02576431A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid TumorsInterventionalPhase 2Recruitment openCzechiaSolid Tumors Harboring NTRK FusionInfos
NCT02576431A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid TumorsInterventionalPhase 2Recruitment openDenmarkSolid Tumors Harboring NTRK FusionInfos
NCT02576431A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid TumorsInterventionalPhase 2Recruitment openFranceSolid Tumors Harboring NTRK FusionInfos
NCT02576431A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid TumorsInterventionalPhase 2Recruitment openGermanySolid Tumors Harboring NTRK FusionInfos
NCT02576431A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid TumorsInterventionalPhase 2Recruitment openGreeceSolid Tumors Harboring NTRK FusionInfos
NCT02576431A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid TumorsInterventionalPhase 2Recruitment openHungarySolid Tumors Harboring NTRK FusionInfos
NCT02576431A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid TumorsInterventionalPhase 2Recruitment openIrelandSolid Tumors Harboring NTRK FusionInfos
NCT02576431A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid TumorsInterventionalPhase 2Recruitment openItalySolid Tumors Harboring NTRK FusionInfos
NCT02576431A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid TumorsInterventionalPhase 2Recruitment openNorwaySolid Tumors Harboring NTRK FusionInfos
NCT02576431A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid TumorsInterventionalPhase 2Recruitment openPolandSolid Tumors Harboring NTRK FusionInfos
NCT02576431A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid TumorsInterventionalPhase 2Recruitment openPortugalSolid Tumors Harboring NTRK FusionInfos
NCT02576431A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid TumorsInterventionalPhase 2Recruitment openRussian FederationSolid Tumors Harboring NTRK FusionInfos
NCT02576431A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid TumorsInterventionalPhase 2Recruitment openSlovakiaSolid Tumors Harboring NTRK FusionInfos
NCT02576431A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid TumorsInterventionalPhase 2Recruitment openSpainSolid Tumors Harboring NTRK FusionInfos
NCT02576431A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid TumorsInterventionalPhase 2Recruitment openSwedenSolid Tumors Harboring NTRK FusionInfos
NCT02576431A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid TumorsInterventionalPhase 2Recruitment openTurkeySolid Tumors Harboring NTRK FusionInfos
NCT02576431A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid TumorsInterventionalPhase 2Recruitment openUkraineSolid Tumors Harboring NTRK FusionInfos
NCT02576431A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid TumorsInterventionalPhase 2Recruitment openUnited KingdomSolid Tumors Harboring NTRK FusionInfos
NCT02576509An Investigational Immuno-therapy Study of Nivolumab Compared to Sorafenib as a First Treatment in Patients With Advanced Hepatocellular CarcinomaInterventionalPhase 3Active but recruitment closedAustriaHepatocellular CarcinomaInfos
NCT02576509An Investigational Immuno-therapy Study of Nivolumab Compared to Sorafenib as a First Treatment in Patients With Advanced Hepatocellular CarcinomaInterventionalPhase 3Active but recruitment closedBelgiumHepatocellular CarcinomaInfos
NCT02576509An Investigational Immuno-therapy Study of Nivolumab Compared to Sorafenib as a First Treatment in Patients With Advanced Hepatocellular CarcinomaInterventionalPhase 3Active but recruitment closedCzechiaHepatocellular CarcinomaInfos
NCT02576509An Investigational Immuno-therapy Study of Nivolumab Compared to Sorafenib as a First Treatment in Patients With Advanced Hepatocellular CarcinomaInterventionalPhase 3Active but recruitment closedFranceHepatocellular CarcinomaInfos
NCT02576509An Investigational Immuno-therapy Study of Nivolumab Compared to Sorafenib as a First Treatment in Patients With Advanced Hepatocellular CarcinomaInterventionalPhase 3Active but recruitment closedGermanyHepatocellular CarcinomaInfos
NCT02576509An Investigational Immuno-therapy Study of Nivolumab Compared to Sorafenib as a First Treatment in Patients With Advanced Hepatocellular CarcinomaInterventionalPhase 3Active but recruitment closedIsraelHepatocellular CarcinomaInfos
NCT02576509An Investigational Immuno-therapy Study of Nivolumab Compared to Sorafenib as a First Treatment in Patients With Advanced Hepatocellular CarcinomaInterventionalPhase 3Active but recruitment closedItalyHepatocellular CarcinomaInfos
NCT02576509An Investigational Immuno-therapy Study of Nivolumab Compared to Sorafenib as a First Treatment in Patients With Advanced Hepatocellular CarcinomaInterventionalPhase 3Active but recruitment closedPolandHepatocellular CarcinomaInfos
NCT02576509An Investigational Immuno-therapy Study of Nivolumab Compared to Sorafenib as a First Treatment in Patients With Advanced Hepatocellular CarcinomaInterventionalPhase 3Active but recruitment closedRussian FederationHepatocellular CarcinomaInfos
NCT02576509An Investigational Immuno-therapy Study of Nivolumab Compared to Sorafenib as a First Treatment in Patients With Advanced Hepatocellular CarcinomaInterventionalPhase 3Active but recruitment closedSpainHepatocellular CarcinomaInfos
NCT02576509An Investigational Immuno-therapy Study of Nivolumab Compared to Sorafenib as a First Treatment in Patients With Advanced Hepatocellular CarcinomaInterventionalPhase 3Active but recruitment closedSwedenHepatocellular CarcinomaInfos
NCT02576509An Investigational Immuno-therapy Study of Nivolumab Compared to Sorafenib as a First Treatment in Patients With Advanced Hepatocellular CarcinomaInterventionalPhase 3Active but recruitment closedSwitzerlandHepatocellular CarcinomaInfos
NCT02576509An Investigational Immuno-therapy Study of Nivolumab Compared to Sorafenib as a First Treatment in Patients With Advanced Hepatocellular CarcinomaInterventionalPhase 3Active but recruitment closedUnited KingdomHepatocellular CarcinomaInfos
NCT02577627Multi-Indication, Retrospective Oncological Study to Validate the Accuracy in Predicting TTP by PrediCare in Patients Under SOCObservationalN/AUnknown statusIsraelColon CancerInfos
NCT02578368Chemotherapy Alone vs. Chemotherapy + Surgical Resection in Patients With Limited-metastatic Adenocarcinoma of the Stomach or Esophagogastric JunctionInterventionalPhase 3Recruitment openGermanyGastric CancerInfos
NCT02579278Circulating Tumour DNA (ctDNA) in Patients With Colorectal Cancer and the Relationship to Imaging Features of Extramural Venous InvasionObservationalN/ARecruitment openUnited KingdomCancerInfos
NCT02579278Circulating Tumour DNA (ctDNA) in Patients With Colorectal Cancer and the Relationship to Imaging Features of Extramural Venous InvasionObservationalN/ARecruitment openUnited KingdomRectal CancerInfos
NCT02591667Histopathological Response to FOLFOXIRI + Bevacizumab in Peritoneal Metastasis From Colorectal CancerInterventionalPhase 2Unknown statusAustriaColorectal CancerInfos
NCT02591667Histopathological Response to FOLFOXIRI + Bevacizumab in Peritoneal Metastasis From Colorectal CancerInterventionalPhase 2Unknown statusAustriaPeritoneal MetastasisInfos
NCT02597348Liver Transplantation in Patients With Unresectable Colorectal Liver Metastases Treated by ChemotherapyInterventionalNot ApplicableActive but recruitment closedFranceColorectal CancerInfos
NCT02614534Clinical Trial to Evaluate Safety and Efficacy of Hyperthermic Intra-peritoneal Chemotherapy (HIPEC) With Mitomycin C Used During Surgery for Treatment of Locally Advanced Colorectal CarcinomaInterventionalPhase 3Active but recruitment closedSpainColorectal CancerInfos
NCT02618850PET/CT Scan as a Tool to Rationalize the Treatment of Patients With Advanced ColoRectal Cancer Undergoing First-line Medical TreatmentInterventionalNot ApplicableActive but recruitment closedItalyColorectal Cancer Stage IVInfos
NCT02619435Regorafenib Monotherapy as Second-line Treatment of Patients With RAS-mutant Advanced Colorectal CancerInterventionalPhase 2Active but recruitment closedItalyAdvanced Colorectal CancerInfos
NCT02624271Diagnosis of Gastric Precancerous Lesions by a Blood Test GastroPanel in Patients With Increased Gastric Cancer RiskInterventionalNot ApplicableUnknown statusFranceGastric CancerInfos
NCT02624271Diagnosis of Gastric Precancerous Lesions by a Blood Test GastroPanel in Patients With Increased Gastric Cancer RiskInterventionalNot ApplicableUnknown statusFranceGastric Precancerous LesionsInfos
NCT02624726Trial in Metastatic Colorectal Cancer With FOLFIRI Plus Aflibercept as First Line TreatmentInterventionalPhase 2Unknown statusGreeceMetastatic Colorectal CancerInfos
NCT02628067Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)InterventionalPhase 2Recruitment openDenmarkAnal CancerInfos
NCT02628067Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)InterventionalPhase 2Recruitment openFranceAnal CancerInfos
NCT02628067Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)InterventionalPhase 2Recruitment openGermanyAnal CancerInfos
NCT02628067Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)InterventionalPhase 2Recruitment openIsraelAnal CancerInfos
NCT02628067Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)InterventionalPhase 2Recruitment openItalyAnal CancerInfos
NCT02628067Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)InterventionalPhase 2Recruitment openNetherlandsAnal CancerInfos
NCT02628067Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)InterventionalPhase 2Recruitment openNorwayAnal CancerInfos
NCT02628067Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)InterventionalPhase 2Recruitment openRussian FederationAnal CancerInfos
NCT02628067Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)InterventionalPhase 2Recruitment openSpainAnal CancerInfos
NCT02628067Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)InterventionalPhase 2Recruitment openUnited KingdomAnal CancerInfos
NCT02633098A Safety and Effectiveness Study of Pre-operative Artesunate in Stage II/III Colorectal CancerInterventionalPhase 2Recruitment openUnited KingdomBowel CancerInfos
NCT02633098A Safety and Effectiveness Study of Pre-operative Artesunate in Stage II/III Colorectal CancerInterventionalPhase 2Recruitment openUnited KingdomColorectal CancerInfos
NCT02637687A Study to Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of Tumors With NTRK-fusion in ChildrenInterventionalPhase 1/Phase 2Active but recruitment closedCzechiaSolid Tumors Harboring NTRK FusionInfos
NCT02637687A Study to Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of Tumors With NTRK-fusion in ChildrenInterventionalPhase 1/Phase 2Active but recruitment closedDenmarkSolid Tumors Harboring NTRK FusionInfos
NCT02637687A Study to Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of Tumors With NTRK-fusion in ChildrenInterventionalPhase 1/Phase 2Active but recruitment closedFranceSolid Tumors Harboring NTRK FusionInfos
NCT02637687A Study to Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of Tumors With NTRK-fusion in ChildrenInterventionalPhase 1/Phase 2Active but recruitment closedGermanySolid Tumors Harboring NTRK FusionInfos
NCT02637687A Study to Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of Tumors With NTRK-fusion in ChildrenInterventionalPhase 1/Phase 2Active but recruitment closedIrelandSolid Tumors Harboring NTRK FusionInfos
NCT02637687A Study to Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of Tumors With NTRK-fusion in ChildrenInterventionalPhase 1/Phase 2Active but recruitment closedIsraelSolid Tumors Harboring NTRK FusionInfos
NCT02637687A Study to Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of Tumors With NTRK-fusion in ChildrenInterventionalPhase 1/Phase 2Active but recruitment closedItalySolid Tumors Harboring NTRK FusionInfos
NCT02637687A Study to Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of Tumors With NTRK-fusion in ChildrenInterventionalPhase 1/Phase 2Active but recruitment closedNetherlandsSolid Tumors Harboring NTRK FusionInfos
NCT02637687A Study to Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of Tumors With NTRK-fusion in ChildrenInterventionalPhase 1/Phase 2Active but recruitment closedPolandSolid Tumors Harboring NTRK FusionInfos
NCT02637687A Study to Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of Tumors With NTRK-fusion in ChildrenInterventionalPhase 1/Phase 2Active but recruitment closedRussian FederationSolid Tumors Harboring NTRK FusionInfos
NCT02637687A Study to Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of Tumors With NTRK-fusion in ChildrenInterventionalPhase 1/Phase 2Active but recruitment closedSpainSolid Tumors Harboring NTRK FusionInfos
NCT02637687A Study to Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of Tumors With NTRK-fusion in ChildrenInterventionalPhase 1/Phase 2Active but recruitment closedSwedenSolid Tumors Harboring NTRK FusionInfos
NCT02637687A Study to Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of Tumors With NTRK-fusion in ChildrenInterventionalPhase 1/Phase 2Active but recruitment closedSwitzerlandSolid Tumors Harboring NTRK FusionInfos
NCT02637687A Study to Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of Tumors With NTRK-fusion in ChildrenInterventionalPhase 1/Phase 2Active but recruitment closedTurkeySolid Tumors Harboring NTRK FusionInfos
NCT02637687A Study to Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of Tumors With NTRK-fusion in ChildrenInterventionalPhase 1/Phase 2Active but recruitment closedUkraineSolid Tumors Harboring NTRK FusionInfos
NCT02637687A Study to Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of Tumors With NTRK-fusion in ChildrenInterventionalPhase 1/Phase 2Active but recruitment closedUnited KingdomSolid Tumors Harboring NTRK FusionInfos
NCT02646462Systematic Lymph Node Sampling and Analysis in Patients With Pancreatic CancerObservationalN/AUnknown statusDenmarkPancreatic CancerInfos
NCT02647099Adjuvant Low Dose Aspirin in Colorectal CancerInterventionalPhase 3Recruitment openDenmarkColorectal CancerInfos
NCT02647099Adjuvant Low Dose Aspirin in Colorectal CancerInterventionalPhase 3Recruitment openFinlandColorectal CancerInfos
NCT02647099Adjuvant Low Dose Aspirin in Colorectal CancerInterventionalPhase 3Recruitment openNorwayColorectal CancerInfos
NCT02647099Adjuvant Low Dose Aspirin in Colorectal CancerInterventionalPhase 3Recruitment openSwedenColorectal CancerInfos
NCT02649790Study of the Safety, Tolerability and Efficacy of KPT-8602 in Participants With Relapsed/Refractory Cancer IndicationsInterventionalPhase 1/Phase 2Active but recruitment closedFranceMetastatic Colorectal Cancer (mCRC)Infos
NCT02649790Study of the Safety, Tolerability and Efficacy of KPT-8602 in Participants With Relapsed/Refractory Cancer IndicationsInterventionalPhase 1/Phase 2Active but recruitment closedSpainMetastatic Colorectal Cancer (mCRC)Infos
NCT02665312Cardiotoxicity and Risk Factors in Patients With Colorectal Cancer Receiving FluoropyrimidineObservationalN/AUnknown statusItalyColorectal CancerInfos
NCT02668913LCC-CARIS-01: Molecular Profiling in Gynaecological CancerInterventionalPhase 1/Phase 2Unknown statusUnited KingdomPeritoneal CancerInfos
NCT02672774Novel Endoscopic Imaging Methods for the Evaluation of Blood Vessels in Gastrointestinal CancersInterventionalNot ApplicableUnknown statusRomaniaColorectal CancerInfos
NCT02672774Novel Endoscopic Imaging Methods for the Evaluation of Blood Vessels in Gastrointestinal CancersInterventionalNot ApplicableUnknown statusRomaniaGastric CancerInfos
NCT02672774Novel Endoscopic Imaging Methods for the Evaluation of Blood Vessels in Gastrointestinal CancersInterventionalNot ApplicableUnknown statusRomaniaGastrointestinal NeoplasmsInfos
NCT02674100American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) RegistryObservationalN/AActive but recruitment closedUnited KingdomPancreatic CancerInfos
NCT02674373Prognostic and Predictive Impact of Circulating Tumor DNA in Gastric Cancer TreatmentObservationalN/AUnknown statusFranceGastric CancerInfos
NCT02678182Planning Treatment for Oesophago-gastric Cancer: a Maintenance Therapy TrialInterventionalPhase 2Recruitment openUnited KingdomAdenocarcinoma of the Gastro-oesophageal JunctionInfos
NCT02678182Planning Treatment for Oesophago-gastric Cancer: a Maintenance Therapy TrialInterventionalPhase 2Recruitment openUnited KingdomAdenocarcinoma of the OesophagusInfos
NCT02678182Planning Treatment for Oesophago-gastric Cancer: a Maintenance Therapy TrialInterventionalPhase 2Recruitment openUnited KingdomAdenocarcinoma of the StomachInfos
NCT02687321The Role of HE4 in the Follow-up of Advanced Ovarian, Fallopian Tube and Primary Peritoneal CancerObservationalN/AUnknown statusCzechiaOvarian NeoplasmsInfos
NCT02687321The Role of HE4 in the Follow-up of Advanced Ovarian, Fallopian Tube and Primary Peritoneal CancerObservationalN/AUnknown statusHungaryOvarian NeoplasmsInfos
NCT02687321The Role of HE4 in the Follow-up of Advanced Ovarian, Fallopian Tube and Primary Peritoneal CancerObservationalN/AUnknown statusPolandOvarian NeoplasmsInfos
NCT02687321The Role of HE4 in the Follow-up of Advanced Ovarian, Fallopian Tube and Primary Peritoneal CancerObservationalN/AUnknown statusSlovakiaOvarian NeoplasmsInfos
NCT02687321The Role of HE4 in the Follow-up of Advanced Ovarian, Fallopian Tube and Primary Peritoneal CancerObservationalN/AUnknown statusSpainOvarian NeoplasmsInfos
NCT02687321The Role of HE4 in the Follow-up of Advanced Ovarian, Fallopian Tube and Primary Peritoneal CancerObservationalN/AUnknown statusUkraineOvarian NeoplasmsInfos
NCT02697084Individual Following in Anal Cancer With PET/CTObservationalN/AUnknown statusFranceAnal CancerInfos
NCT02701088Study of SIB-IMRT in Combination With 5-FU and Mitomycin-C Among Patients With Locally Advanced Anal Canal Cancer: Efficacy, Safety and Quality of LifeInterventionalPhase 2Active but recruitment closedFranceLocally Advanced Anal Canal CancerInfos
NCT02702414Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Advanced Hepatocellular Carcinoma (MK-3475-224/KEYNOTE-224)InterventionalPhase 2Active but recruitment closedBelgiumHepatocellular CarcinomaInfos
NCT02702414Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Advanced Hepatocellular Carcinoma (MK-3475-224/KEYNOTE-224)InterventionalPhase 2Active but recruitment closedFranceHepatocellular CarcinomaInfos
NCT02702414Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Advanced Hepatocellular Carcinoma (MK-3475-224/KEYNOTE-224)InterventionalPhase 2Active but recruitment closedGermanyHepatocellular CarcinomaInfos
NCT02702414Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Advanced Hepatocellular Carcinoma (MK-3475-224/KEYNOTE-224)InterventionalPhase 2Active but recruitment closedItalyHepatocellular CarcinomaInfos
NCT02702414Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Advanced Hepatocellular Carcinoma (MK-3475-224/KEYNOTE-224)InterventionalPhase 2Active but recruitment closedSwedenHepatocellular CarcinomaInfos
NCT02702414Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Advanced Hepatocellular Carcinoma (MK-3475-224/KEYNOTE-224)InterventionalPhase 2Active but recruitment closedUnited KingdomHepatocellular CarcinomaInfos
NCT02704832Role of Geriatric Intervention in Treatment of Older Patients With Cancer (PREPARE)InterventionalPhase 3Unknown statusFranceColorectal CancerInfos
NCT02705300Side Effects to FOLFOXIRI + Tocotrienol/Placebo as First Line Treatment of Metastatic Colorectal CancerInterventionalPhase 2Active but recruitment closedDenmarkColorectal CancerInfos
NCT02707796Correlation Between Partial Oxygen Pressure and Oxygen Reserve IndexInterventionalNot ApplicableUnknown statusTurkeyCOLON CANCERInfos
NCT02715882Clinical Study of Safety and Tolerability of CBLB502 as a Neo-adjuvant Treatment in Patients With Colorectal CancerInterventionalPhase 2Unknown statusRussian FederationColorectal CancerInfos
NCT02716012First-in-Human Safety, Tolerability and Antitumour Activity Study of MTL-CEBPA in Patients With Advanced Liver CancerInterventionalPhase 1Unknown statusUnited KingdomHepatocellular CarcinomaInfos
NCT02716012First-in-Human Safety, Tolerability and Antitumour Activity Study of MTL-CEBPA in Patients With Advanced Liver CancerInterventionalPhase 1Unknown statusUnited KingdomLiver CancerInfos
NCT02726243Intestinal Microbiota and Colorectal Cancer in Inflammatory Bowel DiseaseObservationalN/AUnknown statusFranceColorectal CancerInfos
NCT02726243Intestinal Microbiota and Colorectal Cancer in Inflammatory Bowel DiseaseObservationalN/AUnknown statusFranceInflammatory Bowel DiseaseInfos
NCT02732301Postoperative Gastrointestinal Dysfunction After Cardiac Surgery - Occurrence and Search for BiomarkersObservationalN/AUnknown statusSwedenGastrointestinal TractInfos
NCT02734004A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors.InterventionalPhase 1/Phase 2Active but recruitment closedFranceGastric CancersInfos
NCT02734004A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors.InterventionalPhase 1/Phase 2Active but recruitment closedIsraelGastric CancersInfos
NCT02734004A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors.InterventionalPhase 1/Phase 2Active but recruitment closedNetherlandsGastric CancersInfos
NCT02734004A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors.InterventionalPhase 1/Phase 2Active but recruitment closedSwitzerlandGastric CancersInfos
NCT02734004A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors.InterventionalPhase 1/Phase 2Active but recruitment closedUnited KingdomGastric CancersInfos
NCT02738359Efficacy of Colonoscopy, Colon Capsule and Fecal Immunological Test for Colorectal Cancer ScreeningObservationalN/ARecruitment openFranceColon CancerInfos
NCT02738359Efficacy of Colonoscopy, Colon Capsule and Fecal Immunological Test for Colorectal Cancer ScreeningObservationalN/ARecruitment openFranceRectum CancerInfos
NCT02741167Pathophysiology of Inflammation After Cytoreductive Surgery and Hyperthermic Intraperitoneal ChemotherapyObservationalN/AUnknown statusSwitzerlandPeritoneal CancerInfos
NCT02741856Study of Chemoradiotherapy in Oesophageal Cancer Including PET Response and Dose EscalationInterventionalPhase 2/Phase 3Unknown statusUnited KingdomOesophageal CancerInfos
NCT02745600Clinical Intervention Modelling, Planning and Proof for Ablation Cancer TreatmentInterventionalNot ApplicableUnknown statusAustriaHepatocellular CarcinomaInfos
NCT02745600Clinical Intervention Modelling, Planning and Proof for Ablation Cancer TreatmentInterventionalNot ApplicableUnknown statusFinlandHepatocellular CarcinomaInfos
NCT02745600Clinical Intervention Modelling, Planning and Proof for Ablation Cancer TreatmentInterventionalNot ApplicableUnknown statusGermanyHepatocellular CarcinomaInfos
NCT02745600Clinical Intervention Modelling, Planning and Proof for Ablation Cancer TreatmentInterventionalNot ApplicableUnknown statusNetherlandsHepatocellular CarcinomaInfos
NCT02748551A Comparison Laparoscopic With Open Gastric Cancer Surgery for Locally Advanced Gastric CancerInterventionalPhase 3Unknown statusRussian FederationGastric CancerInfos
NCT02748551A Comparison Laparoscopic With Open Gastric Cancer Surgery for Locally Advanced Gastric CancerInterventionalPhase 3Unknown statusUkraineGastric CancerInfos
NCT02751086Robotic, Laparoscopic and Open Gastrectomy Compared on Short and Long Term OutcomesObservationalN/ARecruitment openItalyGastric CancerInfos
NCT02756455Procalcitonin Reveals Early Dehiscence in Gastric Surgery: the PREDIGS StudyObservationalN/AUnknown statusItalyGastric CancerInfos
NCT02756468Procalcitonin Reveals Early Dehiscence in Pancreatic Surgery: the PREDIPS StudyObservationalN/AUnknown statusItalyPancreatic CancerInfos
NCT02758951Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal MetastasesInterventionalPhase 2/Phase 3Recruitment openBelgiumColorectal CancerInfos
NCT02758951Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal MetastasesInterventionalPhase 2/Phase 3Recruitment openBelgiumPeritoneal CancerInfos
NCT02758951Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal MetastasesInterventionalPhase 2/Phase 3Recruitment openNetherlandsColorectal CancerInfos
NCT02758951Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal MetastasesInterventionalPhase 2/Phase 3Recruitment openNetherlandsPeritoneal CancerInfos
NCT02758977Associating Liver Partition With Portal Vein Ligation for Staged Hepatectomy (ALPPS) vs. Two-Stage Hepatectomy (TSH) for Marginally Resectable Colorectal Liver Metastases (CRLM)InterventionalNot ApplicableUnknown statusSwitzerlandColon Cancer Liver MetastasesInfos
NCT02759601Dose Escalation Trial of Tefinostat for Cancer Associated Inflamation in Hepatocellular Carcinoma (HCC)InterventionalPhase 1/Phase 2Unknown statusUnited KingdomHepatocellular CarcinomaInfos
NCT02767557Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab in Pancreatic Cancer PatientsInterventionalPhase 2Active but recruitment closedDenmarkUnresectable Pancreatic CarcinomaInfos
NCT02767557Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab in Pancreatic Cancer PatientsInterventionalPhase 2Active but recruitment closedNorwayUnresectable Pancreatic CarcinomaInfos
NCT02780921Effect of Prehabilitation in Gastroesophageal Adenocarcinoma: Study Protocol of a Multicentric, Randomised Control TrialInterventionalPhase 3Unknown statusFranceGastric CancerInfos
NCT02780921Effect of Prehabilitation in Gastroesophageal Adenocarcinoma: Study Protocol of a Multicentric, Randomised Control TrialInterventionalPhase 3Unknown statusFranceOesophageal CancerInfos
NCT02781935Diffusion-Weighted MRI for Liver MetastasisObservationalN/AActive but recruitment closedAustriaColon Cancer Liver MetastasisInfos
NCT02781935Diffusion-Weighted MRI for Liver MetastasisObservationalN/AActive but recruitment closedAustriaColorectal CancerInfos
NCT02781935Diffusion-Weighted MRI for Liver MetastasisObservationalN/AActive but recruitment closedBelgiumColon Cancer Liver MetastasisInfos
NCT02781935Diffusion-Weighted MRI for Liver MetastasisObservationalN/AActive but recruitment closedBelgiumColorectal CancerInfos
NCT02781935Diffusion-Weighted MRI for Liver MetastasisObservationalN/AActive but recruitment closedFranceColon Cancer Liver MetastasisInfos
NCT02781935Diffusion-Weighted MRI for Liver MetastasisObservationalN/AActive but recruitment closedFranceColorectal CancerInfos
NCT02781935Diffusion-Weighted MRI for Liver MetastasisObservationalN/AActive but recruitment closedPolandColon Cancer Liver MetastasisInfos
NCT02781935Diffusion-Weighted MRI for Liver MetastasisObservationalN/AActive but recruitment closedPolandColorectal CancerInfos
NCT02785263Shared Decision Making With Anal Cancer Patients on Radiation DoseInterventionalNot ApplicableActive but recruitment closedDenmarkAnal CancerInfos
NCT02786329Anesthesia and Postoperative Outcome in Colorectal Cancer PatientsInterventionalEarly Phase 1Recruitment openRomaniaColorectal CancerInfos
NCT02786342Italian Study Of Validation Of Angiogenesis Polymorphisms In HCC Patients Treated With SorafenibObservationalN/AUnknown statusItalyHepatocellular CarcinomaInfos
NCT02788669LRP1 and Colon CancerObservationalN/AUnknown statusFranceAdenocarcinomaInfos
NCT02788669LRP1 and Colon CancerObservationalN/AUnknown statusFranceColon CancerInfos
NCT02789709Metabolomic Phenotyping After Surgery for Colon Cancer: Study of Novel Predictive BiomarkersObservationalN/AUnknown statusSpainColon CancerInfos
NCT02791334A Study of Anti-PD-L1 Checkpoint Antibody (LY3300054) Alone and in Combination in Participants With Advanced Refractory Solid TumorsInterventionalPhase 1Active but recruitment closedBelgiumPancreatic CancerInfos
NCT02791334A Study of Anti-PD-L1 Checkpoint Antibody (LY3300054) Alone and in Combination in Participants With Advanced Refractory Solid TumorsInterventionalPhase 1Active but recruitment closedFrancePancreatic CancerInfos
NCT02791334A Study of Anti-PD-L1 Checkpoint Antibody (LY3300054) Alone and in Combination in Participants With Advanced Refractory Solid TumorsInterventionalPhase 1Active but recruitment closedIsraelPancreatic CancerInfos
NCT02791334A Study of Anti-PD-L1 Checkpoint Antibody (LY3300054) Alone and in Combination in Participants With Advanced Refractory Solid TumorsInterventionalPhase 1Active but recruitment closedNetherlandsPancreatic CancerInfos
NCT02791334A Study of Anti-PD-L1 Checkpoint Antibody (LY3300054) Alone and in Combination in Participants With Advanced Refractory Solid TumorsInterventionalPhase 1Active but recruitment closedSpainPancreatic CancerInfos
NCT02792023Usefulness of Fecal Immunochemical Test in Iron Deficiency Anemia (IDAFIT)InterventionalNot ApplicableUnknown statusSpainColorectal CancerInfos
NCT02795988A Study of IMU-131(HER-Vaxx) and Chemotherapy Compared to Chemotherapy Only in Patients With HER2 Positive Advanced Gastric CancerInterventionalPhase 1/Phase 2Active but recruitment closedGeorgiaAdenocarcinomaInfos
NCT02795988A Study of IMU-131(HER-Vaxx) and Chemotherapy Compared to Chemotherapy Only in Patients With HER2 Positive Advanced Gastric CancerInterventionalPhase 1/Phase 2Active but recruitment closedGeorgiaGastrointestinal NeoplasmsInfos
NCT02795988A Study of IMU-131(HER-Vaxx) and Chemotherapy Compared to Chemotherapy Only in Patients With HER2 Positive Advanced Gastric CancerInterventionalPhase 1/Phase 2Active but recruitment closedSerbiaAdenocarcinomaInfos
NCT02795988A Study of IMU-131(HER-Vaxx) and Chemotherapy Compared to Chemotherapy Only in Patients With HER2 Positive Advanced Gastric CancerInterventionalPhase 1/Phase 2Active but recruitment closedSerbiaGastrointestinal NeoplasmsInfos
NCT02795988A Study of IMU-131(HER-Vaxx) and Chemotherapy Compared to Chemotherapy Only in Patients With HER2 Positive Advanced Gastric CancerInterventionalPhase 1/Phase 2Active but recruitment closedUkraineAdenocarcinomaInfos
NCT02795988A Study of IMU-131(HER-Vaxx) and Chemotherapy Compared to Chemotherapy Only in Patients With HER2 Positive Advanced Gastric CancerInterventionalPhase 1/Phase 2Active but recruitment closedUkraineGastrointestinal NeoplasmsInfos
NCT02798003Food Reward in Cachexia Induced by Acute or Chronic DiseaseObservationalN/AUnknown statusNetherlandsPancreatic CancerInfos
NCT02799212Evaluation of Postoperative Ascites After Somatostatin Infusion Following Hepatectomy for Hepatocellular CarcinomaInterventionalPhase 3Recruitment openFranceHepatocellular CarcinomaInfos
NCT02804802Impact of DietarY and LIfestyle Risk Factors on Colorectal Cancer ScreeningObservationalN/AUnknown statusFranceColorectal CancerInfos
NCT02804815Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid TumoursInterventionalPhase 3Recruitment openIrelandColorectal CancerInfos
NCT02804815Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid TumoursInterventionalPhase 3Recruitment openIrelandGastro-oesophageal CancerInfos
NCT02804815Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid TumoursInterventionalPhase 3Recruitment openUnited KingdomColorectal CancerInfos
NCT02804815Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid TumoursInterventionalPhase 3Recruitment openUnited KingdomGastro-oesophageal CancerInfos
NCT02811666Impact of Preoperative Sarcopenia on Morbidity and Mortality in Patients Operated on From Digestive CancersInterventionalNot ApplicableUnknown statusFranceLiver CancerInfos
NCT02811666Impact of Preoperative Sarcopenia on Morbidity and Mortality in Patients Operated on From Digestive CancersInterventionalNot ApplicableUnknown statusFrancePancreatic CancerInfos
NCT02813824Effect of Chemoprevention by Low-dose Aspirin of New or Recurrent Colorectal Adenomas in Patients With Lynch SyndromeInterventionalPhase 3Recruitment openFranceLynch SyndromeInfos
NCT02818907Evaluation of Survival Prognostic Factors for Patients With Exocrine Pancreatic Cancer Resectable or Potentially ResectableInterventionalNot ApplicableUnknown statusFrancePancreatic CancerInfos
NCT02820389CT Colonography as the Initial Diagnostic Imaging Tool for Patients With Suspected Colorectal CancerObservationalN/AUnknown statusUnited KingdomColorectal CancerInfos
NCT02821793Expectations and Priorities of Elderly Patients for a First Medical Treatment for CancerObservationalN/AUnknown statusFranceColorectal CancerInfos
NCT02824185Combined Fluorocholine Positron Emission Tomography and Magnetic Resonance Imaging (FCH-PET/MRI) in Curative Treatment of a Hepatocellular CarcinomaInterventionalNot ApplicableUnknown statusFrancePatients Eligible to a Curative Treatment for Primary HCCInfos
NCT02824484A Guided Written Disclosure Intervention to Promote Post-traumatic Growth in Cancer Patients GUIDED WRITTEN DISCLOSUREInterventionalNot ApplicableUnknown statusItalyColorectal CancerInfos
NCT028416573D Laparoscopy Versus 2D LaparoscopyObservationalN/AUnknown statusItalyColorectal CancerInfos
NCT02842294Cohort Study to Assess Impact of Chemotherapy Plus Bevacizumab on Health Related Quality of Life in First Line Metastatic Colorectal CancerObservationalN/AUnknown statusFranceMetastatic Colorectal CancerInfos
NCT02842294Cohort Study to Assess Impact of Chemotherapy Plus Bevacizumab on Health Related Quality of Life in First Line Metastatic Colorectal CancerObservationalN/AUnknown statusFranceQuality of LifeInfos
NCT02844608Feasibility of Quality of Life Assessment in Routine Clinical Oncology Practice at the University Hospital of BesanconInterventionalNot ApplicableUnknown statusFranceColorectal CancerInfos
NCT02847468Multimetabolic 18F-Fluorodeoxyglucose (FDG) and 18F-Fluorocholine (FCH) Positron Emission Tomography (PET) as an Early Predictive Factor of Overall Survival in Patients With Advanced Hepatocellular Carcinoma Treated With SorafenibInterventionalNot ApplicableUnknown statusFranceCarcinoma, HepatocellularInfos
NCT02848807Chemotherapy-related Toxicity, Nutritional Status and Quality of LifeInterventionalNot ApplicableUnknown statusPolandMetastatic Colorectal CancerInfos
NCT02858141Onco-geriatric Database of Patients With Pancreatic CancerObservationalN/AUnknown statusFrancePancreatic NeoplasmsInfos
NCT02859753Comparison of Response and Recurrence Rates Following Percutaneous Microwave Coagulation Therapy Versus Percutaneous Radiofrequency AblationInterventionalNot ApplicableUnknown statusFranceHepatocellular CarcinomaInfos
NCT02861209Collaborative Network to Take Responsibility for Oral Anticancer TherapyInterventionalNot ApplicableUnknown statusBelgiumColorectal CancerInfos
NCT02861430Ex-vivo Sentinel Lymph Node in Stage I-II Colon Cancer: Kappa Analysis With Immunochemistry and Molecular BiologyObservationalN/AUnknown statusFranceColon CancerInfos
NCT02861430Ex-vivo Sentinel Lymph Node in Stage I-II Colon Cancer: Kappa Analysis With Immunochemistry and Molecular BiologyObservationalN/AUnknown statusFranceLymph NodeInfos
NCT02861430Ex-vivo Sentinel Lymph Node in Stage I-II Colon Cancer: Kappa Analysis With Immunochemistry and Molecular BiologyObservationalN/AUnknown statusFranceSentinel NodeInfos
NCT02866383Immune Checkpoint Inhibition in Combination With Radiation Therapy in Pancreatic Cancer or Biliary Tract Cancer PatientsInterventionalPhase 2Active but recruitment closedDenmarkMetastatic Biliary Tract CancerInfos
NCT02866383Immune Checkpoint Inhibition in Combination With Radiation Therapy in Pancreatic Cancer or Biliary Tract Cancer PatientsInterventionalPhase 2Active but recruitment closedDenmarkMetastatic Pancreatic CancerInfos
NCT02869503Institut Paoli Calmettes Colorectal Cancer DatabaseObservationalN/ARecruitment openFranceColorectal NeoplasmsInfos
NCT02872116Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction CancerInterventionalPhase 3Active but recruitment closedCzechiaGastric CancerInfos
NCT02872116Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction CancerInterventionalPhase 3Active but recruitment closedFranceGastric CancerInfos
NCT02872116Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction CancerInterventionalPhase 3Active but recruitment closedGermanyGastric CancerInfos
NCT02872116Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction CancerInterventionalPhase 3Active but recruitment closedGreeceGastric CancerInfos
NCT02872116Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction CancerInterventionalPhase 3Active but recruitment closedHungaryGastric CancerInfos
NCT02872116Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction CancerInterventionalPhase 3Active but recruitment closedIsraelGastric CancerInfos
NCT02872116Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction CancerInterventionalPhase 3Active but recruitment closedItalyGastric CancerInfos
NCT02872116Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction CancerInterventionalPhase 3Active but recruitment closedPolandGastric CancerInfos
NCT02872116Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction CancerInterventionalPhase 3Active but recruitment closedPortugalGastric CancerInfos
NCT02872116Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction CancerInterventionalPhase 3Active but recruitment closedRomaniaGastric CancerInfos
NCT02872116Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction CancerInterventionalPhase 3Active but recruitment closedRussian FederationGastric CancerInfos
NCT02872116Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction CancerInterventionalPhase 3Active but recruitment closedSpainGastric CancerInfos
NCT02872116Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction CancerInterventionalPhase 3Active but recruitment closedTurkeyGastric CancerInfos
NCT02872116Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction CancerInterventionalPhase 3Active but recruitment closedUnited KingdomGastric CancerInfos
NCT02872779Correlation Between Circulating Tumour Markers Early Variations and Clinical Response in First Line Treatment of Metastatic Colorectal CancerInterventionalNot ApplicableUnknown statusFranceCirculating MarkersInfos
NCT02872779Correlation Between Circulating Tumour Markers Early Variations and Clinical Response in First Line Treatment of Metastatic Colorectal CancerInterventionalNot ApplicableUnknown statusFranceMetastatic Colorectal CancerInfos
NCT02873845Role of the Spouse/Partner of Persons Treated With Chemotherapy for Colon CancerObservationalN/AUnknown statusFranceColon CancerInfos
NCT02876133Narrow Band Imaging Versus White Light for Colonoscopy Serrate Lesions DetectionInterventionalNot ApplicableUnknown statusPortugalColon CancerInfos
NCT02884453Proof-of-concept Study of Ibrutinib in c-MYC and HER2 Amplified Oesophagogastric CarcinomaInterventionalPhase 2Unknown statusUnited KingdomGastrooesophageal CancerInfos
NCT02885753Systemic Oxaliplatin or Intra-arterial Chemotherapy Combined With LV5FU2 +/- Irinotecan and an Target Therapy in First Line Treatment of Metastatic Colorectal Cancer Restricted to the LiverInterventionalPhase 3Recruitment openFranceColorectal NeoplasmsInfos
NCT02885753Systemic Oxaliplatin or Intra-arterial Chemotherapy Combined With LV5FU2 +/- Irinotecan and an Target Therapy in First Line Treatment of Metastatic Colorectal Cancer Restricted to the LiverInterventionalPhase 3Recruitment openSwitzerlandColorectal NeoplasmsInfos
NCT02904031Study of I Line FOLFOX + Panitumumab vs 5FU + Panitumumab in RAS and BRAF WT Metastatic Colorectal Cancer Elderly PatientsInterventionalPhase 2Unknown statusItalyElderly Metastatic Colorectal Cancer PatientsInfos
NCT02912559Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch RepairInterventionalPhase 3Active but recruitment closedGermanyColon AdenocarcinomaInfos
NCT02912559Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch RepairInterventionalPhase 3Active but recruitment closedGermanyDNA Repair DisorderInfos
NCT02912559Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch RepairInterventionalPhase 3Active but recruitment closedGermanyLynch SyndromeInfos
NCT02912559Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch RepairInterventionalPhase 3Active but recruitment closedGermanyStage III Colon Cancer AJCC v8Infos
NCT02912949A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy)InterventionalPhase 2Recruitment openAustriaPancreatic Cancer Harboring NRG1 FusionInfos
NCT02912949A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy)InterventionalPhase 2Recruitment openBelgiumPancreatic Cancer Harboring NRG1 FusionInfos
NCT02912949A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy)InterventionalPhase 2Recruitment openFrancePancreatic Cancer Harboring NRG1 FusionInfos
NCT02912949A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy)InterventionalPhase 2Recruitment openGermanyPancreatic Cancer Harboring NRG1 FusionInfos
NCT02912949A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy)InterventionalPhase 2Recruitment openIsraelPancreatic Cancer Harboring NRG1 FusionInfos
NCT02912949A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy)InterventionalPhase 2Recruitment openItalyPancreatic Cancer Harboring NRG1 FusionInfos
NCT02912949A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy)InterventionalPhase 2Recruitment openNetherlandsPancreatic Cancer Harboring NRG1 FusionInfos
NCT02912949A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy)InterventionalPhase 2Recruitment openNorwayPancreatic Cancer Harboring NRG1 FusionInfos
NCT02912949A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy)InterventionalPhase 2Recruitment openPortugalPancreatic Cancer Harboring NRG1 FusionInfos
NCT02912949A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy)InterventionalPhase 2Recruitment openSpainPancreatic Cancer Harboring NRG1 FusionInfos
NCT02912949A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy)InterventionalPhase 2Recruitment openSwedenPancreatic Cancer Harboring NRG1 FusionInfos
NCT02912949A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy)InterventionalPhase 2Recruitment openUnited KingdomPancreatic Cancer Harboring NRG1 FusionInfos
NCT02919644Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumour Homogenate After Curative Resection for Stage IV Colorectal Cancer.InterventionalPhase 2Recruitment openItalyCurative ResectionInfos
NCT02919644Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumour Homogenate After Curative Resection for Stage IV Colorectal Cancer.InterventionalPhase 2Recruitment openItalyStage IV Colorectal CancerInfos
NCT02919787Nordic Pancreatic Cancer Trial (NorPACT) - 1InterventionalPhase 2/Phase 3Active but recruitment closedDenmarkPancreatic CancerInfos
NCT02919787Nordic Pancreatic Cancer Trial (NorPACT) - 1InterventionalPhase 2/Phase 3Active but recruitment closedFinlandPancreatic CancerInfos
NCT02919787Nordic Pancreatic Cancer Trial (NorPACT) - 1InterventionalPhase 2/Phase 3Active but recruitment closedNorwayPancreatic CancerInfos
NCT02919787Nordic Pancreatic Cancer Trial (NorPACT) - 1InterventionalPhase 2/Phase 3Active but recruitment closedSwedenPancreatic CancerInfos
NCT02928120Diagnostic Potential of Hypermethylated DNA in Colorectal CancerObservationalN/AUnknown statusDenmarkAberrant DNA MethylationInfos
NCT02928120Diagnostic Potential of Hypermethylated DNA in Colorectal CancerObservationalN/AUnknown statusDenmarkColorectal NeoplasmsInfos
NCT02928627Clinical Significance of Hepatic and Circulating microRNAs miR-221 and miR-222 in Hepatocellular CarcinomaObservationalN/AUnknown statusUnited KingdomHepatocellular CarcinomaInfos
NCT02931890Multicentric Randomised Trial for Resectable Gastric CancerInterventionalPhase 2Recruitment openNetherlandsGastric CancerInfos
NCT02934529Metastatic Colorectal Cancer (RAS-wildtype) After Response to First-line Treatment With FOLFIR Plus CetuximabInterventionalPhase 3Recruitment openGermanyMetastatic Colorectal CancerInfos
NCT02938481International Prospective Observational Cohort Study for Optimal Bowel Resection Extent and Central Radicality for Colon CancerObservationalN/AActive but recruitment closedGermanyColon CancerInfos
NCT02938481International Prospective Observational Cohort Study for Optimal Bowel Resection Extent and Central Radicality for Colon CancerObservationalN/AActive but recruitment closedLithuaniaColon CancerInfos
NCT02938481International Prospective Observational Cohort Study for Optimal Bowel Resection Extent and Central Radicality for Colon CancerObservationalN/AActive but recruitment closedRussian FederationColon CancerInfos
NCT02938481International Prospective Observational Cohort Study for Optimal Bowel Resection Extent and Central Radicality for Colon CancerObservationalN/AActive but recruitment closedUnited KingdomColon CancerInfos
NCT02945033Study on Aspirin Versus Placebo in Resected Colon Cancer With PI3K Mutation Stage III or II High RiskInterventionalPhase 3Recruitment openFranceColorectal CancerInfos
NCT02950324Does Prehabilitation Improve Exercise Performance and Insulin Resistance After Surgery for Oesophago-gastric Cancer?InterventionalNot ApplicableUnknown statusUnited KingdomCancerInfos
NCT02955940An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of RuxolitinibInterventionalPhase 2Active but recruitment closedSpainColorectal Cancer (CRC)Infos
NCT02955940An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of RuxolitinibInterventionalPhase 2Active but recruitment closedSpainPancreatic CancerInfos
NCT02956876Equivalence of Monitoring by a Nurse Practitioner for Patients With Digestive CancerInterventionalPhase 3Unknown statusFranceColoRectal CancerInfos
NCT02959541PK/PD Investigation of Calciumfolinat in Blood, Tumor and Adjacent Mucosa in Patient With Colon CancerInterventionalNot ApplicableUnknown statusSwedenChemotherapyInfos
NCT02959541PK/PD Investigation of Calciumfolinat in Blood, Tumor and Adjacent Mucosa in Patient With Colon CancerInterventionalNot ApplicableUnknown statusSwedenColon CancerInfos
NCT02967289IRinotecan and Oxaliplatin for Colon Cancer in Adjuvant SettingInterventionalPhase 3Active but recruitment closedFranceColon Cancer (High-risk Stage III: pT4N1 or pT1 to 4 N2)Infos
NCT02974556Proactive Management of Endoperitoneal Spread in Colonic CancerInterventionalPhase 3Not yet recruitingItalyColon CancerInfos
NCT02975141Afatinib and Gemcitabine/Nab-paclitaxel in Metastatic Pancreatic CancerInterventionalPhase 1Unknown statusGermanyMetastatic Pancreatic CancerInfos
NCT02978612Adjuvant Chemotherapy In Elderly With Colon Cancer Stage IIIInterventionalPhase 2Active but recruitment closedNorwayColon CancerInfos
NCT02980510Comparison FOLFIRINOX Panitumumab vs mFOLFOX6 Panitumumab in RAS/B-RAF Wild-type Metastatic Colorectal Cancer PatientsInterventionalPhase 2Active but recruitment closedFranceMetastatic Colorectal CancerInfos
NCT02992912Atezolizumab With Stereotactic Ablative Radiotherapy in Patients With Metastatic TumoursInterventionalPhase 2Unknown statusFrancePatients With Metastatic Tumours (Colorectal Cancer, Non-small Lung Cancer, Renal Cell Carcinoma or Sarcoma )Infos
NCT03009227Study of Oncological Outcomes of D3 Lymph Node Dissection in Colon CancerInterventionalNot ApplicableActive but recruitment closedRussian FederationColonic Neoplasms MalignantInfos
NCT03026140Neoadjuvant Immune Checkpoint Inhibition and Novel IO Combinations in Early-stage Colon CancerInterventionalPhase 2Recruitment openNetherlandsColon CarcinomaInfos
NCT03037385Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid TumorsInterventionalPhase 1/Phase 2Active but recruitment closedBelgiumRET-altered Colon CancerInfos
NCT03037385Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid TumorsInterventionalPhase 1/Phase 2Active but recruitment closedFranceRET-altered Colon CancerInfos
NCT03037385Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid TumorsInterventionalPhase 1/Phase 2Active but recruitment closedGermanyRET-altered Colon CancerInfos
NCT03037385Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid TumorsInterventionalPhase 1/Phase 2Active but recruitment closedItalyRET-altered Colon CancerInfos
NCT03037385Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid TumorsInterventionalPhase 1/Phase 2Active but recruitment closedNetherlandsRET-altered Colon CancerInfos
NCT03037385Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid TumorsInterventionalPhase 1/Phase 2Active but recruitment closedSpainRET-altered Colon CancerInfos
NCT03037385Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid TumorsInterventionalPhase 1/Phase 2Active but recruitment closedUnited KingdomRET-altered Colon CancerInfos
NCT03042169Surgical Resection Plus Chemotherapy Versus Chemotherapy Alone in Oligometastatic Stage IV Gastric CancerInterventionalPhase 3Recruitment openFranceGastric AdenocarcinomaInfos
NCT03043313Tucatinib Plus Trastuzumab in Patients With HER2+ Colorectal CancerInterventionalPhase 2Active but recruitment closedBelgiumMetastatic Colorectal AdenocarcinomaInfos
NCT03043313Tucatinib Plus Trastuzumab in Patients With HER2+ Colorectal CancerInterventionalPhase 2Active but recruitment closedFranceMetastatic Colorectal AdenocarcinomaInfos
NCT03043313Tucatinib Plus Trastuzumab in Patients With HER2+ Colorectal CancerInterventionalPhase 2Active but recruitment closedItalyMetastatic Colorectal AdenocarcinomaInfos
NCT03043313Tucatinib Plus Trastuzumab in Patients With HER2+ Colorectal CancerInterventionalPhase 2Active but recruitment closedSpainMetastatic Colorectal AdenocarcinomaInfos
NCT03043950Validation of a New Prognostic Score for Adult Patients With RAS Wild-type mCRC Treated With VectibixĀ® and FOLFIRI or FOLFOX in First Line (VALIDATE)ObservationalN/AActive but recruitment closedGermanyMetastatic Colorectal CancerInfos
NCT03044223Monocyte Profiles in Critically Ill Patients With Pseudomonas Aeruginosa SepsisObservationalN/AUnknown statusGermanyPseudomonas Gastrointestinal Tract InfectionInfos
NCT03044587Nal-IRI With 5-fluorouracil (5-FU) and Leucovorin or Gemcitabine Plus Cisplatin in Advanced Biliary-tract CancerInterventionalPhase 2Active but recruitment closedGermanyNon-Resectable Hepatocellular CarcinomaInfos
NCT03045107Intracorporeal or Extracorporeal Anastomosis After Laparoscopic Right Colectomy.InterventionalNot ApplicableUnknown statusItalyColon CancerInfos
NCT03047837A Randomized, 2x2 Factorial Design Biomarker Prevention Trial of Low-dose Aspirin and Metformin in Stage I-III Colorectal Cancer Patients.InterventionalPhase 2Unknown statusItalyTertiary Prevention in Colon CancerInfos
NCT03051152D1 Versus D2 Lymphadenectomy in High Risk Elderly With Gastric AdenocarcinomaInterventionalNot ApplicableNot yet recruitingItalyGastric CancerInfos
NCT03052335The Efficiency of Colon Capsule Endoscopy in Colon Cancer ScreeningInterventionalNot ApplicableUnknown statusCzechiaColon CancerInfos
NCT03069508Clemizole HCl for Subjects With Hepatocellular CarcinomaInterventionalPhase 2Unknown statusTurkeyHepatocellular CarcinomaInfos
NCT03069664Palliative Pancreatic Duct Stenting in Patients With Inoperable Pancreatic CancerInterventionalNot ApplicableRecruitment openFinlandPancreatic CancerInfos
NCT03069664Palliative Pancreatic Duct Stenting in Patients With Inoperable Pancreatic CancerInterventionalNot ApplicableRecruitment openFinlandPancreatic Duct StrictureInfos
NCT03070613Investigating the Use of Fluorescent Lectins to Identify Dysplasia and Cancer During Endoscopy and SurgeryInterventionalEarly Phase 1Unknown statusUnited KingdomColorectal CancerInfos
NCT03081143Ramucirumab Plus FOLFIRI Versus Ramucirumab Plus Paclitaxel in Patients With Advanced or Metastatic Gastric Cancer, Who Failed One Prior Line of Palliative ChemotherapyInterventionalPhase 2/Phase 3Recruitment openAustriaAdvanced Gastric or EGJ CancerInfos
NCT03081143Ramucirumab Plus FOLFIRI Versus Ramucirumab Plus Paclitaxel in Patients With Advanced or Metastatic Gastric Cancer, Who Failed One Prior Line of Palliative ChemotherapyInterventionalPhase 2/Phase 3Recruitment openGermanyAdvanced Gastric or EGJ CancerInfos
NCT03081143Ramucirumab Plus FOLFIRI Versus Ramucirumab Plus Paclitaxel in Patients With Advanced or Metastatic Gastric Cancer, Who Failed One Prior Line of Palliative ChemotherapyInterventionalPhase 2/Phase 3Recruitment openItalyAdvanced Gastric or EGJ CancerInfos
NCT03083002Risk of Hepatocellular Carcinoma in Patient With Liver CirrhosisObservationalN/AUnknown statusItalyCarcinoma, HepatocellularInfos
NCT03083951Complete Mesocolon Excision vs Locoregional Lymphadenectomy in Sigmoid Colon Cancer (CMELL)InterventionalNot ApplicableUnknown statusSpainColorectal CancerInfos
NCT03083951Complete Mesocolon Excision vs Locoregional Lymphadenectomy in Sigmoid Colon Cancer (CMELL)InterventionalNot ApplicableUnknown statusSpainSigmoid CancerInfos
NCT03088150COLLISION Trial - Colorectal Liver Metastases: Surgery vs Thermal AblationInterventionalNot ApplicableRecruitment openNetherlandsColoRectal CancerInfos
NCT03088150COLLISION Trial - Colorectal Liver Metastases: Surgery vs Thermal AblationInterventionalNot ApplicableRecruitment openNetherlandsLiver Metastasis Colon CancerInfos
NCT03089268Molecular and Histological Characteristics of Serrated Lesions of the ColonObservationalN/AActive but recruitment closedSpainColorectal CancerInfos
NCT03096054A CR-UK Phase I Trial of LY3143921InterventionalPhase 1Active but recruitment closedUnited Kingdoma. Colorectal CancerInfos
NCT03096054A CR-UK Phase I Trial of LY3143921InterventionalPhase 1Active but recruitment closedUnited Kingdomh. Pancreatic CancerInfos
NCT03097224Prehabilitation in Frail Colon CancerInterventionalNot ApplicableUnknown statusBelgiumColon CancerInfos
NCT03097224Prehabilitation in Frail Colon CancerInterventionalNot ApplicableUnknown statusBelgiumFragilityInfos
NCT03098758Molecular Analysis in Peritoneal Washing Citology for Locally Advanced Gastric CancerObservationalN/AUnknown statusSpainGastric CancerInfos
NCT03098758Molecular Analysis in Peritoneal Washing Citology for Locally Advanced Gastric CancerObservationalN/AUnknown statusSpainPolymerase Chain ReactionInfos
NCT03113318Mediastinal Lymph Node Dissection in Conjunction With Pulmonary Metastasectomy From Colorectal CancerInterventionalNot ApplicableUnknown statusDenmarkColorectal CancerInfos
NCT03113318Mediastinal Lymph Node Dissection in Conjunction With Pulmonary Metastasectomy From Colorectal CancerInterventionalNot ApplicableUnknown statusDenmarkLung NeoplasmsInfos
NCT03113318Mediastinal Lymph Node Dissection in Conjunction With Pulmonary Metastasectomy From Colorectal CancerInterventionalNot ApplicableUnknown statusDenmarkNeoplasm MetastasisInfos
NCT03117972Chemotherapy Intensification in Patients With High Lactate Dehydrogenase Values and Soluble Syndecan1 LevelsInterventionalPhase 2Recruitment openFranceMetastatic Colorectal CancerInfos
NCT03124212Cascade Genetic Testing for Hereditary Breast/Ovarian Cancer and Lynch Syndrome in SwitzerlandObservationalN/ARecruitment openSwitzerlandHereditary Breast and Ovarian CancerInfos
NCT03124212Cascade Genetic Testing for Hereditary Breast/Ovarian Cancer and Lynch Syndrome in SwitzerlandObservationalN/ARecruitment openSwitzerlandLynch SyndromeInfos
NCT03126812Neo-adjuvant Pembrolizumab in Primary Stage IV Ovarian CancerInterventionalPhase 1/Phase 2Recruitment openNetherlandsPeritoneal CancerInfos
NCT03133273Study of the Therapeutic Response and Survival of Patients With Metastatic Colorectal Cancer (Stage IV) and Treated According to the Guidelines of a Chemosensitivity Test, OncogrammeĀ® (ONCOGRAM)InterventionalNot ApplicableActive but recruitment closedFranceChemotherapyInfos
NCT03133273Study of the Therapeutic Response and Survival of Patients With Metastatic Colorectal Cancer (Stage IV) and Treated According to the Guidelines of a Chemosensitivity Test, OncogrammeĀ® (ONCOGRAM)InterventionalNot ApplicableActive but recruitment closedFranceColorectal Cancer MetastaticInfos
NCT03133650A Trial of a New Type of Photodynamic Therapy (VTP) in the Treatment of Patients With Cancer of the Esophagus Who Have Trouble SwallowingInterventionalPhase 1Active but recruitment closedIsraelEsophagogastric CancerInfos
NCT03143153A Study to Evaluate Efficacy in Subjects With Esophageal Cancer Treated With Nivolumab and Ipilimumab or Nivolumab Combined With Fluorouracil Plus Cisplatin Versus Fluorouracil Plus CisplatinInterventionalPhase 3Active but recruitment closedAustriaVarious Advanced CancerInfos
NCT03143153A Study to Evaluate Efficacy in Subjects With Esophageal Cancer Treated With Nivolumab and Ipilimumab or Nivolumab Combined With Fluorouracil Plus Cisplatin Versus Fluorouracil Plus CisplatinInterventionalPhase 3Active but recruitment closedCzechiaVarious Advanced CancerInfos
NCT03143153A Study to Evaluate Efficacy in Subjects With Esophageal Cancer Treated With Nivolumab and Ipilimumab or Nivolumab Combined With Fluorouracil Plus Cisplatin Versus Fluorouracil Plus CisplatinInterventionalPhase 3Active but recruitment closedDenmarkVarious Advanced CancerInfos
NCT03143153A Study to Evaluate Efficacy in Subjects With Esophageal Cancer Treated With Nivolumab and Ipilimumab or Nivolumab Combined With Fluorouracil Plus Cisplatin Versus Fluorouracil Plus CisplatinInterventionalPhase 3Active but recruitment closedFranceVarious Advanced CancerInfos
NCT03143153A Study to Evaluate Efficacy in Subjects With Esophageal Cancer Treated With Nivolumab and Ipilimumab or Nivolumab Combined With Fluorouracil Plus Cisplatin Versus Fluorouracil Plus CisplatinInterventionalPhase 3Active but recruitment closedItalyVarious Advanced CancerInfos
NCT03143153A Study to Evaluate Efficacy in Subjects With Esophageal Cancer Treated With Nivolumab and Ipilimumab or Nivolumab Combined With Fluorouracil Plus Cisplatin Versus Fluorouracil Plus CisplatinInterventionalPhase 3Active but recruitment closedPolandVarious Advanced CancerInfos
NCT03143153A Study to Evaluate Efficacy in Subjects With Esophageal Cancer Treated With Nivolumab and Ipilimumab or Nivolumab Combined With Fluorouracil Plus Cisplatin Versus Fluorouracil Plus CisplatinInterventionalPhase 3Active but recruitment closedPortugalVarious Advanced CancerInfos
NCT03143153A Study to Evaluate Efficacy in Subjects With Esophageal Cancer Treated With Nivolumab and Ipilimumab or Nivolumab Combined With Fluorouracil Plus Cisplatin Versus Fluorouracil Plus CisplatinInterventionalPhase 3Active but recruitment closedRomaniaVarious Advanced CancerInfos
NCT03143153A Study to Evaluate Efficacy in Subjects With Esophageal Cancer Treated With Nivolumab and Ipilimumab or Nivolumab Combined With Fluorouracil Plus Cisplatin Versus Fluorouracil Plus CisplatinInterventionalPhase 3Active but recruitment closedRussian FederationVarious Advanced CancerInfos
NCT03143153A Study to Evaluate Efficacy in Subjects With Esophageal Cancer Treated With Nivolumab and Ipilimumab or Nivolumab Combined With Fluorouracil Plus Cisplatin Versus Fluorouracil Plus CisplatinInterventionalPhase 3Active but recruitment closedSpainVarious Advanced CancerInfos
NCT03143153A Study to Evaluate Efficacy in Subjects With Esophageal Cancer Treated With Nivolumab and Ipilimumab or Nivolumab Combined With Fluorouracil Plus Cisplatin Versus Fluorouracil Plus CisplatinInterventionalPhase 3Active but recruitment closedTurkeyVarious Advanced CancerInfos
NCT03143153A Study to Evaluate Efficacy in Subjects With Esophageal Cancer Treated With Nivolumab and Ipilimumab or Nivolumab Combined With Fluorouracil Plus Cisplatin Versus Fluorouracil Plus CisplatinInterventionalPhase 3Active but recruitment closedUnited KingdomVarious Advanced CancerInfos
NCT03146338Prophylaxis of Magnesium-rich Mineral Water to Prevent Hypomagnesemia Induced by an Anti-EGFR (OPTIMAG)InterventionalNot ApplicableActive but recruitment closedFranceMetastatic Colorectal CancerInfos
NCT03151252Improvement of Foodallergy Diagnostic in Gastrointestinal TractInterventionalNot ApplicableUnknown statusGermanyFood AllergyInfos
NCT03153280Dose Escalation Study of Lithium With Oxaliplatin and Capecitabine in Advanced Oesophago-Gastric or Colorectal CancerInterventionalPhase 1Recruitment openIrelandColorectal NeoplasmsInfos
NCT03153280Dose Escalation Study of Lithium With Oxaliplatin and Capecitabine in Advanced Oesophago-Gastric or Colorectal CancerInterventionalPhase 1Recruitment openIrelandEsophageal NeoplasmsInfos
NCT03153280Dose Escalation Study of Lithium With Oxaliplatin and Capecitabine in Advanced Oesophago-Gastric or Colorectal CancerInterventionalPhase 1Recruitment openIrelandStomach NeoplasmInfos
NCT03157128A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)InterventionalPhase 1/Phase 2Recruitment openDenmarkColon CancerInfos
NCT03157128A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)InterventionalPhase 1/Phase 2Recruitment openFranceColon CancerInfos
NCT03157128A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)InterventionalPhase 1/Phase 2Recruitment openGermanyColon CancerInfos
NCT03157128A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)InterventionalPhase 1/Phase 2Recruitment openIsraelColon CancerInfos
NCT03157128A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)InterventionalPhase 1/Phase 2Recruitment openItalyColon CancerInfos
NCT03157128A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)InterventionalPhase 1/Phase 2Recruitment openSpainColon CancerInfos
NCT03157128A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)InterventionalPhase 1/Phase 2Recruitment openSwitzerlandColon CancerInfos
NCT03157128A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)InterventionalPhase 1/Phase 2Recruitment openUnited KingdomColon CancerInfos
NCT03166436RFA for Malignant Biliary ObstructionInterventionalNot ApplicableUnknown statusCzechiaPancreas CancerInfos
NCT03167268Panitumumab Skin Toxicity Prevention TrialInterventionalPhase 2Unknown statusItalyColorectal Cancer MetastaticInfos
NCT03167814Prevention of Chyle-leak After Major Pancreatic SurgeryInterventionalNot ApplicableRecruitment openFinlandPancreatic CancerInfos
NCT03170960Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid TumorsInterventionalPhase 1/Phase 2Active but recruitment closedBelgiumColorectal CancerInfos
NCT03170960Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid TumorsInterventionalPhase 1/Phase 2Active but recruitment closedBelgiumGastric CancerInfos
NCT03170960Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid TumorsInterventionalPhase 1/Phase 2Active but recruitment closedBelgiumHepatocellular CarcinomaInfos
NCT03170960Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid TumorsInterventionalPhase 1/Phase 2Active but recruitment closedBelgiumLower Esophageal CancerInfos
NCT03170960Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid TumorsInterventionalPhase 1/Phase 2Active but recruitment closedFranceColorectal CancerInfos
NCT03170960Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid TumorsInterventionalPhase 1/Phase 2Active but recruitment closedFranceGastric CancerInfos
NCT03170960Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid TumorsInterventionalPhase 1/Phase 2Active but recruitment closedFranceHepatocellular CarcinomaInfos
NCT03170960Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid TumorsInterventionalPhase 1/Phase 2Active but recruitment closedFranceLower Esophageal CancerInfos
NCT03170960Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid TumorsInterventionalPhase 1/Phase 2Active but recruitment closedGermanyColorectal CancerInfos
NCT03170960Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid TumorsInterventionalPhase 1/Phase 2Active but recruitment closedGermanyGastric CancerInfos
NCT03170960Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid TumorsInterventionalPhase 1/Phase 2Active but recruitment closedGermanyHepatocellular CarcinomaInfos
NCT03170960Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid TumorsInterventionalPhase 1/Phase 2Active but recruitment closedGermanyLower Esophageal CancerInfos
NCT03170960Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid TumorsInterventionalPhase 1/Phase 2Active but recruitment closedItalyColorectal CancerInfos
NCT03170960Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid TumorsInterventionalPhase 1/Phase 2Active but recruitment closedItalyGastric CancerInfos
NCT03170960Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid TumorsInterventionalPhase 1/Phase 2Active but recruitment closedItalyHepatocellular CarcinomaInfos
NCT03170960Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid TumorsInterventionalPhase 1/Phase 2Active but recruitment closedItalyLower Esophageal CancerInfos
NCT03170960Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid TumorsInterventionalPhase 1/Phase 2Active but recruitment closedNetherlandsColorectal CancerInfos
NCT03170960Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid TumorsInterventionalPhase 1/Phase 2Active but recruitment closedNetherlandsGastric CancerInfos
NCT03170960Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid TumorsInterventionalPhase 1/Phase 2Active but recruitment closedNetherlandsHepatocellular CarcinomaInfos
NCT03170960Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid TumorsInterventionalPhase 1/Phase 2Active but recruitment closedNetherlandsLower Esophageal CancerInfos
NCT03170960Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid TumorsInterventionalPhase 1/Phase 2Active but recruitment closedSpainColorectal CancerInfos
NCT03170960Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid TumorsInterventionalPhase 1/Phase 2Active but recruitment closedSpainGastric CancerInfos
NCT03170960Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid TumorsInterventionalPhase 1/Phase 2Active but recruitment closedSpainHepatocellular CarcinomaInfos
NCT03170960Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid TumorsInterventionalPhase 1/Phase 2Active but recruitment closedSpainLower Esophageal CancerInfos
NCT03170960Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid TumorsInterventionalPhase 1/Phase 2Active but recruitment closedUnited KingdomColorectal CancerInfos
NCT03170960Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid TumorsInterventionalPhase 1/Phase 2Active but recruitment closedUnited KingdomGastric CancerInfos
NCT03170960Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid TumorsInterventionalPhase 1/Phase 2Active but recruitment closedUnited KingdomHepatocellular CarcinomaInfos
NCT03170960Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid TumorsInterventionalPhase 1/Phase 2Active but recruitment closedUnited KingdomLower Esophageal CancerInfos
NCT03175224APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid TumorsInterventionalPhase 1/Phase 2Recruitment openFinlandGastric CancerInfos
NCT03175224APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid TumorsInterventionalPhase 1/Phase 2Recruitment openFranceGastric CancerInfos
NCT03175224APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid TumorsInterventionalPhase 1/Phase 2Recruitment openHungaryGastric CancerInfos
NCT03175224APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid TumorsInterventionalPhase 1/Phase 2Recruitment openItalyGastric CancerInfos
NCT03175224APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid TumorsInterventionalPhase 1/Phase 2Recruitment openRussian FederationGastric CancerInfos
NCT03175224APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid TumorsInterventionalPhase 1/Phase 2Recruitment openSpainGastric CancerInfos
NCT03175224APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid TumorsInterventionalPhase 1/Phase 2Recruitment openUkraineGastric CancerInfos
NCT03175224APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid TumorsInterventionalPhase 1/Phase 2Recruitment openUnited KingdomGastric CancerInfos
NCT03178812Role of the Cystic Fluid Interleukins and Tumor Necrosis Factor (TNF) Levels in Characterizing Pancreatic Cysts Detected by Endoscopic Ultrasound (EUS)InterventionalNot ApplicableUnknown statusIsraelPancreatic CancerInfos
NCT03186326Standard Chemotherapy vs Immunotherapie in 2nd Line Treatment of MSI Colorectal Mestastatic CancerInterventionalPhase 2Active but recruitment closedFranceMetastatic Colorectal CancerInfos
NCT03189576Measuring Molecular Residual Disease in Colorectal Cancer After Primary Surgery and Resection of MetastasesInterventionalNot ApplicableActive but recruitment closedFinlandColorectal CancerInfos
NCT03189576Measuring Molecular Residual Disease in Colorectal Cancer After Primary Surgery and Resection of MetastasesInterventionalNot ApplicableActive but recruitment closedFinlandResidual DiseaseInfos
NCT03191110The COLON Study: Colorectal Cancer CohortObservationalN/ARecruitment openNetherlandsColorectal Neoplasms MalignantInfos
NCT03193190A Study of Multiple Immunotherapy-Based Treatment Combinations in Participants With Metastatic Pancreatic Ductal Adenocarcinoma (Morpheus-Pancreatic Cancer)InterventionalPhase 1/Phase 2Recruitment openGermanyPancreatic AdenocarcinomaInfos
NCT03193190A Study of Multiple Immunotherapy-Based Treatment Combinations in Participants With Metastatic Pancreatic Ductal Adenocarcinoma (Morpheus-Pancreatic Cancer)InterventionalPhase 1/Phase 2Recruitment openSpainPancreatic AdenocarcinomaInfos
NCT03200834Comparison of D2 vs D3 Lymph Node Dissection for Right Colon Cancer (RICON)InterventionalNot ApplicableActive but recruitment closedUkraineColon CancerInfos
NCT03205735The Enzymatic Activity of Lymphocyte Dihydropyrimidine Dehydrogenase DPD in the Blood as a Predictive and Prognostic Factor in Patients With Digestive Cancer in the First or Second Metastatic LineObservationalN/AUnknown statusFranceMetastatic or Locally-advanced Digestive CancerInfos
NCT03208621Evaluation of PET and Laparoscopy in STagIng Advanced Gastric CancerObservationalN/AActive but recruitment closedNetherlandsDiagnostic LaparoscopyInfos
NCT03208621Evaluation of PET and Laparoscopy in STagIng Advanced Gastric CancerObservationalN/AActive but recruitment closedNetherlandsFDG-PET/CTInfos
NCT03208621Evaluation of PET and Laparoscopy in STagIng Advanced Gastric CancerObservationalN/AActive but recruitment closedNetherlandsGastric CancerInfos
NCT03208621Evaluation of PET and Laparoscopy in STagIng Advanced Gastric CancerObservationalN/AActive but recruitment closedNetherlandsStagingInfos
NCT03210298International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)ObservationalN/AUnknown statusAustriaAppendix CancerInfos
NCT03210298International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)ObservationalN/AUnknown statusAustriaColorectal CancerInfos
NCT03210298International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)ObservationalN/AUnknown statusAustriaGastric CancerInfos
NCT03210298International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)ObservationalN/AUnknown statusAustriaPancreas CancerInfos
NCT03210298International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)ObservationalN/AUnknown statusBelgiumAppendix CancerInfos
NCT03210298International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)ObservationalN/AUnknown statusBelgiumColorectal CancerInfos
NCT03210298International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)ObservationalN/AUnknown statusBelgiumGastric CancerInfos
NCT03210298International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)ObservationalN/AUnknown statusBelgiumPancreas CancerInfos
NCT03210298International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)ObservationalN/AUnknown statusDenmarkAppendix CancerInfos
NCT03210298International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)ObservationalN/AUnknown statusDenmarkColorectal CancerInfos
NCT03210298International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)ObservationalN/AUnknown statusDenmarkGastric CancerInfos
NCT03210298International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)ObservationalN/AUnknown statusDenmarkPancreas CancerInfos
NCT03210298International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)ObservationalN/AUnknown statusFranceAppendix CancerInfos
NCT03210298International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)ObservationalN/AUnknown statusFranceColorectal CancerInfos
NCT03210298International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)ObservationalN/AUnknown statusFranceGastric CancerInfos
NCT03210298International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)ObservationalN/AUnknown statusFrancePancreas CancerInfos
NCT03210298International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)ObservationalN/AUnknown statusGermanyAppendix CancerInfos
NCT03210298International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)ObservationalN/AUnknown statusGermanyColorectal CancerInfos
NCT03210298International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)ObservationalN/AUnknown statusGermanyGastric CancerInfos
NCT03210298International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)ObservationalN/AUnknown statusGermanyPancreas CancerInfos
NCT03210298International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)ObservationalN/AUnknown statusItalyAppendix CancerInfos
NCT03210298International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)ObservationalN/AUnknown statusItalyColorectal CancerInfos
NCT03210298International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)ObservationalN/AUnknown statusItalyGastric CancerInfos
NCT03210298International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)ObservationalN/AUnknown statusItalyPancreas CancerInfos
NCT03210298International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)ObservationalN/AUnknown statusPolandAppendix CancerInfos
NCT03210298International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)ObservationalN/AUnknown statusPolandColorectal CancerInfos
NCT03210298International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)ObservationalN/AUnknown statusPolandGastric CancerInfos
NCT03210298International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)ObservationalN/AUnknown statusPolandPancreas CancerInfos
NCT03210298International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)ObservationalN/AUnknown statusRussian FederationAppendix CancerInfos
NCT03210298International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)ObservationalN/AUnknown statusRussian FederationColorectal CancerInfos
NCT03210298International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)ObservationalN/AUnknown statusRussian FederationGastric CancerInfos
NCT03210298International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)ObservationalN/AUnknown statusRussian FederationPancreas CancerInfos
NCT03210298International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)ObservationalN/AUnknown statusSpainAppendix CancerInfos
NCT03210298International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)ObservationalN/AUnknown statusSpainColorectal CancerInfos
NCT03210298International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)ObservationalN/AUnknown statusSpainGastric CancerInfos
NCT03210298International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)ObservationalN/AUnknown statusSpainPancreas CancerInfos
NCT03210298International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)ObservationalN/AUnknown statusSwitzerlandAppendix CancerInfos
NCT03210298International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)ObservationalN/AUnknown statusSwitzerlandColorectal CancerInfos
NCT03210298International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)ObservationalN/AUnknown statusSwitzerlandGastric CancerInfos
NCT03210298International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)ObservationalN/AUnknown statusSwitzerlandPancreas CancerInfos
NCT03210948Conventional Versus Elastography Targeted Endoscopic Ultrasound Fine Needle Aspiration of Solid Pancreatic LesionsInterventionalNot ApplicableUnknown statusItalyPancreas CancerInfos
NCT03212469A Trial of Durvalumab and Tremelimumab in Combination With SBRT in Patients With Metastatic CancerInterventionalPhase 1/Phase 2Active but recruitment closedFranceOesophageal CancerInfos
NCT03214939Autologous Antigen-activated Dendritic Cells in the Treatment of Patients With Colorectal CancerInterventionalEarly Phase 1Unknown statusRussian FederationColorectal CancerInfos
NCT03221426Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)InterventionalPhase 3Active but recruitment closedBelgiumGastric CancerInfos
NCT03221426Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)InterventionalPhase 3Active but recruitment closedEstoniaGastric CancerInfos
NCT03221426Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)InterventionalPhase 3Active but recruitment closedFranceGastric CancerInfos
NCT03221426Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)InterventionalPhase 3Active but recruitment closedGermanyGastric CancerInfos
NCT03221426Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)InterventionalPhase 3Active but recruitment closedHungaryGastric CancerInfos
NCT03221426Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)InterventionalPhase 3Active but recruitment closedIsraelGastric CancerInfos
NCT03221426Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)InterventionalPhase 3Active but recruitment closedItalyGastric CancerInfos
NCT03221426Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)InterventionalPhase 3Active but recruitment closedLatviaGastric CancerInfos
NCT03221426Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)InterventionalPhase 3Active but recruitment closedLithuaniaGastric CancerInfos
NCT03221426Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)InterventionalPhase 3Active but recruitment closedPolandGastric CancerInfos
NCT03221426Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)InterventionalPhase 3Active but recruitment closedRussian FederationGastric CancerInfos
NCT03221426Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)InterventionalPhase 3Active but recruitment closedSpainGastric CancerInfos
NCT03221426Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)InterventionalPhase 3Active but recruitment closedUkraineGastric CancerInfos
NCT03221426Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)InterventionalPhase 3Active but recruitment closedUnited KingdomGastric CancerInfos
NCT03225937Evaluation of Trastuzumab in Combination With Lapatinib or Pertuzumab in Combination With Trastuzumab-Emtansine to Treat Patients With HER2-positive Metastatic Colorectal CancerInterventionalPhase 2Unknown statusItalyMetastatic Colorectal CancerInfos
NCT03225989Trial Investigating an Immunostimulatory Oncolytic Adenovirus for CancerInterventionalPhase 1/Phase 2Active but recruitment closedSwedenColorectal CancerInfos
NCT03232541The Effects of Acupuncture and the Therapist“s Communication on Chemotherapy Induced Nausea and VomitingInterventionalNot ApplicableRecruitment openSwedenColorectal CancerInfos
NCT03245658The Effect of Cannabis in Pancreatic CancerInterventionalPhase 2Unknown statusDenmarkAppetite LossInfos
NCT03245658The Effect of Cannabis in Pancreatic CancerInterventionalPhase 2Unknown statusDenmarkCachexia; CancerInfos
NCT03245658The Effect of Cannabis in Pancreatic CancerInterventionalPhase 2Unknown statusDenmarkCannabisInfos
NCT03245658The Effect of Cannabis in Pancreatic CancerInterventionalPhase 2Unknown statusDenmarkMorbidityInfos
NCT03245658The Effect of Cannabis in Pancreatic CancerInterventionalPhase 2Unknown statusDenmarkMortalityInfos
NCT03245658The Effect of Cannabis in Pancreatic CancerInterventionalPhase 2Unknown statusDenmarkNeoplasms PancreaticInfos
NCT03245658The Effect of Cannabis in Pancreatic CancerInterventionalPhase 2Unknown statusDenmarkPalliative MedicineInfos
NCT03246516Determinants of Patient Delay in Doctor Consultation in Oeso-gastric CancersInterventionalNot ApplicableActive but recruitment closedFranceGastric AdenocarcinomaInfos
NCT03246516Determinants of Patient Delay in Doctor Consultation in Oeso-gastric CancersInterventionalNot ApplicableActive but recruitment closedFranceOesophageal CarcinomaInfos
NCT03250091Surveillance of Patients With Precancerous Lesions of the StomachObservationalN/ARecruitment openLatviaGastric CancerInfos
NCT03251365Intrabdominal Hyperthermic Chemotherapy and Pancreatic CancerInterventionalPhase 2/Phase 3Recruitment openSpainResectable Pancreatic AdenocarcinomaInfos
NCT03253536Prospective Observational Trial to Evaluate Quality of Life After Stereotactic Ablative Radiation Therapy in Patients With Hepatocellular CarcinomaObservationalN/ARecruitment openGermanyHepatocellular CancerInfos
NCT03253536Prospective Observational Trial to Evaluate Quality of Life After Stereotactic Ablative Radiation Therapy in Patients With Hepatocellular CarcinomaObservationalN/ARecruitment openGermanyObservationalInfos
NCT03253536Prospective Observational Trial to Evaluate Quality of Life After Stereotactic Ablative Radiation Therapy in Patients With Hepatocellular CarcinomaObservationalN/ARecruitment openGermanyQuality of LifeInfos
NCT03253536Prospective Observational Trial to Evaluate Quality of Life After Stereotactic Ablative Radiation Therapy in Patients With Hepatocellular CarcinomaObservationalN/ARecruitment openGermanyStereotactic Body Radiation TherapyInfos
NCT03254836Sleep and Survival in Colorectal CancerObservationalN/AUnknown statusDenmarkCircadian Rhythm Sleep DisorderInfos
NCT03254836Sleep and Survival in Colorectal CancerObservationalN/AUnknown statusDenmarkColorectal NeoplasmInfos
NCT03254836Sleep and Survival in Colorectal CancerObservationalN/AUnknown statusDenmarkDepressionInfos
NCT03254836Sleep and Survival in Colorectal CancerObservationalN/AUnknown statusDenmarkQuality of LifeInfos
NCT03254836Sleep and Survival in Colorectal CancerObservationalN/AUnknown statusDenmarkSleepInfos
NCT03255434LEAn Body Mass Normalization of OXaliplatin Based ChemotherapyInterventionalPhase 2Active but recruitment closedFranceStage III Colon CancerInfos
NCT03256084Tumoral Circulating Cells and Colorectal Cancer ProgressionInterventionalNot ApplicableRecruitment openFranceColorectal CancerInfos
NCT03257033Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPCInterventionalPhase 3Recruitment openBelgiumLocally Advanced Pancreatic CancerInfos
NCT03257280Trial on Impact on the Hospital Stay, of an Early Oral Nutrition Protocol Applied to Patients After Total Gastrectomy. (DOPGT_2015)InterventionalNot ApplicableUnknown statusSpainGastric CancerInfos
NCT03267316A First-in-Human Study of CAN04 in Patients With Solid Malignant TumorsInterventionalPhase 1/Phase 2Unknown statusAustriaColorectal CancerInfos
NCT03267316A First-in-Human Study of CAN04 in Patients With Solid Malignant TumorsInterventionalPhase 1/Phase 2Unknown statusBelgiumColorectal CancerInfos
NCT03267316A First-in-Human Study of CAN04 in Patients With Solid Malignant TumorsInterventionalPhase 1/Phase 2Unknown statusDenmarkColorectal CancerInfos
NCT03267316A First-in-Human Study of CAN04 in Patients With Solid Malignant TumorsInterventionalPhase 1/Phase 2Unknown statusEstoniaColorectal CancerInfos
NCT03267316A First-in-Human Study of CAN04 in Patients With Solid Malignant TumorsInterventionalPhase 1/Phase 2Unknown statusGermanyColorectal CancerInfos
NCT03267316A First-in-Human Study of CAN04 in Patients With Solid Malignant TumorsInterventionalPhase 1/Phase 2Unknown statusLatviaColorectal CancerInfos
NCT03267316A First-in-Human Study of CAN04 in Patients With Solid Malignant TumorsInterventionalPhase 1/Phase 2Unknown statusLithuaniaColorectal CancerInfos
NCT03267316A First-in-Human Study of CAN04 in Patients With Solid Malignant TumorsInterventionalPhase 1/Phase 2Unknown statusNetherlandsColorectal CancerInfos
NCT03267316A First-in-Human Study of CAN04 in Patients With Solid Malignant TumorsInterventionalPhase 1/Phase 2Unknown statusNorwayColorectal CancerInfos
NCT03267316A First-in-Human Study of CAN04 in Patients With Solid Malignant TumorsInterventionalPhase 1/Phase 2Unknown statusSpainColorectal CancerInfos
NCT03267316A First-in-Human Study of CAN04 in Patients With Solid Malignant TumorsInterventionalPhase 1/Phase 2Unknown statusSwedenColorectal CancerInfos
NCT03277144Incidence of Duodenal Stump Fistula After Gastrectomy for Gastric Cancer. A Randomized Controlled TrialInterventionalNot ApplicableUnknown statusItalyDuodenal Stump LeakInfos
NCT03277144Incidence of Duodenal Stump Fistula After Gastrectomy for Gastric Cancer. A Randomized Controlled TrialInterventionalNot ApplicableUnknown statusItalyGastric CancerInfos
NCT03280407NEOadjuvant Chemotherapy Only Compared With Standard Treatment for Locally Advanced Rectal CancerInterventionalPhase 2Recruitment openDenmarkColorectal CancerInfos
NCT03280511Adjuvant Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in Resected High Risk Colon Cancer PatientsInterventionalPhase 2Recruitment openDenmarkColo-rectal CancerInfos
NCT03280511Adjuvant Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in Resected High Risk Colon Cancer PatientsInterventionalPhase 2Recruitment openDenmarkPeritoneal CarcinomatosisInfos
NCT03280511Adjuvant Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in Resected High Risk Colon Cancer PatientsInterventionalPhase 2Recruitment openDenmarkPeritoneal MetastasesInfos
NCT03280511Adjuvant Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in Resected High Risk Colon Cancer PatientsInterventionalPhase 2Recruitment openDenmarkPeritoneum CancerInfos
NCT03281369A Study of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Cancer (G/GEJ) or Esophageal Cancer (Morpheus-Gastric and Esophageal Cancer)InterventionalPhase 1/Phase 2Recruitment openFranceGastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal CarcinomaInfos
NCT03281369A Study of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Cancer (G/GEJ) or Esophageal Cancer (Morpheus-Gastric and Esophageal Cancer)InterventionalPhase 1/Phase 2Recruitment openGermanyGastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal CarcinomaInfos
NCT03281369A Study of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Cancer (G/GEJ) or Esophageal Cancer (Morpheus-Gastric and Esophageal Cancer)InterventionalPhase 1/Phase 2Recruitment openIsraelGastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal CarcinomaInfos
NCT03281369A Study of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Cancer (G/GEJ) or Esophageal Cancer (Morpheus-Gastric and Esophageal Cancer)InterventionalPhase 1/Phase 2Recruitment openNetherlandsGastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal CarcinomaInfos
NCT03281369A Study of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Cancer (G/GEJ) or Esophageal Cancer (Morpheus-Gastric and Esophageal Cancer)InterventionalPhase 1/Phase 2Recruitment openSpainGastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal CarcinomaInfos
NCT03281369A Study of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Cancer (G/GEJ) or Esophageal Cancer (Morpheus-Gastric and Esophageal Cancer)InterventionalPhase 1/Phase 2Recruitment openUnited KingdomGastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal CarcinomaInfos
NCT03283527Organoid Based Response Prediction in Esophageal CancerObservationalN/ARecruitment openNetherlandsChemoradiationInfos
NCT03283527Organoid Based Response Prediction in Esophageal CancerObservationalN/ARecruitment openNetherlandsEsophageal CancerInfos
NCT03283527Organoid Based Response Prediction in Esophageal CancerObservationalN/ARecruitment openNetherlandsOrganoidInfos
NCT03289962A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic TumorsInterventionalPhase 1Active but recruitment closedBelgiumColorectal CancerInfos
NCT03289962A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic TumorsInterventionalPhase 1Active but recruitment closedGermanyColorectal CancerInfos
NCT03289962A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic TumorsInterventionalPhase 1Active but recruitment closedNetherlandsColorectal CancerInfos
NCT03289962A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic TumorsInterventionalPhase 1Active but recruitment closedSpainColorectal CancerInfos
NCT03289962A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic TumorsInterventionalPhase 1Active but recruitment closedSwedenColorectal CancerInfos
NCT03289962A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic TumorsInterventionalPhase 1Active but recruitment closedUnited KingdomColorectal CancerInfos
NCT03298451Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular CarcinomaInterventionalPhase 3Active but recruitment closedFranceHepatocellular CarcinomaInfos
NCT03298451Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular CarcinomaInterventionalPhase 3Active but recruitment closedGermanyHepatocellular CarcinomaInfos
NCT03298451Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular CarcinomaInterventionalPhase 3Active but recruitment closedItalyHepatocellular CarcinomaInfos
NCT03298451Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular CarcinomaInterventionalPhase 3Active but recruitment closedRussian FederationHepatocellular CarcinomaInfos
NCT03298451Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular CarcinomaInterventionalPhase 3Active but recruitment closedSpainHepatocellular CarcinomaInfos
NCT03298451Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular CarcinomaInterventionalPhase 3Active but recruitment closedUkraineHepatocellular CarcinomaInfos
NCT03301454Study of the Interest of Pursuing or Not the Chemotherapy for Patients With Metastatic Esophageal CancerInterventionalPhase 2Unknown statusFranceEsophageal Cancer, Squamous CellInfos
NCT03303833The GEOLynch Cohort StudyObservationalN/ARecruitment openNetherlandsHereditary Nonpolyposis Colorectal CancerInfos
NCT03303833The GEOLynch Cohort StudyObservationalN/ARecruitment openNetherlandsLynch SyndromeInfos
NCT03307408Hepatocellular Carcinoma in Patients With a Cirrhosis Due to an Alcoholic or a Non Alcoholic Fatty Liver DiseaseObservationalN/AUnknown statusFranceHepatocellular CarcinomaInfos
NCT03309722Molecular Pathology of Colorectal Cancer: Investigating the Role of Novel Molecular Profiles, microRNA's, and Their Targets in Colorectal Cancer ProgressionObservationalN/ARecruitment openUnited KingdomColorectal CancerInfos
NCT03310008Dose Escalation and Dose Expansion Phase I Study to Assess the Safety and Clinical Activity of Multiple Doses of NKR-2 Administered Concurrently With FOLFOX in Colorectal Cancer With Potentially Resectable Liver MetastasesInterventionalPhase 1Unknown statusBelgiumColon Cancer Liver MetastasisInfos
NCT03311152Circulating Cell-free DNA-based Epigenetic Biomarker mSEPT9 for Hepatocellular Carcinoma Detection in CirrhosisInterventionalNot ApplicableRecruitment openFranceCirrhosisInfos
NCT03311152Circulating Cell-free DNA-based Epigenetic Biomarker mSEPT9 for Hepatocellular Carcinoma Detection in CirrhosisInterventionalNot ApplicableRecruitment openFranceHepatocellular CarcinomaInfos
NCT03311776BIOmarkers in Patients With Pancreatic Cancer ("BIOPAC")ObservationalN/ARecruitment openDenmarkPancreatic CancerInfos
NCT03326791Aspirin in Colorectal Cancer Liver MetastasesInterventionalPhase 2/Phase 3Active but recruitment closedDenmarkColorectal CancerInfos
NCT03326791Aspirin in Colorectal Cancer Liver MetastasesInterventionalPhase 2/Phase 3Active but recruitment closedDenmarkColorectal Cancer Liver MetastasesInfos
NCT03326791Aspirin in Colorectal Cancer Liver MetastasesInterventionalPhase 2/Phase 3Active but recruitment closedDenmarkLiver MetastasesInfos
NCT03326791Aspirin in Colorectal Cancer Liver MetastasesInterventionalPhase 2/Phase 3Active but recruitment closedNorwayColorectal CancerInfos
NCT03326791Aspirin in Colorectal Cancer Liver MetastasesInterventionalPhase 2/Phase 3Active but recruitment closedNorwayColorectal Cancer Liver MetastasesInfos
NCT03326791Aspirin in Colorectal Cancer Liver MetastasesInterventionalPhase 2/Phase 3Active but recruitment closedNorwayLiver MetastasesInfos
NCT03326791Aspirin in Colorectal Cancer Liver MetastasesInterventionalPhase 2/Phase 3Active but recruitment closedSwedenColorectal CancerInfos
NCT03326791Aspirin in Colorectal Cancer Liver MetastasesInterventionalPhase 2/Phase 3Active but recruitment closedSwedenColorectal Cancer Liver MetastasesInfos
NCT03326791Aspirin in Colorectal Cancer Liver MetastasesInterventionalPhase 2/Phase 3Active but recruitment closedSwedenLiver MetastasesInfos
NCT03334708A Study of Blood Based Biomarkers for Pancreas AdenocarcinomaObservationalN/ARecruitment openIsraelPancreatic CancerInfos
NCT03336229Enhancing Fitness With Preoperative Exercise in Colorectal Cancer SurgeryInterventionalNot ApplicableUnknown statusUnited KingdomColorectal CancerInfos
NCT03340259Intestinal Colonization in Newborn Infants With EnterostomyObservationalN/AUnknown statusPortugalNewborn Infants With Enterostomy by Congenital Malformations of the Gastrointestinal Tract, Necrotizing Enterocolitis and Spontaneous Intestinal PerforationInfos
NCT03340636Residual Plasma Concentration of Sorafenib and Adverse Events in CHCObservationalN/AUnknown statusFranceAdvanced or Metastatic Hepatocellular CarcinomaInfos
NCT03348150Gastrectomy + Cytoreductive Surgery + HIPEC for Gastric Cancer With Peritoneal Dissemination.InterventionalPhase 3Recruitment openNetherlandsPeritoneal CarcinomatosisInfos
NCT03348150Gastrectomy + Cytoreductive Surgery + HIPEC for Gastric Cancer With Peritoneal Dissemination.InterventionalPhase 3Recruitment openNetherlandsStomach NeoplasmInfos
NCT03350126Interest of iRECIST Evaluation for DCR for Evaluation of Patients With Deficient MMR and /or MSI Metastatic Colorectal Cancer Treated With Nivolumab and IpilimumabInterventionalPhase 2Active but recruitment closedFranceMetastatic Cancer ColorectalInfos
NCT03350412Genotyping of Metastatic Colorectal Cancer Patients for Precision Medicine Clinical TrialsObservationalN/AUnknown statusItalyMetastatic Colorectal CancerInfos
NCT03351296Two Chemotherapy Regimens Plus or Minus BevacizumabInterventionalPhase 2Recruitment openFrancePancreatic CancerInfos
NCT03357991E6/E7 mRNA Performance to Detect HSIL and Cost-effectiveness Analysis of This Screening Strategy in HIV + MSMObservationalN/AUnknown statusSpainAnal CancerInfos
NCT03362177Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal CancerInterventionalPhase 3Recruitment openAustriaChemotherapy-induced ThrombocytopeniaInfos
NCT03362177Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal CancerInterventionalPhase 3Recruitment openBulgariaChemotherapy-induced ThrombocytopeniaInfos
NCT03362177Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal CancerInterventionalPhase 3Recruitment openFranceChemotherapy-induced ThrombocytopeniaInfos
NCT03362177Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal CancerInterventionalPhase 3Recruitment openGermanyChemotherapy-induced ThrombocytopeniaInfos
NCT03362177Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal CancerInterventionalPhase 3Recruitment openGreeceChemotherapy-induced ThrombocytopeniaInfos
NCT03362177Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal CancerInterventionalPhase 3Recruitment openHungaryChemotherapy-induced ThrombocytopeniaInfos
NCT03362177Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal CancerInterventionalPhase 3Recruitment openItalyChemotherapy-induced ThrombocytopeniaInfos
NCT03362177Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal CancerInterventionalPhase 3Recruitment openPolandChemotherapy-induced ThrombocytopeniaInfos
NCT03362177Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal CancerInterventionalPhase 3Recruitment openPortugalChemotherapy-induced ThrombocytopeniaInfos
NCT03362177Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal CancerInterventionalPhase 3Recruitment openRomaniaChemotherapy-induced ThrombocytopeniaInfos
NCT03362177Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal CancerInterventionalPhase 3Recruitment openRussian FederationChemotherapy-induced ThrombocytopeniaInfos
NCT03362177Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal CancerInterventionalPhase 3Recruitment openSpainChemotherapy-induced ThrombocytopeniaInfos
NCT03362177Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal CancerInterventionalPhase 3Recruitment openTurkeyChemotherapy-induced ThrombocytopeniaInfos
NCT03362177Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal CancerInterventionalPhase 3Recruitment openUkraineChemotherapy-induced ThrombocytopeniaInfos
NCT03370198Hepatic Transarterial Administrations of NKR-2 in Patients With Unresectable Liver Metastases From Colorectal CancerInterventionalPhase 1Unknown statusBelgiumColon Cancer Liver MetastasisInfos
NCT03377361An Investigational Immuno-therapy Study Of Nivolumab In Combination With Trametinib With Or Without Ipilimumab In Participants With Previously Treated Cancer of the Colon or Rectum That Has SpreadInterventionalPhase 1/Phase 2Active but recruitment closedBelgiumColorectal CancerInfos
NCT03377361An Investigational Immuno-therapy Study Of Nivolumab In Combination With Trametinib With Or Without Ipilimumab In Participants With Previously Treated Cancer of the Colon or Rectum That Has SpreadInterventionalPhase 1/Phase 2Active but recruitment closedCzechiaColorectal CancerInfos
NCT03377361An Investigational Immuno-therapy Study Of Nivolumab In Combination With Trametinib With Or Without Ipilimumab In Participants With Previously Treated Cancer of the Colon or Rectum That Has SpreadInterventionalPhase 1/Phase 2Active but recruitment closedGermanyColorectal CancerInfos
NCT03377361An Investigational Immuno-therapy Study Of Nivolumab In Combination With Trametinib With Or Without Ipilimumab In Participants With Previously Treated Cancer of the Colon or Rectum That Has SpreadInterventionalPhase 1/Phase 2Active but recruitment closedItalyColorectal CancerInfos
NCT03377361An Investigational Immuno-therapy Study Of Nivolumab In Combination With Trametinib With Or Without Ipilimumab In Participants With Previously Treated Cancer of the Colon or Rectum That Has SpreadInterventionalPhase 1/Phase 2Active but recruitment closedRussian FederationColorectal CancerInfos
NCT03377361An Investigational Immuno-therapy Study Of Nivolumab In Combination With Trametinib With Or Without Ipilimumab In Participants With Previously Treated Cancer of the Colon or Rectum That Has SpreadInterventionalPhase 1/Phase 2Active but recruitment closedSpainColorectal CancerInfos
NCT03377361An Investigational Immuno-therapy Study Of Nivolumab In Combination With Trametinib With Or Without Ipilimumab In Participants With Previously Treated Cancer of the Colon or Rectum That Has SpreadInterventionalPhase 1/Phase 2Active but recruitment closedUnited KingdomColorectal CancerInfos
NCT03380858REINFORCEMENT ANASTOMOSIS WITH Modified Cyanacrylate IN Patients Undergoing to Oncologic Colorectal Surgery With Colorectal AnastomosisObservationalN/AUnknown statusItalyColorectal CancerInfos
NCT03383367Colorectal Cancer Screening French Organizations for the Follow-up After ColonoscopyInterventionalNot ApplicableUnknown statusFranceColorectal CancerInfos
NCT03383458A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or AblationInterventionalPhase 3Active but recruitment closedAustriaHepatocellular CarcinomaInfos
NCT03383458A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or AblationInterventionalPhase 3Active but recruitment closedAustriaLiver CancerInfos
NCT03383458A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or AblationInterventionalPhase 3Active but recruitment closedBelgiumHepatocellular CarcinomaInfos
NCT03383458A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or AblationInterventionalPhase 3Active but recruitment closedBelgiumLiver CancerInfos
NCT03383458A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or AblationInterventionalPhase 3Active but recruitment closedFranceHepatocellular CarcinomaInfos
NCT03383458A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or AblationInterventionalPhase 3Active but recruitment closedFranceLiver CancerInfos
NCT03383458A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or AblationInterventionalPhase 3Active but recruitment closedGermanyHepatocellular CarcinomaInfos
NCT03383458A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or AblationInterventionalPhase 3Active but recruitment closedGermanyLiver CancerInfos
NCT03383458A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or AblationInterventionalPhase 3Active but recruitment closedItalyHepatocellular CarcinomaInfos
NCT03383458A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or AblationInterventionalPhase 3Active but recruitment closedItalyLiver CancerInfos
NCT03383458A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or AblationInterventionalPhase 3Active but recruitment closedNetherlandsHepatocellular CarcinomaInfos
NCT03383458A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or AblationInterventionalPhase 3Active but recruitment closedNetherlandsLiver CancerInfos
NCT03383458A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or AblationInterventionalPhase 3Active but recruitment closedPolandHepatocellular CarcinomaInfos
NCT03383458A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or AblationInterventionalPhase 3Active but recruitment closedPolandLiver CancerInfos
NCT03383458A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or AblationInterventionalPhase 3Active but recruitment closedRomaniaHepatocellular CarcinomaInfos
NCT03383458A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or AblationInterventionalPhase 3Active but recruitment closedRomaniaLiver CancerInfos
NCT03383458A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or AblationInterventionalPhase 3Active but recruitment closedRussian FederationHepatocellular CarcinomaInfos
NCT03383458A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or AblationInterventionalPhase 3Active but recruitment closedRussian FederationLiver CancerInfos
NCT03383458A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or AblationInterventionalPhase 3Active but recruitment closedSpainHepatocellular CarcinomaInfos
NCT03383458A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or AblationInterventionalPhase 3Active but recruitment closedSpainLiver CancerInfos
NCT03383458A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or AblationInterventionalPhase 3Active but recruitment closedUnited KingdomHepatocellular CarcinomaInfos
NCT03383458A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or AblationInterventionalPhase 3Active but recruitment closedUnited KingdomLiver CancerInfos
NCT03388190METIMMOX: Colorectal Cancer METastasis - Shaping Anti-tumor IMMunity by OXaliplatinInterventionalPhase 2Active but recruitment closedNorwayColorectal Cancer MetastaticInfos
NCT03390764Hernia After Colorectal Cancer SurgeryInterventionalNot ApplicableActive but recruitment closedSwedenIncisional HerniaInfos
NCT03390764Hernia After Colorectal Cancer SurgeryInterventionalNot ApplicableActive but recruitment closedSwedenQuality of LifeInfos
NCT03390764Hernia After Colorectal Cancer SurgeryInterventionalNot ApplicableActive but recruitment closedSwedenWound ComplicationInfos
NCT03390764Hernia After Colorectal Cancer SurgeryInterventionalNot ApplicableActive but recruitment closedSwedenWound DehiscenceInfos
NCT03399071Study Title: Peri-operative Immuno-Chemotherapy in Operable Oesophageal and Gastric CancerInterventionalPhase 2Active but recruitment closedUnited KingdomGastric AdenocarcinomaInfos
NCT03399071Study Title: Peri-operative Immuno-Chemotherapy in Operable Oesophageal and Gastric CancerInterventionalPhase 2Active but recruitment closedUnited KingdomOesophageal AdenocarcinomaInfos
NCT03400072Adapted Physical Activity in Patients With Resected Pancreatic Cancer (APACaPOp PRODIGE-56 Study): a National Multicenter Randomized Controlled Phase II TrialInterventionalNot ApplicableRecruitment openFrancePancreas CancerInfos
NCT03400072Adapted Physical Activity in Patients With Resected Pancreatic Cancer (APACaPOp PRODIGE-56 Study): a National Multicenter Randomized Controlled Phase II TrialInterventionalNot ApplicableRecruitment openFranceQuality of LifeInfos
NCT03400280POstopeRative Standardization of Care: THe Implementation of Best Practice After Pancreatic ResectionInterventionalNot ApplicableUnknown statusNetherlandsPancreatic CancerInfos
NCT03408665Stereotactic Body Radiation Therapy (SBRT) Efficiency and Toxicity in Liver CancerInterventionalNot ApplicableRecruitment openFranceLiver CancerInfos
NCT03408665Stereotactic Body Radiation Therapy (SBRT) Efficiency and Toxicity in Liver CancerInterventionalNot ApplicableRecruitment openFranceLiver MetastasesInfos
NCT03412773Phase 3 Study of Tislelizumab Versus Sorafenib in Participants With Unresectable HCCInterventionalPhase 3Active but recruitment closedCzechiaHepatocellular Carcinoma (HCC)Infos
NCT03412773Phase 3 Study of Tislelizumab Versus Sorafenib in Participants With Unresectable HCCInterventionalPhase 3Active but recruitment closedFranceHepatocellular Carcinoma (HCC)Infos
NCT03412773Phase 3 Study of Tislelizumab Versus Sorafenib in Participants With Unresectable HCCInterventionalPhase 3Active but recruitment closedGermanyHepatocellular Carcinoma (HCC)Infos
NCT03412773Phase 3 Study of Tislelizumab Versus Sorafenib in Participants With Unresectable HCCInterventionalPhase 3Active but recruitment closedItalyHepatocellular Carcinoma (HCC)Infos
NCT03412773Phase 3 Study of Tislelizumab Versus Sorafenib in Participants With Unresectable HCCInterventionalPhase 3Active but recruitment closedPolandHepatocellular Carcinoma (HCC)Infos
NCT03412773Phase 3 Study of Tislelizumab Versus Sorafenib in Participants With Unresectable HCCInterventionalPhase 3Active but recruitment closedSlovakiaHepatocellular Carcinoma (HCC)Infos
NCT03412773Phase 3 Study of Tislelizumab Versus Sorafenib in Participants With Unresectable HCCInterventionalPhase 3Active but recruitment closedSpainHepatocellular Carcinoma (HCC)Infos
NCT03412773Phase 3 Study of Tislelizumab Versus Sorafenib in Participants With Unresectable HCCInterventionalPhase 3Active but recruitment closedUnited KingdomHepatocellular Carcinoma (HCC)Infos
NCT03413254Second and Third Look Laparoscopy in pT4 Colon Cancer Patients for Early Detection of Peritoneal MetastasesInterventionalPhase 3Recruitment openNetherlandsColorectal CancerInfos
NCT03413254Second and Third Look Laparoscopy in pT4 Colon Cancer Patients for Early Detection of Peritoneal MetastasesInterventionalPhase 3Recruitment openNetherlandsPeritoneal MetastasesInfos
NCT03418558Study of Trastuzumab-emtansine in Patients With HER2-positive Metastatic Colorectal Cancer Progressing After Trastuzumab and Lapatinib.InterventionalPhase 2Unknown statusItalyMetastatic Colorectal CancerInfos
NCT03421288Study of Atezolizumab + FLOT vs. FLOT Alone in Patients With GC/GEJ and High Immune ResponsivenessInterventionalPhase 2Recruitment openGermanyGastric CancerInfos
NCT03421288Study of Atezolizumab + FLOT vs. FLOT Alone in Patients With GC/GEJ and High Immune ResponsivenessInterventionalPhase 2Recruitment openSwitzerlandGastric CancerInfos
NCT03422601Prognostic Value of the ImmunoscoreĀ® Colon Test for Disease Free Survival Stratification in Stage III Patients Under Oxaliplatin TreatmentObservationalN/AUnknown statusFranceColorectal CancerInfos
NCT03422601Prognostic Value of the ImmunoscoreĀ® Colon Test for Disease Free Survival Stratification in Stage III Patients Under Oxaliplatin TreatmentObservationalN/AUnknown statusFranceStage III Colon CancerInfos
NCT03428477EPA for Metastasis Trial 2InterventionalPhase 3Recruitment openUnited KingdomColon CancerInfos
NCT03428958A Safety, Pharmacokinetic and Efficacy Study of NUC-3373 in Combination With Standard Agents Used in Colorectal Cancer TreatmentInterventionalPhase 1/Phase 2Recruitment openFranceColorectal CancerInfos
NCT03428958A Safety, Pharmacokinetic and Efficacy Study of NUC-3373 in Combination With Standard Agents Used in Colorectal Cancer TreatmentInterventionalPhase 1/Phase 2Recruitment openFranceColorectal CarcinomaInfos
NCT03428958A Safety, Pharmacokinetic and Efficacy Study of NUC-3373 in Combination With Standard Agents Used in Colorectal Cancer TreatmentInterventionalPhase 1/Phase 2Recruitment openFranceColorectal NeoplasmsInfos
NCT03428958A Safety, Pharmacokinetic and Efficacy Study of NUC-3373 in Combination With Standard Agents Used in Colorectal Cancer TreatmentInterventionalPhase 1/Phase 2Recruitment openFranceColorectal TumorsInfos
NCT03428958A Safety, Pharmacokinetic and Efficacy Study of NUC-3373 in Combination With Standard Agents Used in Colorectal Cancer TreatmentInterventionalPhase 1/Phase 2Recruitment openFranceNeoplasms, ColorectalInfos
NCT03428958A Safety, Pharmacokinetic and Efficacy Study of NUC-3373 in Combination With Standard Agents Used in Colorectal Cancer TreatmentInterventionalPhase 1/Phase 2Recruitment openUnited KingdomColorectal CancerInfos
NCT03428958A Safety, Pharmacokinetic and Efficacy Study of NUC-3373 in Combination With Standard Agents Used in Colorectal Cancer TreatmentInterventionalPhase 1/Phase 2Recruitment openUnited KingdomColorectal CarcinomaInfos
NCT03428958A Safety, Pharmacokinetic and Efficacy Study of NUC-3373 in Combination With Standard Agents Used in Colorectal Cancer TreatmentInterventionalPhase 1/Phase 2Recruitment openUnited KingdomColorectal NeoplasmsInfos
NCT03428958A Safety, Pharmacokinetic and Efficacy Study of NUC-3373 in Combination With Standard Agents Used in Colorectal Cancer TreatmentInterventionalPhase 1/Phase 2Recruitment openUnited KingdomColorectal TumorsInfos
NCT03428958A Safety, Pharmacokinetic and Efficacy Study of NUC-3373 in Combination With Standard Agents Used in Colorectal Cancer TreatmentInterventionalPhase 1/Phase 2Recruitment openUnited KingdomNeoplasms, ColorectalInfos
NCT03430700Trial of Pembrolizumab Following Weekly Paclitaxel for Platinum-resistant Ovarian, Fallopian Tube or Peritoneal CancerInterventionalPhase 2Active but recruitment closedUnited KingdomFallopian Tube CancerInfos
NCT03430700Trial of Pembrolizumab Following Weekly Paclitaxel for Platinum-resistant Ovarian, Fallopian Tube or Peritoneal CancerInterventionalPhase 2Active but recruitment closedUnited KingdomOvarian CancerInfos
NCT03430700Trial of Pembrolizumab Following Weekly Paclitaxel for Platinum-resistant Ovarian, Fallopian Tube or Peritoneal CancerInterventionalPhase 2Active but recruitment closedUnited KingdomPeritoneal CancerInfos
NCT03434925Multi Parametric Test Predicting the Risk of Colorectal Neoplasia RecurrenceInterventionalNot ApplicableUnknown statusCzechiaColon CancerInfos
NCT03443856Postoperative Immunotherapy vs Standard Chemotherapy for Gastric Cancer With High Risk for RecurrenceInterventionalPhase 2Active but recruitment closedCzechiaGastric and Esophagogastric Junction AdenocarcinomaInfos
NCT03443856Postoperative Immunotherapy vs Standard Chemotherapy for Gastric Cancer With High Risk for RecurrenceInterventionalPhase 2Active but recruitment closedFranceGastric and Esophagogastric Junction AdenocarcinomaInfos
NCT03443856Postoperative Immunotherapy vs Standard Chemotherapy for Gastric Cancer With High Risk for RecurrenceInterventionalPhase 2Active but recruitment closedGermanyGastric and Esophagogastric Junction AdenocarcinomaInfos
NCT03443856Postoperative Immunotherapy vs Standard Chemotherapy for Gastric Cancer With High Risk for RecurrenceInterventionalPhase 2Active but recruitment closedIsraelGastric and Esophagogastric Junction AdenocarcinomaInfos
NCT03443856Postoperative Immunotherapy vs Standard Chemotherapy for Gastric Cancer With High Risk for RecurrenceInterventionalPhase 2Active but recruitment closedItalyGastric and Esophagogastric Junction AdenocarcinomaInfos
NCT03443856Postoperative Immunotherapy vs Standard Chemotherapy for Gastric Cancer With High Risk for RecurrenceInterventionalPhase 2Active but recruitment closedNorwayGastric and Esophagogastric Junction AdenocarcinomaInfos
NCT03443856Postoperative Immunotherapy vs Standard Chemotherapy for Gastric Cancer With High Risk for RecurrenceInterventionalPhase 2Active but recruitment closedPolandGastric and Esophagogastric Junction AdenocarcinomaInfos
NCT03443856Postoperative Immunotherapy vs Standard Chemotherapy for Gastric Cancer With High Risk for RecurrenceInterventionalPhase 2Active but recruitment closedPortugalGastric and Esophagogastric Junction AdenocarcinomaInfos
NCT03443856Postoperative Immunotherapy vs Standard Chemotherapy for Gastric Cancer With High Risk for RecurrenceInterventionalPhase 2Active but recruitment closedSpainGastric and Esophagogastric Junction AdenocarcinomaInfos
NCT03443856Postoperative Immunotherapy vs Standard Chemotherapy for Gastric Cancer With High Risk for RecurrenceInterventionalPhase 2Active but recruitment closedUnited KingdomGastric and Esophagogastric Junction AdenocarcinomaInfos
NCT03444194Treatment Response Evaluation in Patients With Non-resectable Colorectal Liver Metastases A Feasibility StudyInterventionalNot ApplicableUnknown statusDenmarkLiver Metastasis Colon CancerInfos
NCT03445936PRELOOP Trial: Synthetic Versus Biological Mesh for Prevention of Incisional Hernia After Loop-ileostomy ClosureInterventionalNot ApplicableActive but recruitment closedFinlandRectum CancerInfos
NCT03447431Aberrant Splicings Due to Microsatellite Instability in Colorectal Cancer : Physiopathological and Clinical ImpactObservationalN/AUnknown statusFranceColorectal CancerInfos
NCT03447431Aberrant Splicings Due to Microsatellite Instability in Colorectal Cancer : Physiopathological and Clinical ImpactObservationalN/AUnknown statusFranceMicrosatellite InstabilityInfos
NCT03449264Development of Clinical and Biological DatabaseInterventionalNot ApplicableRecruitment openFranceDigestive CancerInfos
NCT03449914The GOLD Study: G8 in OLDer PatientsObservationalN/AActive but recruitment closedItalyElderly Metastatic Colorectal Cancer PatientsInfos
NCT03451370First-line Combination of Capecitabine and Oxaliplatin Plus Bevacizumab in Elderly Patients With Metastatic Colorectal CancerObservationalN/AActive but recruitment closedItalyElderly Metastatic Colorectal Cancer PatientsInfos
NCT03451643Stenting and Resection for Stage IV Colorectal Cancer Endoscopic Stenting and Colorectal Resection in Stage IVInterventionalNot ApplicableUnknown statusItalyColorectal NeoplasmInfos
NCT03452319Effects of Increased Physical Activity Before Thoracoabdominal Esophageal SurgeryInterventionalNot ApplicableRecruitment openSwedenOesophageal CancerInfos
NCT03458949Pilot Study in a Company in Maine-et-Loire to Evaluate the Feasibility, Acceptability, and Impact on the Participation Rate of Awareness of Colorectal Cancer Screening by Occupational Health TeamsInterventionalNot ApplicableUnknown statusFranceColorectal CancerInfos
NCT03460925Improving REsectability in Pancreatic NEoplasms (IRENE)InterventionalNot ApplicableUnknown statusItalyPancreatic CancerInfos
NCT03462992Peripheral Blood Monocytes as Predictive Marker for Colorectal Cancer Diagnosis: A Comparative Study of a Stool Based Versus Blood Based Screening TestObservationalN/AUnknown statusBelgiumColorectal CancerInfos
NCT03464305ASPIRIN Trial BelgiumInterventionalPhase 3Recruitment openBelgiumColon CancerInfos
NCT034683352nd-line Therapy With Nal-IRI After Gem/Nab-pac in Advanced Pancreatic Cancer - Predictive Role of 1st-line TherapyInterventionalPhase 3Active but recruitment closedGermanyLocally Advanced Pancreatic CancerInfos
NCT034683352nd-line Therapy With Nal-IRI After Gem/Nab-pac in Advanced Pancreatic Cancer - Predictive Role of 1st-line TherapyInterventionalPhase 3Active but recruitment closedGermanyMetastatic Pancreatic CancerInfos
NCT03469726Contrast-enhanced Diffusion-weighted MRI to Detect Liver Metastases in Patients With Pancreatic CancerInterventionalNot ApplicableUnknown statusGreecePancreatic NeoplasmsInfos
NCT03469726Contrast-enhanced Diffusion-weighted MRI to Detect Liver Metastases in Patients With Pancreatic CancerInterventionalNot ApplicableUnknown statusNetherlandsPancreatic NeoplasmsInfos
NCT03469726Contrast-enhanced Diffusion-weighted MRI to Detect Liver Metastases in Patients With Pancreatic CancerInterventionalNot ApplicableUnknown statusSpainPancreatic NeoplasmsInfos
NCT03469726Contrast-enhanced Diffusion-weighted MRI to Detect Liver Metastases in Patients With Pancreatic CancerInterventionalNot ApplicableUnknown statusSwitzerlandPancreatic NeoplasmsInfos
NCT03474341Preoperative Image-guided Identification of Response to Neoadjuvant Chemoradiotherapy in Esophageal CancerObservationalN/AUnknown statusNetherlandsEsophageal AdenocarcinomaInfos
NCT03474341Preoperative Image-guided Identification of Response to Neoadjuvant Chemoradiotherapy in Esophageal CancerObservationalN/AUnknown statusNetherlandsEsophageal CancerInfos
NCT03474341Preoperative Image-guided Identification of Response to Neoadjuvant Chemoradiotherapy in Esophageal CancerObservationalN/AUnknown statusNetherlandsEsophageal NeoplasmsInfos
NCT03474341Preoperative Image-guided Identification of Response to Neoadjuvant Chemoradiotherapy in Esophageal CancerObservationalN/AUnknown statusNetherlandsEsophageal Squamous Cell CarcinomaInfos
NCT03475953A Phase I/II Study of Regorafenib Plus Avelumab in Solid TumorsInterventionalPhase 1/Phase 2Recruitment openFranceColorectal Cancer Not MSI-H or MMR-deficientInfos
NCT03475953A Phase I/II Study of Regorafenib Plus Avelumab in Solid TumorsInterventionalPhase 1/Phase 2Recruitment openFranceHepatocellular CarcinomaInfos
NCT03482362Vinorelbine in Advanced BRAF-like Colon CancerInterventionalPhase 2Unknown statusNetherlandsColon CancerInfos
NCT03485209Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid TumorsInterventionalPhase 2Recruitment openFranceExocrine Pancreatic CancerInfos
NCT03485209Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid TumorsInterventionalPhase 2Recruitment openGermanyExocrine Pancreatic CancerInfos
NCT03485209Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid TumorsInterventionalPhase 2Recruitment openItalyExocrine Pancreatic CancerInfos
NCT03485209Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid TumorsInterventionalPhase 2Recruitment openSpainExocrine Pancreatic CancerInfos
NCT03485209Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid TumorsInterventionalPhase 2Recruitment openUnited KingdomExocrine Pancreatic CancerInfos
NCT03486730BT1718 in Patients With Advanced Solid Tumours.InterventionalPhase 1/Phase 2Active but recruitment closedUnited KingdomOesophageal CancerInfos
NCT03487016First-line Therapy in Metastatic PDACInterventionalPhase 2Active but recruitment closedGermanyMetastatic Pancreatic CancerInfos
NCT03488953Living Donor Liver Transplantation With Two Stage Hepatectomy for Patients With Isolated, Irresectable Colorectal Liver MetastasesInterventionalNot ApplicableRecruitment openGermanyColorectal Cancer MetastaticInfos
NCT03490565PREoperativ Study of Exercise TrainingInterventionalNot ApplicableActive but recruitment closedDenmarkGastroEsophageal CancerInfos
NCT03494946Liver Transplantation Compared to Chemotherapy in Patients With ColoRectal CancerInterventionalNot ApplicableRecruitment openNorwayColorectal CancerInfos
NCT03494946Liver Transplantation Compared to Chemotherapy in Patients With ColoRectal CancerInterventionalNot ApplicableRecruitment openNorwayLiver MetastasesInfos
NCT03500068Establishing Organoids From Metastatic Pancreatic Cancer Patients, the OPT-I Study.InterventionalNot ApplicableUnknown statusNetherlandsCarcinoma, Pancreatic DuctalInfos
NCT03505320A Study to Assess the Antitumor Activity, Safety, Pharmacokinetics and Biomarkers of Zolbetuximab (IMAB362) in Participants With Claudin (CLDN) 18.2 Positive, Metastatic or Advanced Unresectable Gastric and Gastroesophageal Junction (GEJ) AdenocarcinomaInterventionalPhase 2Recruitment openFranceGastric CancerInfos
NCT03505320A Study to Assess the Antitumor Activity, Safety, Pharmacokinetics and Biomarkers of Zolbetuximab (IMAB362) in Participants With Claudin (CLDN) 18.2 Positive, Metastatic or Advanced Unresectable Gastric and Gastroesophageal Junction (GEJ) AdenocarcinomaInterventionalPhase 2Recruitment openItalyGastric CancerInfos
NCT03507140Microbiota Study in Liver Transplanted PatientsObservationalN/AUnknown statusFranceHepatocellular CarcinomaInfos
NCT03510858Randomized Controlled Trial on Colorectal Cancer Screening Among Quality Circles of Primary Care PhysiciansInterventionalNot ApplicableUnknown statusSwitzerlandColorectal CancerInfos
NCT03517332Circulating Tumor DNA Exposure in Peripheral BloodObservationalN/AUnknown statusSwitzerlandColorectal CancerInfos
NCT03517332Circulating Tumor DNA Exposure in Peripheral BloodObservationalN/AUnknown statusSwitzerlandGastric CancerInfos
NCT03517332Circulating Tumor DNA Exposure in Peripheral BloodObservationalN/AUnknown statusSwitzerlandHepatocellular CarcinomaInfos
NCT03519178A Study of PF-06873600 in People With CancerInterventionalPhase 2Active but recruitment closedBulgariaHR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast CancerInfos
NCT03519178A Study of PF-06873600 in People With CancerInterventionalPhase 2Active but recruitment closedRussian FederationHR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast CancerInfos
NCT03519178A Study of PF-06873600 in People With CancerInterventionalPhase 2Active but recruitment closedUkraineHR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast CancerInfos
NCT03519295A Study of mDCF in Combination or Not With Atezolizumab in Advanced Squamous Cell Anal CarcinomaInterventionalPhase 2Unknown statusFranceAnal CancerInfos
NCT03519412Pembrolizumab in MMR-Proficient Metastatic Colorectal Cancer Pharmacologically Primed to Trigger Hypermutation StatusInterventionalPhase 2Recruitment openItalyColorectal NeoplasmsInfos
NCT03519412Pembrolizumab in MMR-Proficient Metastatic Colorectal Cancer Pharmacologically Primed to Trigger Hypermutation StatusInterventionalPhase 2Recruitment openItalyMicrosatellite InstabilityInfos
NCT03520946RAMucirumab in Combination Wth TAS102 vs. TAS102 Alone in Chemotherapy Refractory Metastatic Colorectal Cancer PatientsInterventionalPhase 3Active but recruitment closedGermanyColorectal CancerInfos
NCT03524677Mutation of K-RAS, CDKN2A, SMAD4 and TP53 in Pancreatic Cancer: Role of Liquid Biopsy in Preoperative DiagnosisObservationalN/AUnknown statusIrelandPancreatic CancerInfos
NCT03524677Mutation of K-RAS, CDKN2A, SMAD4 and TP53 in Pancreatic Cancer: Role of Liquid Biopsy in Preoperative DiagnosisObservationalN/AUnknown statusItalyPancreatic CancerInfos
NCT03526835A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid TumorsInterventionalPhase 1/Phase 2Recruitment openBelgiumColorectal CancerInfos
NCT03526835A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid TumorsInterventionalPhase 1/Phase 2Recruitment openBelgiumGastric CancerInfos
NCT03526835A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid TumorsInterventionalPhase 1/Phase 2Recruitment openFranceColorectal CancerInfos
NCT03526835A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid TumorsInterventionalPhase 1/Phase 2Recruitment openFranceGastric CancerInfos
NCT03526835A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid TumorsInterventionalPhase 1/Phase 2Recruitment openSpainColorectal CancerInfos
NCT03526835A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid TumorsInterventionalPhase 1/Phase 2Recruitment openSpainGastric CancerInfos
NCT03526835A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid TumorsInterventionalPhase 1/Phase 2Recruitment openUnited KingdomColorectal CancerInfos
NCT03526835A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid TumorsInterventionalPhase 1/Phase 2Recruitment openUnited KingdomGastric CancerInfos
NCT03528785A Study of Nal-IRI With 5-FU, Levofolinic Acid and Oxaliplatin in Patients With Resectable Pancreatic CancerInterventionalPhase 2Unknown statusItalyPancreatic AdenocarcinomaInfos
NCT03530267Aflibercept and 5-FU vs. FOLFOX as 1st Line Treatment for Elderly or Frail Elderly Patients With Met. Colorectal CancerInterventionalPhase 2Active but recruitment closedGermanyColorectal CancerInfos
NCT03536793Tumour Regulatory Molecules in Early Pancreatic Cancer DetectionObservationalN/ARecruitment openUnited KingdomCancer of PancreasInfos
NCT03536793Tumour Regulatory Molecules in Early Pancreatic Cancer DetectionObservationalN/ARecruitment openUnited KingdomPancreas CystInfos
NCT03543813PROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With Solid Tumors or DLBCLInterventionalPhase 1/Phase 2Active but recruitment closedSpainEsophageal CancerInfos
NCT03543813PROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With Solid Tumors or DLBCLInterventionalPhase 1/Phase 2Active but recruitment closedUnited KingdomEsophageal CancerInfos
NCT03544736Safety and Feasibility of Irradiation and Nivolumab in Esophageal Cancer (INEC)InterventionalPhase 1/Phase 2Active but recruitment closedNorwayEsophageal CancerInfos
NCT03551470Minimally Invasive Simultaneous Colorectal and Liver SurgeryObservationalN/AUnknown statusItalyColorectal CancerInfos
NCT03562234The CLiFF Study: Change in Liver Function and Fat in Pre-operative Chemotherapy for Colorectal Liver MetastasesObservationalN/AUnknown statusUnited KingdomColorectal CancerInfos
NCT03562234The CLiFF Study: Change in Liver Function and Fat in Pre-operative Chemotherapy for Colorectal Liver MetastasesObservationalN/AUnknown statusUnited KingdomLiver Metastasis Colon CancerInfos
NCT03563586Mechanical Bowel Preparation With or Without Oral Antibiotics for Colorectal Cancer SurgeryInterventionalNot ApplicableUnknown statusGreeceAntibioticInfos
NCT03563586Mechanical Bowel Preparation With or Without Oral Antibiotics for Colorectal Cancer SurgeryInterventionalNot ApplicableUnknown statusGreeceBowel CancerInfos
NCT03563586Mechanical Bowel Preparation With or Without Oral Antibiotics for Colorectal Cancer SurgeryInterventionalNot ApplicableUnknown statusGreeceColorectal CancerInfos
NCT03563586Mechanical Bowel Preparation With or Without Oral Antibiotics for Colorectal Cancer SurgeryInterventionalNot ApplicableUnknown statusGreeceSurgical Site InfectionInfos
NCT03564340Study of REGN4018 Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian CancerInterventionalPhase 1/Phase 2Recruitment openBelgiumRecurrent Primary Peritoneal CancerInfos
NCT03564340Study of REGN4018 Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian CancerInterventionalPhase 1/Phase 2Recruitment openFranceRecurrent Primary Peritoneal CancerInfos
NCT03564340Study of REGN4018 Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian CancerInterventionalPhase 1/Phase 2Recruitment openSpainRecurrent Primary Peritoneal CancerInfos
NCT03564340Study of REGN4018 Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian CancerInterventionalPhase 1/Phase 2Recruitment openUnited KingdomRecurrent Primary Peritoneal CancerInfos
NCT03568110Frailty and Postoperative Outcomes After Gastric Cancer SurgeryObservationalN/ARecruitment openSpainFrail Elderly SyndromeInfos
NCT03568110Frailty and Postoperative Outcomes After Gastric Cancer SurgeryObservationalN/ARecruitment openSpainGastric CancerInfos
NCT03568110Frailty and Postoperative Outcomes After Gastric Cancer SurgeryObservationalN/ARecruitment openSpainPostoperative ComplicationsInfos
NCT03568110Frailty and Postoperative Outcomes After Gastric Cancer SurgeryObservationalN/ARecruitment openSpainQuality of LifeInfos
NCT03570502Incidence of POPF in the Resection of the Left Pancreas With RFATObservationalN/AUnknown statusSpainPancreas CancerInfos
NCT03579004Neoadjuvant Chemotherapy Followed by Preoperative Chemoradiation in Resectable Squamous-cell Esophageal CancerInterventionalPhase 2Unknown statusRussian FederationConcurrent ChemoradiotherapyInfos
NCT03579004Neoadjuvant Chemotherapy Followed by Preoperative Chemoradiation in Resectable Squamous-cell Esophageal CancerInterventionalPhase 2Unknown statusRussian FederationEsophageal NeoplasmsInfos
NCT03579004Neoadjuvant Chemotherapy Followed by Preoperative Chemoradiation in Resectable Squamous-cell Esophageal CancerInterventionalPhase 2Unknown statusRussian FederationSquamous Cell CarcinomaInfos
NCT03584711FOLFOX + Panitumumab According to a "Stop and go" Strategy With a Reintroduction Loop After Progression on Fluoropyrimidine as Maintenance Treatment, as the First Line in Patients With Metastatic Colorectal Adenocarcinoma Without a RAS MutationInterventionalPhase 2Active but recruitment closedFranceMetastatic Colorectal CancerInfos
NCT03587532Assessment of Graft Perfusion and Oxygenation for Improved Outcome in Esophageal Cancer SurgeryInterventionalNot ApplicableRecruitment openBelgiumAnastomotic LeakInfos
NCT03587532Assessment of Graft Perfusion and Oxygenation for Improved Outcome in Esophageal Cancer SurgeryInterventionalNot ApplicableRecruitment openBelgiumEsophageal CancerInfos
NCT03588416Multicentric Study About Pathological Risk Factors for Lymph Node Metastasis in Malignant Colorectal PolypsObservationalN/AUnknown statusItalyColorectal CancerInfos
NCT03602677Indocyanine Green Fluorescence Imaging in Prevention of Colorectal Anastomotic LeakageInterventionalNot ApplicableRecruitment openFinlandColorectal CancerInfos
NCT03602677Indocyanine Green Fluorescence Imaging in Prevention of Colorectal Anastomotic LeakageInterventionalNot ApplicableRecruitment openFinlandGastrointestinal CancerInfos
NCT03606590Effect of Tumor Treating Fields (TTFields, 150kHz) Concomitant With Sorafenib For Advanced Hepatocellular Carcinoma (HCC) (HEPANOVA)InterventionalPhase 2Unknown statusCzechiaHepatocellular CarcinomaInfos
NCT03606590Effect of Tumor Treating Fields (TTFields, 150kHz) Concomitant With Sorafenib For Advanced Hepatocellular Carcinoma (HCC) (HEPANOVA)InterventionalPhase 2Unknown statusFranceHepatocellular CarcinomaInfos
NCT03606590Effect of Tumor Treating Fields (TTFields, 150kHz) Concomitant With Sorafenib For Advanced Hepatocellular Carcinoma (HCC) (HEPANOVA)InterventionalPhase 2Unknown statusGermanyHepatocellular CarcinomaInfos
NCT03606590Effect of Tumor Treating Fields (TTFields, 150kHz) Concomitant With Sorafenib For Advanced Hepatocellular Carcinoma (HCC) (HEPANOVA)InterventionalPhase 2Unknown statusItalyHepatocellular CarcinomaInfos
NCT03606590Effect of Tumor Treating Fields (TTFields, 150kHz) Concomitant With Sorafenib For Advanced Hepatocellular Carcinoma (HCC) (HEPANOVA)InterventionalPhase 2Unknown statusPolandHepatocellular CarcinomaInfos
NCT03606590Effect of Tumor Treating Fields (TTFields, 150kHz) Concomitant With Sorafenib For Advanced Hepatocellular Carcinoma (HCC) (HEPANOVA)InterventionalPhase 2Unknown statusSpainHepatocellular CarcinomaInfos
NCT03606863Peripheral Parenteral Nutrition vs Conventional Fluid in Colorectal Resection in ERASInterventionalPhase 3Unknown statusSpainColon CancerInfos
NCT03612674Adenoma Detection Rate With Endocuff-Assisted Colonoscopy - an Italian TrialInterventionalNot ApplicableUnknown statusItalyColorectal CancerInfos
NCT03613194Mechanistic and Molecular Study of the Process of Metastatic Dissemination in Colorectal CancerInterventionalNot ApplicableUnknown statusFranceColorectal CancerInfos
NCT03620643Crizotinib in Lobular Breast, Diffuse Gastric and Triple Negative Lobular Breast Cancer or CDH1-mutated Solid TumoursInterventionalPhase 2Recruitment openUnited KingdomGastric CancerInfos
NCT03620877A Program for Improved Family Screening for Colorectal CancerInterventionalNot ApplicableUnknown statusFranceColorectal CancerInfos
NCT03620916Comparison of Intrathecal and Intravenous Analgesia in Patients Undergoing Liver ResectionInterventionalNot ApplicableUnknown statusPolandLiver CancerInfos
NCT03621644Stereotactic MRI-guided On-table Adaptive Radiation Therapy (SMART) for Locally Advanced Pancreatic CancerInterventionalNot ApplicableActive but recruitment closedIsraelPancreatic CancerInfos
NCT03621852Prospective Evaluation of the Diagnostic Efficacy of a EUS Guided FNB Needle (AQUIREĀ®)ObservationalN/AUnknown statusGermanySubmucosal Tumor of Gastrointestinal Tract (Disorder)Infos
NCT03627728Study Maintenance Regorafenib vs Placebo, no Progression Patients After I Line Chemotherapy Metastatic Gastric CancerInterventionalPhase 2Recruitment openItalyGastric CancerInfos
NCT03630640Neoadjuvant and Adjuvant Nivolumab in HCC Patients Treated by ElectroporationInterventionalPhase 2Active but recruitment closedFranceHepatocellular CarcinomaInfos
NCT03631173Monitoring of patIents With Microdialysis Following PancreaticoduodenectomyInterventionalNot ApplicableActive but recruitment closedNorwayPancreatic CancerInfos
NCT03635021Study to Evaluate the Efficacy of FOLFOX + Panitumumab Followed by FOLFIRI + Bevacizumab (Sequence 1) Versus FOLFOX + Bevacizumab Followed by FOLFIRI + Panitumumab (Sequence 2) in Untreated Patients With Wild-type RAS Metastatic, Primary Left-sided, Unresectable Colorectal CancerInterventionalPhase 3Active but recruitment closedSpainColorectal CancerInfos
NCT03637686Circulating Tumor DNA Analysis to Optimize Treatment for Patients With Colorectal CancerObservationalN/AActive but recruitment closedDenmarkColorectal CancerInfos
NCT03645980DKN-01 Inhibition in Advanced Liver CancerInterventionalPhase 1/Phase 2Unknown statusGermanyHepatocellular CarcinomaInfos
NCT03647969Modified FOLFOX Plus/Minus Nivolumab and Ipilimumab vs. FLOT Plus Nivolumab in Patients With Previously Untreated Advanced or Metastatic Gastric CancerInterventionalPhase 2Active but recruitment closedGermanyAdenocarcinoma of the StomachInfos
NCT03647969Modified FOLFOX Plus/Minus Nivolumab and Ipilimumab vs. FLOT Plus Nivolumab in Patients With Previously Untreated Advanced or Metastatic Gastric CancerInterventionalPhase 2Active but recruitment closedGermanyGastroEsophageal CancerInfos
NCT03648489Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma)InterventionalPhase 2Active but recruitment closedGermanyFallopian Tube CancerInfos
NCT03648489Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma)InterventionalPhase 2Active but recruitment closedGermanyFallopian Tube NeoplasmsInfos
NCT03648489Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma)InterventionalPhase 2Active but recruitment closedGermanyOvarian CancerInfos
NCT03648489Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma)InterventionalPhase 2Active but recruitment closedGermanyOvarian CarcinosarcomaInfos
NCT03648489Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma)InterventionalPhase 2Active but recruitment closedGermanyOvarian Clear Cell AdenocarcinomaInfos
NCT03648489Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma)InterventionalPhase 2Active but recruitment closedGermanyOvarian Endometrioid AdenocarcinomaInfos
NCT03648489Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma)InterventionalPhase 2Active but recruitment closedGermanyOvarian NeoplasmsInfos
NCT03648489Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma)InterventionalPhase 2Active but recruitment closedGermanyOvarian Serous AdenocarcinomaInfos
NCT03648489Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma)InterventionalPhase 2Active but recruitment closedGermanyPrimary Peritoneal CarcinomaInfos
NCT03648489Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma)InterventionalPhase 2Active but recruitment closedGermanyPrimary Peritoneal Serous AdenocarcinomaInfos
NCT03648489Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma)InterventionalPhase 2Active but recruitment closedUnited KingdomFallopian Tube CancerInfos
NCT03648489Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma)InterventionalPhase 2Active but recruitment closedUnited KingdomFallopian Tube NeoplasmsInfos
NCT03648489Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma)InterventionalPhase 2Active but recruitment closedUnited KingdomOvarian CancerInfos
NCT03648489Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma)InterventionalPhase 2Active but recruitment closedUnited KingdomOvarian CarcinosarcomaInfos
NCT03648489Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma)InterventionalPhase 2Active but recruitment closedUnited KingdomOvarian Clear Cell AdenocarcinomaInfos
NCT03648489Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma)InterventionalPhase 2Active but recruitment closedUnited KingdomOvarian Endometrioid AdenocarcinomaInfos
NCT03648489Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma)InterventionalPhase 2Active but recruitment closedUnited KingdomOvarian NeoplasmsInfos
NCT03648489Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma)InterventionalPhase 2Active but recruitment closedUnited KingdomOvarian Serous AdenocarcinomaInfos
NCT03648489Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma)InterventionalPhase 2Active but recruitment closedUnited KingdomPrimary Peritoneal CarcinomaInfos
NCT03648489Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma)InterventionalPhase 2Active but recruitment closedUnited KingdomPrimary Peritoneal Serous AdenocarcinomaInfos
NCT03650517Minimally Invasive Right Colectomy Anastomosis StudyObservationalN/AUnknown statusCroatiaColorectal CancerInfos
NCT03650517Minimally Invasive Right Colectomy Anastomosis StudyObservationalN/AUnknown statusDenmarkColorectal CancerInfos
NCT03650517Minimally Invasive Right Colectomy Anastomosis StudyObservationalN/AUnknown statusFinlandColorectal CancerInfos
NCT03650517Minimally Invasive Right Colectomy Anastomosis StudyObservationalN/AUnknown statusFranceColorectal CancerInfos
NCT03650517Minimally Invasive Right Colectomy Anastomosis StudyObservationalN/AUnknown statusGermanyColorectal CancerInfos
NCT03650517Minimally Invasive Right Colectomy Anastomosis StudyObservationalN/AUnknown statusGreeceColorectal CancerInfos
NCT03650517Minimally Invasive Right Colectomy Anastomosis StudyObservationalN/AUnknown statusItalyColorectal CancerInfos
NCT03650517Minimally Invasive Right Colectomy Anastomosis StudyObservationalN/AUnknown statusPortugalColorectal CancerInfos
NCT03650517Minimally Invasive Right Colectomy Anastomosis StudyObservationalN/AUnknown statusSpainColorectal CancerInfos
NCT03650517Minimally Invasive Right Colectomy Anastomosis StudyObservationalN/AUnknown statusUnited KingdomColorectal CancerInfos
NCT03653052Do Changes in ctDNA Predict Response for Patients With Oesophageal Cancer Receiving DurvalumabInterventionalPhase 2Active but recruitment closedUnited KingdomOesophageal CancerInfos
NCT03654131Stereotactic Body Radiation Therapy vs. Microwave Ablation for Colorectal Cancer Patients With Metastatic Disease in the LiverInterventionalPhase 2Recruitment openDenmarkColorectal CarcinomaInfos
NCT03654131Stereotactic Body Radiation Therapy vs. Microwave Ablation for Colorectal Cancer Patients With Metastatic Disease in the LiverInterventionalPhase 2Recruitment openDenmarkLiver MetastasesInfos
NCT03658837Gastrointestinal Functional Outcome Ivor LewisObservationalN/AUnknown statusUnited KingdomOesophageal CancerInfos
NCT03659448Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal CancerInterventionalPhase 3Recruitment openGermanyColorectal NeoplasmsInfos
NCT03659448Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal CancerInterventionalPhase 3Recruitment openItalyColorectal NeoplasmsInfos
NCT03659448Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal CancerInterventionalPhase 3Recruitment openNetherlandsColorectal NeoplasmsInfos
NCT03662659An Investigational Study of Immunotherapy Combinations With Chemotherapy in Patients With Gastric or Gastroesophageal Junction (GEJ) CancersInterventionalPhase 2Active but recruitment closedAustriaGastric CancerInfos
NCT03662659An Investigational Study of Immunotherapy Combinations With Chemotherapy in Patients With Gastric or Gastroesophageal Junction (GEJ) CancersInterventionalPhase 2Active but recruitment closedBelgiumGastric CancerInfos
NCT03662659An Investigational Study of Immunotherapy Combinations With Chemotherapy in Patients With Gastric or Gastroesophageal Junction (GEJ) CancersInterventionalPhase 2Active but recruitment closedCzechiaGastric CancerInfos
NCT03662659An Investigational Study of Immunotherapy Combinations With Chemotherapy in Patients With Gastric or Gastroesophageal Junction (GEJ) CancersInterventionalPhase 2Active but recruitment closedFranceGastric CancerInfos
NCT03662659An Investigational Study of Immunotherapy Combinations With Chemotherapy in Patients With Gastric or Gastroesophageal Junction (GEJ) CancersInterventionalPhase 2Active but recruitment closedGermanyGastric CancerInfos
NCT03662659An Investigational Study of Immunotherapy Combinations With Chemotherapy in Patients With Gastric or Gastroesophageal Junction (GEJ) CancersInterventionalPhase 2Active but recruitment closedItalyGastric CancerInfos
NCT03662659An Investigational Study of Immunotherapy Combinations With Chemotherapy in Patients With Gastric or Gastroesophageal Junction (GEJ) CancersInterventionalPhase 2Active but recruitment closedNorwayGastric CancerInfos
NCT03662659An Investigational Study of Immunotherapy Combinations With Chemotherapy in Patients With Gastric or Gastroesophageal Junction (GEJ) CancersInterventionalPhase 2Active but recruitment closedPolandGastric CancerInfos
NCT03662659An Investigational Study of Immunotherapy Combinations With Chemotherapy in Patients With Gastric or Gastroesophageal Junction (GEJ) CancersInterventionalPhase 2Active but recruitment closedSpainGastric CancerInfos
NCT03662659An Investigational Study of Immunotherapy Combinations With Chemotherapy in Patients With Gastric or Gastroesophageal Junction (GEJ) CancersInterventionalPhase 2Active but recruitment closedUnited KingdomGastric CancerInfos
NCT03667612Endogenous Mechanisms of Inactivation of the Endothelium TumorObservationalN/AUnknown statusFranceColon CancerInfos
NCT03668418Xenotransplantation of Primary Cancer Samples in Zebrafish EmbryosObservationalN/AUnknown statusItalyEsophageal CancerInfos
NCT03668418Xenotransplantation of Primary Cancer Samples in Zebrafish EmbryosObservationalN/AUnknown statusItalyGastric CancerInfos
NCT03668418Xenotransplantation of Primary Cancer Samples in Zebrafish EmbryosObservationalN/AUnknown statusItalyLiver CancerInfos
NCT03668418Xenotransplantation of Primary Cancer Samples in Zebrafish EmbryosObservationalN/AUnknown statusItalyPancreatic CancerInfos
NCT03670199Improving the Quality of Life of Cancer Patients Through a Perioperative and Coordinated Nutrition and Physical Care Program.InterventionalNot ApplicableRecruitment openFranceDigestive CancerInfos
NCT03673423Evaluation of the Interobserver Agreement on the Resectability Status of Patients With a Pancreatic CancerObservationalN/AUnknown statusItalyPancreatic AdenocarcinomaInfos
NCT03673501A Study of DCC-2618 vs Sunitinib in Advanced GIST Patients After Treatment With ImatinibInterventionalPhase 3Unknown statusBelgiumGastrointestinal Stromal TumorsInfos
NCT03673501A Study of DCC-2618 vs Sunitinib in Advanced GIST Patients After Treatment With ImatinibInterventionalPhase 3Unknown statusCzechiaGastrointestinal Stromal TumorsInfos
NCT03673501A Study of DCC-2618 vs Sunitinib in Advanced GIST Patients After Treatment With ImatinibInterventionalPhase 3Unknown statusFranceGastrointestinal Stromal TumorsInfos
NCT03673501A Study of DCC-2618 vs Sunitinib in Advanced GIST Patients After Treatment With ImatinibInterventionalPhase 3Unknown statusGermanyGastrointestinal Stromal TumorsInfos
NCT03673501A Study of DCC-2618 vs Sunitinib in Advanced GIST Patients After Treatment With ImatinibInterventionalPhase 3Unknown statusHungaryGastrointestinal Stromal TumorsInfos
NCT03673501A Study of DCC-2618 vs Sunitinib in Advanced GIST Patients After Treatment With ImatinibInterventionalPhase 3Unknown statusIsraelGastrointestinal Stromal TumorsInfos
NCT03673501A Study of DCC-2618 vs Sunitinib in Advanced GIST Patients After Treatment With ImatinibInterventionalPhase 3Unknown statusItalyGastrointestinal Stromal TumorsInfos
NCT03673501A Study of DCC-2618 vs Sunitinib in Advanced GIST Patients After Treatment With ImatinibInterventionalPhase 3Unknown statusNetherlandsGastrointestinal Stromal TumorsInfos
NCT03673501A Study of DCC-2618 vs Sunitinib in Advanced GIST Patients After Treatment With ImatinibInterventionalPhase 3Unknown statusNorwayGastrointestinal Stromal TumorsInfos
NCT03673501A Study of DCC-2618 vs Sunitinib in Advanced GIST Patients After Treatment With ImatinibInterventionalPhase 3Unknown statusPolandGastrointestinal Stromal TumorsInfos
NCT03673501A Study of DCC-2618 vs Sunitinib in Advanced GIST Patients After Treatment With ImatinibInterventionalPhase 3Unknown statusSpainGastrointestinal Stromal TumorsInfos
NCT03673501A Study of DCC-2618 vs Sunitinib in Advanced GIST Patients After Treatment With ImatinibInterventionalPhase 3Unknown statusSwedenGastrointestinal Stromal TumorsInfos
NCT03673501A Study of DCC-2618 vs Sunitinib in Advanced GIST Patients After Treatment With ImatinibInterventionalPhase 3Unknown statusSwitzerlandGastrointestinal Stromal TumorsInfos
NCT03673501A Study of DCC-2618 vs Sunitinib in Advanced GIST Patients After Treatment With ImatinibInterventionalPhase 3Unknown statusUnited KingdomGastrointestinal Stromal TumorsInfos
NCT03674801Status of Superficial Esophageal Cancers Treated by Endoscopy "OESOFARE"ObservationalN/AActive but recruitment closedFranceSuperficial Esophageal CancersInfos
NCT03676478Assessing Timing of Enteral Feeding Support in Esophageal Cancer Patients on Muscle functTion and SurvivalInterventionalNot ApplicableUnknown statusBelgiumEsophageal CancerInfos
NCT03676478Assessing Timing of Enteral Feeding Support in Esophageal Cancer Patients on Muscle functTion and SurvivalInterventionalNot ApplicableUnknown statusBelgiumJejunostomy; ComplicationsInfos
NCT03676478Assessing Timing of Enteral Feeding Support in Esophageal Cancer Patients on Muscle functTion and SurvivalInterventionalNot ApplicableUnknown statusBelgiumMuscle WeaknessInfos
NCT03676478Assessing Timing of Enteral Feeding Support in Esophageal Cancer Patients on Muscle functTion and SurvivalInterventionalNot ApplicableUnknown statusBelgiumNutrition Aspect of CancerInfos
NCT03676478Assessing Timing of Enteral Feeding Support in Esophageal Cancer Patients on Muscle functTion and SurvivalInterventionalNot ApplicableUnknown statusBelgiumPostoperative ComplicationsInfos
NCT03676478Assessing Timing of Enteral Feeding Support in Esophageal Cancer Patients on Muscle functTion and SurvivalInterventionalNot ApplicableUnknown statusBelgiumSarcopeniaInfos
NCT036788839-ING-41 in Patients With Advanced CancersInterventionalPhase 2Recruitment openFrancePancreas CancerInfos
NCT036788839-ING-41 in Patients With Advanced CancersInterventionalPhase 2Recruitment openFrancePancreatic CancerInfos
NCT036788839-ING-41 in Patients With Advanced CancersInterventionalPhase 2Recruitment openNetherlandsPancreas CancerInfos
NCT036788839-ING-41 in Patients With Advanced CancersInterventionalPhase 2Recruitment openNetherlandsPancreatic CancerInfos
NCT036788839-ING-41 in Patients With Advanced CancersInterventionalPhase 2Recruitment openSpainPancreas CancerInfos
NCT036788839-ING-41 in Patients With Advanced CancersInterventionalPhase 2Recruitment openSpainPancreatic CancerInfos
NCT03679169Evaluation of Complete microscopicE Resection Margin (R0) and Lymph Node Involvement After Standard Pancreatosplenectomy (SPS) Versus Radical Anterograde Modular PancreatosplenectomyInterventionalNot ApplicableRecruitment openFrancePancreatic CancerInfos
NCT03682276Safety and Bioactivity of Ipilimumab and Nivolumab Combination Prior to Liver Resection in Hepatocellular CarcinomaInterventionalPhase 1/Phase 2Recruitment openUnited KingdomHepatocellular CarcinomaInfos
NCT03685370PERiX: Comparison of Efficacy Between Placement of Epidural Catheters X-ray Guided and LOS TechniqueInterventionalNot ApplicableUnknown statusItalyPancreatic CancerInfos
NCT03690323Pancreatic Locally Advanced Irresectable Cancer AblationInterventionalNot ApplicableUnknown statusNetherlandsLocally Advanced Pancreatic CancerInfos
NCT03692429alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cellsInterventionalPhase 1Recruitment openBelgiumUnresectable Metastatic Colorectal CancerInfos
NCT03692429alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cellsInterventionalPhase 1Recruitment openUnited KingdomUnresectable Metastatic Colorectal CancerInfos
NCT03693170Encorafenib, Binimetinib and Cetuximab in Subjects With Previously Untreated BRAF-mutant ColoRectal CancerInterventionalPhase 2Active but recruitment closedAustriaBRAF V600E-mutant Metastatic Colorectal CancerInfos
NCT03693170Encorafenib, Binimetinib and Cetuximab in Subjects With Previously Untreated BRAF-mutant ColoRectal CancerInterventionalPhase 2Active but recruitment closedBelgiumBRAF V600E-mutant Metastatic Colorectal CancerInfos
NCT03693170Encorafenib, Binimetinib and Cetuximab in Subjects With Previously Untreated BRAF-mutant ColoRectal CancerInterventionalPhase 2Active but recruitment closedFranceBRAF V600E-mutant Metastatic Colorectal CancerInfos
NCT03693170Encorafenib, Binimetinib and Cetuximab in Subjects With Previously Untreated BRAF-mutant ColoRectal CancerInterventionalPhase 2Active but recruitment closedGermanyBRAF V600E-mutant Metastatic Colorectal CancerInfos
NCT03693170Encorafenib, Binimetinib and Cetuximab in Subjects With Previously Untreated BRAF-mutant ColoRectal CancerInterventionalPhase 2Active but recruitment closedItalyBRAF V600E-mutant Metastatic Colorectal CancerInfos
NCT03693170Encorafenib, Binimetinib and Cetuximab in Subjects With Previously Untreated BRAF-mutant ColoRectal CancerInterventionalPhase 2Active but recruitment closedNetherlandsBRAF V600E-mutant Metastatic Colorectal CancerInfos
NCT03693170Encorafenib, Binimetinib and Cetuximab in Subjects With Previously Untreated BRAF-mutant ColoRectal CancerInterventionalPhase 2Active but recruitment closedSpainBRAF V600E-mutant Metastatic Colorectal CancerInfos
NCT03693170Encorafenib, Binimetinib and Cetuximab in Subjects With Previously Untreated BRAF-mutant ColoRectal CancerInterventionalPhase 2Active but recruitment closedUnited KingdomBRAF V600E-mutant Metastatic Colorectal CancerInfos
NCT03693677First Line Metastatic Pancreatic Cancer : 5FU/LV+Nal-IRI, Gemcitabine+Nab-paclitaxel or a Sequential Regimen of 2 Months 5FU/LV+Nal-IRIInterventionalPhase 2Recruitment openFranceMetastatic Pancreatic CancerInfos
NCT03694080Calcium Electroporation for Early Colorectal CancerInterventionalPhase 1Unknown statusDenmarkColorectal CancerInfos
NCT03694938Detection of Brain Metastasis by MRI in Metastatic Colorectal Cancer PatientsInterventionalNot ApplicableRecruitment openFranceMetastatic Colon CancerInfos
NCT03697044Irinotecan Drug-eluting Bead Liver Embolisation RegistryObservationalN/ANot yet recruitingUnited KingdomColorectal Cancer MetastaticInfos
NCT03699163The Colorectal Breath Analysis (COBRA) StudyObservationalN/AActive but recruitment closedUnited KingdomColorectal CancerInfos
NCT03699332Multi-modality Imaging in Peritoneal Carcinomatosis of Colorectal OriginInterventionalPhase 1/Phase 2Unknown statusNetherlandsColorectal CancerInfos
NCT03699332Multi-modality Imaging in Peritoneal Carcinomatosis of Colorectal OriginInterventionalPhase 1/Phase 2Unknown statusNetherlandsGastrointestinal CancerInfos
NCT03700411Influence of Opioid Analgesia on Circulating Tumor Cells in Open Colorectal Cancer SurgeryInterventionalPhase 4Recruitment openCzechiaCirculating Tumor CellInfos
NCT03700411Influence of Opioid Analgesia on Circulating Tumor Cells in Open Colorectal Cancer SurgeryInterventionalPhase 4Recruitment openCzechiaColorectal CancerInfos
NCT03700541Influence of Opioid Analgesia on Circulating Tumor Cells in Laparoscopic Colorectal Cancer SurgeryInterventionalPhase 4Recruitment openCzechiaCirculating Tumor CellInfos
NCT03700541Influence of Opioid Analgesia on Circulating Tumor Cells in Laparoscopic Colorectal Cancer SurgeryInterventionalPhase 4Recruitment openCzechiaColorectal CancerInfos
NCT03705442Probiotics as Adjuvant Therapy in the Treatment of Metastatic Colorectal CancerInterventionalPhase 2Unknown statusCroatiaColorectal Cancer MetastaticInfos</